{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/ic901671j.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": "error", "content": "<p>By exploring the Anderson type rearrangement reactions, osmium(IV) complexes of the general formula [cation]<sup>+</sup>[Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup>, where [cation]<sup>+</sup> = <italic toggle=\"yes\">n</italic>-Bu<sub>4</sub>N<sup>+</sup>, Hazole = 1<italic toggle=\"yes\">H</italic>-pyrazole (Hpz) (<bold>1</bold>), 1<italic toggle=\"yes\">H</italic>-indazole (Hind) (<bold>2</bold>), 1<italic toggle=\"yes\">H</italic>-imidazole (Him) (<bold>3</bold>), 1<italic toggle=\"yes\">H</italic>-benzimidazole (Hbzim) (<bold>4</bold>), 1<italic toggle=\"yes\">H</italic>,2,4-triazole (Htrz) (<bold>5</bold>), have been synthesized. To improve water solubility of tetrabutylammonium compounds, complexes with [cation]<sup>+</sup> = Na<sup>+</sup> [Hazole = Hpz <bold>6</bold>), Hind (<bold>7</bold>), Htrz (<bold>8</bold>)] or H<sub>2</sub>azole<sup>+</sup> [Hazole = Hpz (<bold>9</bold>), Hind (<bold>10</bold>), Htrz (<bold>11</bold>)] have been also prepared with the aim of testing them for cytotoxicity in cancer cells. In addition, the preparation of the complex {(<italic toggle=\"yes\">n</italic>-Bu<sub>4</sub>N)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>]}<sub>2</sub>[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] (<bold>12</bold>) is also reported. The compounds have been comprehensively characterized by elemental analysis, electrospray ionization (ESI) mass spectrometry, spectroscopy (IR, UV\u2212vis, 1D and 2D NMR), cyclic voltammetry, X-ray crystallography (<bold>1</bold>\u2212<bold>6</bold> and <bold>12</bold>) and magnetic susceptibility (<bold>5</bold>). Complexes <bold>6</bold>, <bold>7</bold>, <bold>9</bold> are kinetically inert in aqueous solution and resistant to hydrolysis. Compounds <bold>6\u221211</bold> were found to possess modest antiproliferative acitivity in vitro against CH1 (ovarian carcinoma), A549 (non\u2212small cell lung carcinoma), and SW480 (colon adenocarcinoma) cells with IC<sub>50</sub> values in the 10<sup>\u22124</sup> M concentration range. Replacement of azolium cations by sodium had significant effects; cytotoxicity increased in the case of the pyrazole system from 3 (A549) to the 5.5\u2212fold (CH1).</p>", "clean_text": "By exploring the Anderson type rearrangement reactions, osmium(IV) complexes of the general formula [cation]+[OsIVCl5(Hazole)]-, where [cation]+ = n-Bu4N+, Hazole = 1H-pyrazole (Hpz) (1), 1H-indazole (Hind) (2), 1H-imidazole (Him) (3), 1H-benzimidazole (Hbzim) (4), 1H,2,4-triazole (Htrz) (5), have been synthesized. To improve water solubility of tetrabutylammonium compounds, complexes with [cation]+ = Na+ [Hazole = Hpz 6), Hind (7), Htrz (8)] or H2azole+ [Hazole = Hpz (9), Hind (10), Htrz (11)] have been also prepared with the aim of testing them for cytotoxicity in cancer cells. In addition, the preparation of the complex {(n-Bu4N)2[OsIVCl6]}2[OsIVCl4(Him)2] (12) is also reported. The compounds have been comprehensively characterized by elemental analysis, electrospray ionization (ESI) mass spectrometry, spectroscopy (IR, UV-vis, 1D and 2D NMR), cyclic voltammetry, X-ray crystallography (1-6 and 12) and magnetic susceptibility (5). Complexes 6, 7, 9 are kinetically inert in aqueous solution and resistant to hydrolysis. Compounds 6-11 were found to possess modest antiproliferative acitivity in vitro against CH1 (ovarian carcinoma), A549 (non-small cell lung carcinoma), and SW480 (colon adenocarcinoma) cells with IC50 values in the 10-4 M concentration range. Replacement of azolium cations by sodium had significant effects; cytotoxicity increased in the case of the pyrazole system from 3 (A549) to the 5.5-fold (CH1).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>On exploring the Anderson rearrangement reactions [Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup> complexes have been prepared and structurally and spectroscopically characterized. In addition, their antiproliferative activity in human cancer cell lines is reported.</p>", "clean_text": "On exploring the Anderson rearrangement reactions [OsIVCl5(Hazole)]- complexes have been prepared and structurally and spectroscopically characterized. In addition, their antiproliferative activity in human cancer cell lines is reported.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>The past several years have seen conscious efforts directed at the synthesis and screening of osmium coordination compounds and organometallic species as potential antitumor drugs, as well as studies of their reactivity with DNA model compounds.\n</p>", "clean_text": "Introduction\n\nThe past several years have seen conscious efforts directed at the synthesis and screening of osmium coordination compounds and organometallic species as potential antitumor drugs, as well as studies of their reactivity with DNA model compounds. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": "error", "content": "<p>The spectrum of the antiproliferative activity of osmium-based compounds reported so far is broadly varying from non-cytotoxic with IC<sub>50</sub> values exceeding 1600 \u03bcM (e.g., [Os(\u03b7<sup>6</sup>-<italic toggle=\"yes\">p</italic>-cymene)(pta)Cl<sub>2</sub>], where pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (in the human T47D breast carcinoma cell line), to fairly cytotoxic with IC<sub>50</sub> values in the low micromolar concentration range from 1 to 10 \u03bcM, comparable to that of carboplatin, as in the case of [Os(\u03b7<sup>6</sup>-biphenyl)(dppz)Cl]PF<sub>6</sub>, where dppz = [3,2-a: 2\u2032,3\u2032-<italic toggle=\"yes\">c</italic>]phenazine (in the human A2780 ovarian  carcinoma cell line), [Os(\u03b7<sup>6</sup>-biphenyl)(pico)Cl], where pico = picolinate (in the human A549 non-small cell lung cancer and A2780), [Os(\u03b7<sup>6</sup>-p-cymene)(oxine)(Hazole)]Cl, where oxine = deprotonated 8-hydroxyquinoline, and Hazole = azole heterocycle, i.e., pyrazole, imidazole (in the human CH1 ovarian carcinoma and SW480 colon carcinoma cell lines), [Os(\u03b7<sup>6</sup>-p-cymene)(paullone)Cl]Cl, (in CH1, SW480 and A549), <italic toggle=\"yes\">trans</italic>-[Os<sup>III</sup>Cl<sub>2</sub>(Hazole)<sub>4</sub>]Cl, where Hazole = pyrazole, benzimidazole (in A549, CH1 and SW480 cells).</p>", "clean_text": "The spectrum of the antiproliferative activity of osmium-based compounds reported so far is broadly varying from non-cytotoxic with IC50 values exceeding 1600 \u03bcM (e.g., [Os(\u03b76-p-cymene)(pta)Cl2], where pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (in the human T47D breast carcinoma cell line), to fairly cytotoxic with IC50 values in the low micromolar concentration range from 1 to 10 \u03bcM, comparable to that of carboplatin, as in the case of [Os(\u03b76-biphenyl)(dppz)Cl]PF6, where dppz = [3,2-a: 2',3'-c]phenazine (in the human A2780 ovarian  carcinoma cell line), [Os(\u03b76-biphenyl)(pico)Cl], where pico = picolinate (in the human A549 non-small cell lung cancer and A2780), [Os(\u03b76-p-cymene)(oxine)(Hazole)]Cl, where oxine = deprotonated 8-hydroxyquinoline, and Hazole = azole heterocycle, i.e., pyrazole, imidazole (in the human CH1 ovarian carcinoma and SW480 colon carcinoma cell lines), [Os(\u03b76-p-cymene)(paullone)Cl]Cl, (in CH1, SW480 and A549), trans-[OsIIICl2(Hazole)4]Cl, where Hazole = pyrazole, benzimidazole (in A549, CH1 and SW480 cells).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 5, "type": "text", "classification": "error", "content": "<p>Comparison of antiproliferative activity of closely related ruthenium and osmium compounds shows that these can be very similar, as is the case for [Ru(\u03b7<sup>6</sup>-biphenyl)(en)Cl]BPh<sub>4</sub> and [Os(\u03b7<sup>6</sup>-biphenyl)(en)Cl]BF<sub>4</sub>, similar against certain human cancer cell lines, while different in respect to other cells, or quite contrasting, as is the case for compounds closely related to (H<sub>2</sub>im)[Ru<sup>III</sup>Cl<sub>4</sub>(DMSO)(Him)] (NAMI-A), an antimetastatic drug candidate which just entered phase II clinical trials. The IC<sub>50</sub> value for (H<sub>2</sub>ind)[Os<sup>III</sup>Cl<sub>4</sub>(DMSO)(Hind)] in the human cancer cell line HT29 (colon carcinoma) is 21 \u00b1 1 \u03bcM. This is 1 order of magnitude lower than the respective value for its ruthenium congener (212 \u00b1 22 \u03bcM). Reversed activity profiles were documented for <italic toggle=\"yes\">trans</italic>-[Os<sup>III</sup>Cl<sub>2</sub>(Him)<sub>4</sub>]Cl and its ruthenium analogue.\n</p>", "clean_text": "Comparison of antiproliferative activity of closely related ruthenium and osmium compounds shows that these can be very similar, as is the case for [Ru(\u03b76-biphenyl)(en)Cl]BPh4 and [Os(\u03b76-biphenyl)(en)Cl]BF4, similar against certain human cancer cell lines, while different in respect to other cells, or quite contrasting, as is the case for compounds closely related to (H2im)[RuIIICl4(DMSO)(Him)] (NAMI-A), an antimetastatic drug candidate which just entered phase II clinical trials. The IC50 value for (H2ind)[OsIIICl4(DMSO)(Hind)] in the human cancer cell line HT29 (colon carcinoma) is 21 \u00b1 1 \u03bcM. This is 1 order of magnitude lower than the respective value for its ruthenium congener (212 \u00b1 22 \u03bcM). Reversed activity profiles were documented for trans-[OsIIICl2(Him)4]Cl and its ruthenium analogue. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>Investigation of osmium compounds is of particular interest not only because it complements the growing family of ruthenium compounds which exhibit antitumor activity but also because of well established differences between the metals, reflected in preparation approaches to their coordination and organometallic compounds, the preference for higher oxidation states, the stronger \u03c0 back-donation from lower oxidation states, and the much stronger spin\u2212orbit coupling of the heavier congener, as well as the marked differences in metal\u2212ligand exchange kinetics, which are essential for their medicinal applicability as anticancer drugs. The advantage of using osmium analogues with a cytotoxicity similar to their ruthenium congener lies in their higher inertness under conditions relevant for drug formulation. All this suggests that osmium is another metal that deserves attention for the development of effective inorganic antitumor drugs.</p>", "clean_text": "Investigation of osmium compounds is of particular interest not only because it complements the growing family of ruthenium compounds which exhibit antitumor activity but also because of well established differences between the metals, reflected in preparation approaches to their coordination and organometallic compounds, the preference for higher oxidation states, the stronger \u03c0 back-donation from lower oxidation states, and the much stronger spin-orbit coupling of the heavier congener, as well as the marked differences in metal-ligand exchange kinetics, which are essential for their medicinal applicability as anticancer drugs. The advantage of using osmium analogues with a cytotoxicity similar to their ruthenium congener lies in their higher inertness under conditions relevant for drug formulation. All this suggests that osmium is another metal that deserves attention for the development of effective inorganic antitumor drugs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<p>Being involved in the development of metal-based antitumor drugs, compounds of the general formula [Ru<sup>III</sup>Cl<sub>(6\u2212<italic toggle=\"yes\">n</italic>)</sub>(Hazole)<sub>\n<italic toggle=\"yes\">n</italic>\n</sub>]<sup>(3\u2212<italic toggle=\"yes\">n</italic>)\u2212</sup>, with <italic toggle=\"yes\">n</italic> = 1\u22124, were prepared and tested for antiproliferative activity in human cancer cell lines. A correlation between cytotoxicity in the two cell lines and Ru<sup>III</sup>/Ru<sup>II</sup> redox potentials was found. The antiproliferative activity of these compounds varied broadly in the following order: [Ru<sup>III</sup>Cl<sub>6</sub>]<sup>3\u2212</sup> &lt; [Ru<sup>III</sup>Cl<sub>4</sub>(Hind)<sub>2</sub>]<sup>\u2212</sup> &lt; [Ru<sup>III</sup>Cl<sub>5</sub>(Hind)]<sup>2\u2212</sup> \u226a [Ru<sup>III</sup>Cl<sub>3</sub>(Hind)<sub>3</sub>] &lt; [Ru<sup>III</sup>Cl<sub>2</sub>(Hind)<sub>4</sub>]<sup>+</sup>, but largely correlated with their redox potentials.</p>", "clean_text": "Being involved in the development of metal-based antitumor drugs, compounds of the general formula [RuIIICl(6-n)(Hazole) n ](3-n)-, with n = 1-4, were prepared and tested for antiproliferative activity in human cancer cell lines. A correlation between cytotoxicity in the two cell lines and RuIII/RuII redox potentials was found. The antiproliferative activity of these compounds varied broadly in the following order: [RuIIICl6]3- < [RuIIICl4(Hind)2]- < [RuIIICl5(Hind)]2- \u226a [RuIIICl3(Hind)3] < [RuIIICl2(Hind)4]+, but largely correlated with their redox potentials.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<p>In pursuing the long-term goal of establishing structure\u2212cytotoxicity relationships for the osmium-azole-chlorido series, we already reported the synthesis of <italic toggle=\"yes\">trans</italic>-[Os<sup>III</sup>Cl<sub>2</sub>(Hazole)<sub>4</sub>]Cl, <italic toggle=\"yes\">cis</italic>-[Os<sup>III</sup>Cl<sub>2</sub>(Him)<sub>4</sub>]Cl, and <italic toggle=\"yes\">mer</italic>-[Os<sup>III</sup>Cl<sub>3</sub>(Hazole)<sub>3</sub>]. Compounds of the last type were insoluble in water, precluding their testing for antiproliferative activity in vitro. Herein we report the synthesis and characterization of the first members of a new series, namely, complexes of the general formula [cation]<sup>+</sup>[Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup>, where [cation]<sup>+</sup> = <italic toggle=\"yes\">n</italic>-Bu<sub>4</sub>N<sup>+</sup> [Hazole = 1<italic toggle=\"yes\">H</italic>-pyrazole (Hpz) (<bold>1</bold>), 1<italic toggle=\"yes\">H</italic>-indazole (Hind) (<bold>2</bold>), 1<italic toggle=\"yes\">H</italic>-imidazole (Him) (<bold>3</bold>), 1<italic toggle=\"yes\">H</italic>-benzimidazole (Hbzim) (<bold>4</bold>), 1<italic toggle=\"yes\">H</italic>,2,4-triazole (Htrz) (<bold>5</bold>)], Na<sup>+</sup> [Hazole = Hpz (<bold>6</bold>), Hind (<bold>7</bold>), Htrz (<bold>8</bold>)] or H<sub>2</sub>azole<sup>+</sup> [Hazole = Hpz (<bold>9</bold>), Hind (<bold>10</bold>), Htrz (<bold>11</bold>)] (Chart ). The antiproliferative activity of compounds <bold>6</bold>\u2212<bold>11</bold> in three human cancer cell lines was assessed and compared to that of ruthenium(III) analogues (H<sub>2</sub>azole)<sub>2</sub>[Ru<sup>III</sup>Cl<sub>5</sub>(Hazole)]. In addition, the synthesis and crystal structure of the complex {(Bu<sub>4</sub>N)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>]}<sub>2</sub>[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] (<bold>12</bold>) is reported.</p>", "clean_text": "In pursuing the long-term goal of establishing structure-cytotoxicity relationships for the osmium-azole-chlorido series, we already reported the synthesis of trans-[OsIIICl2(Hazole)4]Cl, cis-[OsIIICl2(Him)4]Cl, and mer-[OsIIICl3(Hazole)3]. Compounds of the last type were insoluble in water, precluding their testing for antiproliferative activity in vitro. Herein we report the synthesis and characterization of the first members of a new series, namely, complexes of the general formula [cation]+[OsIVCl5(Hazole)]-, where [cation]+ = n-Bu4N+ [Hazole = 1H-pyrazole (Hpz) (1), 1H-indazole (Hind) (2), 1H-imidazole (Him) (3), 1H-benzimidazole (Hbzim) (4), 1H,2,4-triazole (Htrz) (5)], Na+ [Hazole = Hpz (6), Hind (7), Htrz (8)] or H2azole+ [Hazole = Hpz (9), Hind (10), Htrz (11)] (Chart ). The antiproliferative activity of compounds 6-11 in three human cancer cell lines was assessed and compared to that of ruthenium(III) analogues (H2azole)2[RuIIICl5(Hazole)]. In addition, the synthesis and crystal structure of the complex {(Bu4N)2[OsIVCl6]}2[OsIVCl4(Him)2] (12) is reported.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig fig-type=\"chart\" id=\"cht1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Compounds Reported in This Work<xref rid=\"c1fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0002.tif\"></graphic>\n<p>\n<fn id=\"c1fn1\">\n<label>a</label>\n<p>Underlined complexes have been characterized by X-ray crystallography; atom labeling was introduced for assignments of resonances in NMR spectra.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 1  Compounds Reported in This Work      a Underlined complexes have been characterized by X-ray crystallography; atom labeling was introduced for assignments of resonances in NMR spectra.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "text", "classification": ["else"], "content": "<p>\n<fn id=\"c1fn1\">\n<label>a</label>\n<p>Underlined complexes have been characterized by X-ray crystallography; atom labeling was introduced for assignments of resonances in NMR spectra.</p>\n</fn>\n</p><title>Experimental Section</title><title>Materials</title><p>The starting compounds [(DMSO)<sub>2</sub>H]<sub>2</sub>[OsCl<sub>6</sub>] and (H<sub>2</sub>azole)<sub>2</sub>[OsCl<sub>6</sub>] (Hazole = Hpz, Him, Hind, Hbzim) were synthesized as previously reported in the literature. OsO<sub>4</sub> (99.8%) and N<sub>2</sub>H<sub>4</sub>\u00b72HCl were purchased from Johnson Matthey and Fluka, respectively. 1<italic toggle=\"yes\">H</italic>-pyrazole, 1<italic toggle=\"yes\">H</italic>-indazole, 1<italic toggle=\"yes\">H</italic>-imidazole, and 1<italic toggle=\"yes\">H</italic>-benzimidazole were from Aldrich and Fluka and 1<italic toggle=\"yes\">H</italic>,2,4-triazole from Acros. All these chemicals were used without further purification. (Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Hazole)] complexes were prepared under argon atmosphere using standard Schlenk techniques as described below. Solvents were distilled according to standard procedures.\n</p>", "clean_text": "  a Underlined complexes have been characterized by X-ray crystallography; atom labeling was introduced for assignments of resonances in NMR spectra.  \n\nExperimental Section\n\nMaterials\n\nThe starting compounds [(DMSO)2H]2[OsCl6] and (H2azole)2[OsCl6] (Hazole = Hpz, Him, Hind, Hbzim) were synthesized as previously reported in the literature. OsO4 (99.8%) and N2H4\u22c52HCl were purchased from Johnson Matthey and Fluka, respectively. 1H-pyrazole, 1H-indazole, 1H-imidazole, and 1H-benzimidazole were from Aldrich and Fluka and 1H,2,4-triazole from Acros. All these chemicals were used without further purification. (Bu4N)[OsCl5(Hazole)] complexes were prepared under argon atmosphere using standard Schlenk techniques as described below. Solvents were distilled according to standard procedures. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 11, "type": "text", "classification": ["synthesis condition"], "content": "<title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Hpz)] (<bold>1</bold>)</title><p>To a solution of (H<sub>2</sub>pz)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu<sub>4</sub>NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at \u221220 \u00b0C for 2 days. The yellow product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl<sub>3</sub>/CH<sub>3</sub>OH 4:1 and collecting the first fraction (R<sub>f</sub> = 0.75). Yield: 30 mg, 24%. Anal. Calcd for C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 677.99 g/mol): C, 33.66; H, 5.95; N, 6.20. Found: C, 33.73; H, 5.73; N, 6.11. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 435 [Os<sup>IV</sup>Cl<sub>5</sub>(Hpz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 573, 665, 740, 773, 881, 1053, 1125, 1165, 1265, 1352, 1381, 1404, 1472, 1513, 2872, 2961, 3142, and 3330. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 254 sh (4 064), 360 (9 503). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.71 (s, 1H), \u22122.44 (s, 1H), 0.95 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.4 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.4 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.8 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 6.39 (d, <italic toggle=\"yes\">J</italic> = 1.6 Hz), 15.71 (s, 1H<sub>1</sub>) ppm. <sup>13</sup>C{<sup>1</sup>H} NMR (d<sub>6</sub>-DMSO, 125.81 MHz): \u03b4 14.11 (C<sub>D</sub>), 19.88 (C<sub>C</sub>), 23.78 (C<sub>B</sub>), 58.43 (C<sub>A</sub>), 71.08 {6.39}, 180.92 {\u22122.71}, 191.31 {\u22122.44} ppm. <sup>15</sup>N NMR (d<sub>6</sub>-DMSO, 50.68 MHz): \u03b4 144.3 (N<sub>1</sub>) ppm. Suitable crystals for X-ray diffraction study were selected directly from the reaction vessel.</p>", "clean_text": "(Bu4N)[OsCl5(Hpz)] (1)\n\nTo a solution of (H2pz)2[OsCl6] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu4NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at -20 \u00b0C for 2 days. The yellow product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl3/CH3OH 4:1 and collecting the first fraction (Rf = 0.75). Yield: 30 mg, 24%. Anal. Calcd for C19H40Cl5N3Os (M r = 677.99 g/mol): C, 33.66; H, 5.95; N, 6.20. Found: C, 33.73; H, 5.73; N, 6.11. ESI-MS in MeOH (negative): m/z 435 [OsIVCl5(Hpz)]-, 367 [OsIVCl5]-. IR, cm-1: 573, 665, 740, 773, 881, 1053, 1125, 1165, 1265, 1352, 1381, 1404, 1472, 1513, 2872, 2961, 3142, and 3330. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 254 sh (4 064), 360 (9 503). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.71 (s, 1H), -2.44 (s, 1H), 0.95 (t, 12HD, J = 7.4 Hz), 1.32 (sxt, 8HC, J = 7.4 Hz), 1.58 (qui, 8HB, J = 7.8 Hz), 3.17 (t, 8HA, J = 8.4 Hz), 6.39 (d, J = 1.6 Hz), 15.71 (s, 1H1) ppm. 13C{1H} NMR (d6-DMSO, 125.81 MHz): \u03b4 14.11 (CD), 19.88 (CC), 23.78 (CB), 58.43 (CA), 71.08 {6.39}, 180.92 {-2.71}, 191.31 {-2.44} ppm. 15N NMR (d6-DMSO, 50.68 MHz): \u03b4 144.3 (N1) ppm. Suitable crystals for X-ray diffraction study were selected directly from the reaction vessel.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 12, "type": "text", "classification": ["synthesis condition"], "content": "<title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Hind)] (<bold>2</bold>)</title><p>To a solution of (H<sub>2</sub>ind)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu<sub>4</sub>NCl (150 mg, 0.54 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at room temperature overnight. The dark-red product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl<sub>3</sub>/CH<sub>3</sub>OH 7:1 and collecting the first fraction (R<sub>f</sub> = 0.67). Yield: 80 mg, 70%. Anal. Calcd for C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 728.05 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 38.05; H, 5.78; N, 5.66. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 431, 613, 752, 883, 1089, 1147, 1241, 1360, 1378, 1475, 1513, 1627, 2872, 2959, and 3341. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 282 (9 492), 362 (11 031). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.54 (s, 1H<sub>3</sub>), 0.95 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.8 Hz), 3.08 (t, 1H<sub>6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 5.89 (d, 1H<sub>4</sub>, <italic toggle=\"yes\">J</italic> = 8.2 Hz), 8.24 (t, 1H<sub>5</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 10.84 (d, 1H<sub>7</sub>, <italic toggle=\"yes\">J</italic> = 8.5 Hz), 17.76 (s, 1H<sub>1</sub>) ppm. <sup>13</sup>C{<sup>1</sup>H} NMR (d<sub>6</sub>-DMSO, 125.81 MHz): \u03b4 14.08 (C<sub>D</sub>), 19.84 (C<sub>C</sub>), 23.74 (C<sub>B</sub>), 58.36 (C<sub>A</sub>), 75.94 (C<sub>9</sub>), 81.88 (C<sub>7</sub>), 106.16 (C<sub>5</sub>), 139.58 (C<sub>4</sub>), 163.74 (C<sub>6</sub>), 173.67 (C<sub>8</sub>), 200.66 (C<sub>3</sub>) ppm. <sup>15</sup>N NMR (d<sub>6</sub>-DMSO, 50.68 MHz): \u03b4 124.7 (N<sub>1</sub>) ppm. X-ray diffraction quality single crystals were obtained by slow diffusion of hexane into a chloroform solution of <bold>2</bold> in a NMR tube.</p>", "clean_text": "(Bu4N)[OsCl5(Hind)] (2)\n\nTo a solution of (H2ind)2[OsCl6] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu4NCl (150 mg, 0.54 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at room temperature overnight. The dark-red product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl3/CH3OH 7:1 and collecting the first fraction (Rf = 0.67). Yield: 80 mg, 70%. Anal. Calcd for C23H42Cl5N3Os (M r = 728.05 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 38.05; H, 5.78; N, 5.66. ESI-MS in MeOH (negative): m/z 485 [OsIVCl5(Hind)]-, 332 [OsIIICl4]-. IR, cm-1: 431, 613, 752, 883, 1089, 1147, 1241, 1360, 1378, 1475, 1513, 1627, 2872, 2959, and 3341. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 282 (9 492), 362 (11 031). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.54 (s, 1H3), 0.95 (t, 12HD, J = 7.3 Hz), 1.32 (sxt, 8HC, J = 7.3 Hz), 1.58 (qui, 8HB, J = 7.8 Hz), 3.08 (t, 1H6, J = 7.7 Hz), 3.17 (t, 8HA, J = 8.4 Hz), 5.89 (d, 1H4, J = 8.2 Hz), 8.24 (t, 1H5, J = 7.5 Hz), 10.84 (d, 1H7, J = 8.5 Hz), 17.76 (s, 1H1) ppm. 13C{1H} NMR (d6-DMSO, 125.81 MHz): \u03b4 14.08 (CD), 19.84 (CC), 23.74 (CB), 58.36 (CA), 75.94 (C9), 81.88 (C7), 106.16 (C5), 139.58 (C4), 163.74 (C6), 173.67 (C8), 200.66 (C3) ppm. 15N NMR (d6-DMSO, 50.68 MHz): \u03b4 124.7 (N1) ppm. X-ray diffraction quality single crystals were obtained by slow diffusion of hexane into a chloroform solution of 2 in a NMR tube.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 13, "type": "text", "classification": ["synthesis condition"], "content": "<title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Him)] (<bold>3</bold>)</title><p>A mixture of (H<sub>2</sub>im)<sub>2</sub>[OsCl<sub>6</sub>] (12 mg, 0.02 mmol) and excess Bu<sub>4</sub>NCl (16 mg, 0.06 mmol) in isoamyl alcohol (1 mL) was stirred at 100 \u00b0C for 72 h. The solvent was evaporated, and the red residue was dissolved in methanol. The mixture was allowed to stand at \u221220 \u00b0C for 2 days, producing single crystals suitable for X-ray diffraction study.</p>", "clean_text": "(Bu4N)[OsCl5(Him)] (3)\n\nA mixture of (H2im)2[OsCl6] (12 mg, 0.02 mmol) and excess Bu4NCl (16 mg, 0.06 mmol) in isoamyl alcohol (1 mL) was stirred at 100 \u00b0C for 72 h. The solvent was evaporated, and the red residue was dissolved in methanol. The mixture was allowed to stand at -20 \u00b0C for 2 days, producing single crystals suitable for X-ray diffraction study.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 14, "type": "text", "classification": ["synthesis condition"], "content": "<title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Hbzim)] (<bold>4</bold>)</title><p>To a solution of (H<sub>2</sub>bzim)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu<sub>4</sub>NCl (130 mg, 0.47 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter. The dark-red product formed was separated by filtration and purified by column chromatography on silica, using as eluent a mixture of CHCl<sub>3</sub>/CH<sub>3</sub>OH 7:1 and collecting the second fraction (R<sub>f</sub> = 0.47). Yield: 90 mg, 79%. Anal. Calcd for C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 728.09 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 37.84; H, 5.53; N, 5.59. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hbzim)]<sup>\u2212</sup>, 450 [Os<sup>III</sup>Cl<sub>4</sub>(Hbzim)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 613, 699, 737, 760, 798, 882, 981, 1012, 1106, 1150, 1184, 1243, 1265, 1303, 1379, 1411, 1477, 1504, 2873, 2931, 2962, 3269. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 267 (10 253), 342 sh (7 109), 366 (9 034). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.64 (s, 1H<sub>2</sub>), 0.94 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 6.04 (t, 1H<sub>5 or 6</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 6.52 (d, 1H<sub>4 or 7</sub>, <italic toggle=\"yes\">J</italic> = 8.2 Hz), 6.98 (t, 1H<sub>5 or 6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 7.34 (d, 1H<sub>4 or 7</sub>, <italic toggle=\"yes\">J</italic> = 8.1 Hz), 9.41 (s, 1H<sub>1</sub>) ppm. X-ray diffraction quality crystals of <bold>4</bold>\u00b7CH<sub>3</sub>OH were obtained from a solution of <bold>4</bold> in methanol at \u221216 \u00b0C after 24 h.</p>", "clean_text": "(Bu4N)[OsCl5(Hbzim)] (4)\n\nTo a solution of (H2bzim)2[OsCl6] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu4NCl (130 mg, 0.47 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter. The dark-red product formed was separated by filtration and purified by column chromatography on silica, using as eluent a mixture of CHCl3/CH3OH 7:1 and collecting the second fraction (Rf = 0.47). Yield: 90 mg, 79%. Anal. Calcd for C23H42Cl5N3Os (M r = 728.09 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 37.84; H, 5.53; N, 5.59. ESI-MS in MeOH (negative): m/z 485 [OsIVCl5(Hbzim)]-, 450 [OsIIICl4(Hbzim)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. IR, cm-1: 613, 699, 737, 760, 798, 882, 981, 1012, 1106, 1150, 1184, 1243, 1265, 1303, 1379, 1411, 1477, 1504, 2873, 2931, 2962, 3269. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 267 (10 253), 342 sh (7 109), 366 (9 034). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.64 (s, 1H2), 0.94 (t, 12HD, J = 7.3 Hz), 1.32 (sxt, 8HC, J = 7.3 Hz), 1.58 (qui, 8HB, J = 7.6 Hz), 3.17 (t, 8HA, J = 8.4 Hz), 6.04 (t, 1H5 or 6, J = 7.3 Hz), 6.52 (d, 1H4 or 7, J = 8.2 Hz), 6.98 (t, 1H5 or 6, J = 7.7 Hz), 7.34 (d, 1H4 or 7, J = 8.1 Hz), 9.41 (s, 1H1) ppm. X-ray diffraction quality crystals of 4\u22c5CH3OH were obtained from a solution of 4 in methanol at -16 \u00b0C after 24 h.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 15, "type": "text", "classification": ["synthesis condition"], "content": "<title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Htrz)]\u00b7C<sub>2</sub>H<sub>5</sub>OH (<bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH)</title><p>To a solution of (H<sub>2</sub>trz)<sub>2</sub>[OsCl<sub>6</sub>] (300 mg, 0.55 mmol) in dry ethanol (10 mL) excess Bu<sub>4</sub>NCl (450 mg, 1.62 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The solution produced yellow needle-like crystals on cooling. These were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 130 mg, 33%. Anal. Calcd for C<sub>18</sub>H<sub>39</sub>Cl<sub>5</sub>N<sub>4</sub>Os\u00b7C<sub>2</sub>H<sub>5</sub>OH (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 725.05 g/mol): C, 33.13; H, 6.26; N, 7.73. Found: C, 33.28; H, 6.29; N, 7.81. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 436 [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 584, 631, 736, 880, 1001, 1059, 1306, 1381, 1427, 1466, 1983, 2359, 2872, 2960. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 270 sh (5 076), 366 (10 384), 425 sh (2 365). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.22 (brs), 0.94 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.3 Hz), 9.39 (brs), 13.65 (brs) ppm. Suitable crystals of <bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH for X-ray diffraction study were selected directly from the reaction vessel.</p>", "clean_text": "(Bu4N)[OsCl5(Htrz)]\u22c5C2H5OH (5\u22c5C2H5OH)\n\nTo a solution of (H2trz)2[OsCl6] (300 mg, 0.55 mmol) in dry ethanol (10 mL) excess Bu4NCl (450 mg, 1.62 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The solution produced yellow needle-like crystals on cooling. These were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 130 mg, 33%. Anal. Calcd for C18H39Cl5N4Os\u22c5C2H5OH (M r = 725.05 g/mol): C, 33.13; H, 6.26; N, 7.73. Found: C, 33.28; H, 6.29; N, 7.81. ESI-MS in MeOH (negative): m/z 436 [OsIVCl5(Htrz)]-, 367 [OsIVCl5]-. IR, cm-1: 584, 631, 736, 880, 1001, 1059, 1306, 1381, 1427, 1466, 1983, 2359, 2872, 2960. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 270 sh (5 076), 366 (10 384), 425 sh (2 365). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.22 (brs), 0.94 (t, 12HD, J = 7.3 Hz), 1.32 (sxt, 8HC, J = 7.3 Hz), 1.58 (qui, 8HB, J = 7.5 Hz), 3.17 (t, 8HA, J = 8.3 Hz), 9.39 (brs), 13.65 (brs) ppm. Suitable crystals of 5\u22c5C2H5OH for X-ray diffraction study were selected directly from the reaction vessel.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 16, "type": "text", "classification": ["synthesis condition"], "content": "<title>Na[OsCl<sub>5</sub>(Hpz)]\u00b72H<sub>2</sub>O (<bold>6</bold>\u00b72H<sub>2</sub>O)</title><p>To a solution of <bold>1</bold> (106 mg, 0.16 mmol) in water (400 mL) ion exchanger Dowex Marathon C Na<sup>+</sup>\u2212form (10 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 73 mg, 94%. Anal. Calcd for C<sub>3</sub>H<sub>4</sub>Cl<sub>5</sub>N<sub>2</sub>NaOs\u00b72H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 494.55 g/mol): C, 7.29; H, 1.63; N, 5.66. Found: C, 7.77; H, 1.35; N, 5.23. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 400 [Os<sup>III</sup>Cl<sub>4</sub>(Hpz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. Solubility in water 34.3 mM at 298 K. IR, cm<sup>\u22121</sup>: 569, 656, 768, 905, 1055, 1072, 1111, 1169, 1265, 1345, 1398, 1485, 1506, 1620, 3144, 3314, 3481, 3559. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 207 (15 376), 256 sh (3 663), 351 (6 131), 368 sh (6 079). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.75 (s, 1H), \u22122.48 (s, 1H), 6.34 (s, 1H), 15.69 (s, 1H<sub>1</sub>) ppm. X-ray diffraction quality crystals were obtained by slow evaporation of a solution of <bold>6</bold> in water.</p>", "clean_text": "Na[OsCl5(Hpz)]\u22c52H2O (6\u22c52H2O)\n\nTo a solution of 1 (106 mg, 0.16 mmol) in water (400 mL) ion exchanger Dowex Marathon C Na+-form (10 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 73 mg, 94%. Anal. Calcd for C3H4Cl5N2NaOs\u22c52H2O (M r = 494.55 g/mol): C, 7.29; H, 1.63; N, 5.66. Found: C, 7.77; H, 1.35; N, 5.23. ESI-MS in MeOH (negative): m/z 400 [OsIIICl4(Hpz)]-, 367 [OsIVCl5]-. Solubility in water 34.3 mM at 298 K. IR, cm-1: 569, 656, 768, 905, 1055, 1072, 1111, 1169, 1265, 1345, 1398, 1485, 1506, 1620, 3144, 3314, 3481, 3559. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 207 (15 376), 256 sh (3 663), 351 (6 131), 368 sh (6 079). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.75 (s, 1H), -2.48 (s, 1H), 6.34 (s, 1H), 15.69 (s, 1H1) ppm. X-ray diffraction quality crystals were obtained by slow evaporation of a solution of 6 in water.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 17, "type": "text", "classification": ["synthesis condition"], "content": "<title>Na[OsCl<sub>5</sub>(Hind)]\u00b72H<sub>2</sub>O (<bold>7</bold>\u00b72H<sub>2</sub>O)</title><p>To a solution of <bold>2</bold> (50 mg, 0.07 mmol) in water/ethanol 1:1 (160 mL) ion exchanger Dowex Marathon C Na<sup>+</sup>\u2212form (5 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 34 mg, 91%. Anal. Calcd for C<sub>7</sub>H<sub>6</sub>Cl<sub>5</sub>N<sub>2</sub>NaOs\u00b72H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 544.65 g/mol): C, 15.44; H, 1.85; N, 5.14. Found: C, 15.64; H, 1.64; N, 5.03. ESI-MS in MeOH/CH<sub>3</sub>CN (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. Solubility in water 3.9 mM at 298 K. IR, cm<sup>\u22121</sup>: 636, 748, 759, 785, 967, 1087, 1243, 1360, 1516, 1626, 3307, 3355, 3471, 3551. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 199 (760 730), 269 (159 591), 359 (143 943), 403 sh (96406). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.54 (s, 1H<sub>3</sub>), 3.08 (t, 1H<sub>6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 5.89 (d, 1H<sub>4</sub>, <italic toggle=\"yes\">J</italic> = 8.2 Hz), 8.24 (t, 1H<sub>5</sub>, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 10.84 (d, 1H<sub>7</sub>, <italic toggle=\"yes\">J</italic> = 8.5 Hz), 17.76 (s, 1H<sub>1</sub>) ppm.</p>", "clean_text": "Na[OsCl5(Hind)]\u22c52H2O (7\u22c52H2O)\n\nTo a solution of 2 (50 mg, 0.07 mmol) in water/ethanol 1:1 (160 mL) ion exchanger Dowex Marathon C Na+-form (5 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 34 mg, 91%. Anal. Calcd for C7H6Cl5N2NaOs\u22c52H2O (M r = 544.65 g/mol): C, 15.44; H, 1.85; N, 5.14. Found: C, 15.64; H, 1.64; N, 5.03. ESI-MS in MeOH/CH3CN (negative): m/z 485 [OsIVCl5(Hind)]-, 367 [OsIVCl5]-. Solubility in water 3.9 mM at 298 K. IR, cm-1: 636, 748, 759, 785, 967, 1087, 1243, 1360, 1516, 1626, 3307, 3355, 3471, 3551. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 199 (760 730), 269 (159 591), 359 (143 943), 403 sh (96406). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.54 (s, 1H3), 3.08 (t, 1H6, J = 7.7 Hz), 5.89 (d, 1H4, J = 8.2 Hz), 8.24 (t, 1H5, J = 7.6 Hz), 10.84 (d, 1H7, J = 8.5 Hz), 17.76 (s, 1H1) ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 18, "type": "text", "classification": ["synthesis condition"], "content": "<title>Na[OsCl<sub>5</sub>(Htrz)]\u00b71.5H<sub>2</sub>O (<bold>8</bold>\u00b71.5H<sub>2</sub>O)</title><p>To a solution of <bold>5</bold> (100 mg, 0.15 mmol) in water (420 mL) ion exchanger Dowex Marathon C Na<sup>+</sup>\u2212form (10 g), after 12 h of soaking in water, was added. The suspension was allowed to stir for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give an orange solid. Yield: 70 mg, 98%. Anal. Calcd for C<sub>2</sub>H<sub>3</sub>Cl<sub>5</sub>N<sub>3</sub>NaOs\u00b71.5H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 486.57 g/mol): C, 4.94; H, 1.24; N, 8.64. Found: C, 5.24; H, 1.08; N, 8.28. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 436 [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup>, 401 [Os<sup>III</sup>Cl<sub>4</sub>(Htrz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. Solubility in water 15.4 mM at 298 K. IR, cm<sup>\u22121</sup>: 573, 614, 676, 865, 890, 962, 1079, 1144, 1192, 1257, 1301, 1374, 1412, 1493, 1523, 1613, 2363, 3127, 3322, 3534. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 343 sh (5 432), 362 (6 112). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22127.23 (brs) ppm.</p>", "clean_text": "Na[OsCl5(Htrz)]\u22c51.5H2O (8\u22c51.5H2O)\n\nTo a solution of 5 (100 mg, 0.15 mmol) in water (420 mL) ion exchanger Dowex Marathon C Na+-form (10 g), after 12 h of soaking in water, was added. The suspension was allowed to stir for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give an orange solid. Yield: 70 mg, 98%. Anal. Calcd for C2H3Cl5N3NaOs\u22c51.5H2O (M r = 486.57 g/mol): C, 4.94; H, 1.24; N, 8.64. Found: C, 5.24; H, 1.08; N, 8.28. ESI-MS in MeOH (negative): m/z 436 [OsIVCl5(Htrz)]-, 401 [OsIIICl4(Htrz)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. Solubility in water 15.4 mM at 298 K. IR, cm-1: 573, 614, 676, 865, 890, 962, 1079, 1144, 1192, 1257, 1301, 1374, 1412, 1493, 1523, 1613, 2363, 3127, 3322, 3534. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 343 sh (5 432), 362 (6 112). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -7.23 (brs) ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 19, "type": "text", "classification": ["synthesis condition"], "content": "<title>(H<sub>2</sub>pz)[OsCl<sub>5</sub>(Hpz)]\u00b7H<sub>2</sub>O (<bold>9</bold>\u00b7H<sub>2</sub>O)</title><p>To pyrazole (14 mg, 0.21 mmol) in water (1.4 mL) 12 M hydrochloric acid (0.02 mL, 0.24 mmol) was added. The resulting solution of pyrazolium chloride was then added to a solution of <bold>6</bold> (47 mg, 0.10 mmol) in water (0.6 mL). The reaction mixture produced red crystals. Yield: 26 mg, 52%. Anal. Calcd for C<sub>6</sub>H<sub>9</sub>Cl<sub>5</sub>N<sub>4</sub>Os\u00b7H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 522.67): C, 13.79; H, 2.12; N, 10.72. Found: C, 13.82; H, 1.82; N, 10.32. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 435 [Os<sup>IV</sup>Cl<sub>5</sub>(Hpz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. Solubility in water 6.7 mM at 298 K. IR, cm<sup>\u22121</sup>: 599, 609, 771, 905, 1051, 1070, 1110, 1131, 1170, 1276, 1351, 1398, 1487, 1524, 1563, 1601, 2862, 3044, 3136, 3472, 3513. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 208 (19 463), 253 sh (3 806), 357 (8 678). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.71 (s, 1H), \u22122.44 (s, 1H), 6.31 (s, 1H<sub>4</sub>\u2032), 6.39 (s, 1H), 7.68 (s, 2H<sub>3,5</sub>\u2032), 15.71 (s, 1H<sub>1</sub>) ppm. <sup>13</sup>C{<sup>1</sup>H} NMR (d<sub>6</sub>-DMSO, 125.81 MHz): \u03b4 71.18 {6.39}, 106.16 (C<sub>4</sub>\u2032), 134.25 (C<sub>3,5</sub>\u2032), 181.33 {\u22122.71}, 191.99 {\u22122.44} ppm. <sup>15</sup>N NMR (d<sub>6</sub>-DMSO, 50.68 MHz): \u03b4 144.1 (N<sub>1</sub>) ppm.</p>", "clean_text": "(H2pz)[OsCl5(Hpz)]\u22c5H2O (9\u22c5H2O)\n\nTo pyrazole (14 mg, 0.21 mmol) in water (1.4 mL) 12 M hydrochloric acid (0.02 mL, 0.24 mmol) was added. The resulting solution of pyrazolium chloride was then added to a solution of 6 (47 mg, 0.10 mmol) in water (0.6 mL). The reaction mixture produced red crystals. Yield: 26 mg, 52%. Anal. Calcd for C6H9Cl5N4Os\u22c5H2O (M r = 522.67): C, 13.79; H, 2.12; N, 10.72. Found: C, 13.82; H, 1.82; N, 10.32. ESI-MS in MeOH (negative): m/z 435 [OsIVCl5(Hpz)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. Solubility in water 6.7 mM at 298 K. IR, cm-1: 599, 609, 771, 905, 1051, 1070, 1110, 1131, 1170, 1276, 1351, 1398, 1487, 1524, 1563, 1601, 2862, 3044, 3136, 3472, 3513. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 208 (19 463), 253 sh (3 806), 357 (8 678). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.71 (s, 1H), -2.44 (s, 1H), 6.31 (s, 1H4'), 6.39 (s, 1H), 7.68 (s, 2H3,5'), 15.71 (s, 1H1) ppm. 13C{1H} NMR (d6-DMSO, 125.81 MHz): \u03b4 71.18 {6.39}, 106.16 (C4'), 134.25 (C3,5'), 181.33 {-2.71}, 191.99 {-2.44} ppm. 15N NMR (d6-DMSO, 50.68 MHz): \u03b4 144.1 (N1) ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 20, "type": "text", "classification": ["synthesis condition"], "content": "<title>(H<sub>2</sub>ind)[OsCl<sub>5</sub>(Hind)]\u00b7H<sub>2</sub>O (<bold>10</bold>\u00b7H<sub>2</sub>O)</title><p>To indazole (12 mg, 0.10 mmol) in water (1.2 mL) was added 12 M hydrochloric acid (0.01 mL, 0.12 mmol). The resulting solution of indazolium chloride was then added to a solution of <bold>7</bold> (45 mg, 0.08 mmol) in water (4 mL). The reaction mixture produced a brown solid. Yield: 40 mg, 78%. Anal. Calcd for C<sub>14</sub>H<sub>13</sub>Cl<sub>5</sub>N<sub>4</sub>Os\u00b7H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 622.79): C, 27.00; H, 2.43; N, 9.00. Found: C, 27.36; H, 2.31; N, 8.72. ESI-MS in MeOH/CH<sub>3</sub>CN (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. Solubility in water 1.3 mM at 298 K. IR, cm<sup>\u22121</sup>: 614, 744, 787, 830, 967, 1002, 1087, 1126, 1152, 1247, 1359, 1384, 1483, 1516, 1628, 2359, 3127, 3248, 3466, 3519. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 201 (31 605), 249 (4 565), 286 (4 721), 358 (3 571). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.56 (s, 1H<sub>3</sub>), 3.06 (t, 1H<sub>6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 5.89 (d, 1H<sub>4</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 7.11 (t, 1H<sub>5</sub>\u2032, <italic toggle=\"yes\">J</italic> = 7.4 Hz), 7.34 (t, 1H<sub>6</sub>\u2032, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 7.53 (d, 1H<sub>7</sub>\u2032, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 7.75 (d, 1H<sub>4</sub>\u2032, <italic toggle=\"yes\">J</italic> = 8.1 Hz), 8.08 (s, 1H<sub>3</sub>\u2032), 8.23 (t, 1H<sub>5</sub>, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 10.85 (d, 1H<sub>7</sub>, <italic toggle=\"yes\">J</italic> = 8.5 Hz), 17.76 (s, 1H<sub>1</sub>) ppm.</p>", "clean_text": "(H2ind)[OsCl5(Hind)]\u22c5H2O (10\u22c5H2O)\n\nTo indazole (12 mg, 0.10 mmol) in water (1.2 mL) was added 12 M hydrochloric acid (0.01 mL, 0.12 mmol). The resulting solution of indazolium chloride was then added to a solution of 7 (45 mg, 0.08 mmol) in water (4 mL). The reaction mixture produced a brown solid. Yield: 40 mg, 78%. Anal. Calcd for C14H13Cl5N4Os\u22c5H2O (M r = 622.79): C, 27.00; H, 2.43; N, 9.00. Found: C, 27.36; H, 2.31; N, 8.72. ESI-MS in MeOH/CH3CN (negative): m/z 485 [OsIVCl5(Hind)]-, 367 [OsIVCl5]-. Solubility in water 1.3 mM at 298 K. IR, cm-1: 614, 744, 787, 830, 967, 1002, 1087, 1126, 1152, 1247, 1359, 1384, 1483, 1516, 1628, 2359, 3127, 3248, 3466, 3519. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 201 (31 605), 249 (4 565), 286 (4 721), 358 (3 571). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.56 (s, 1H3), 3.06 (t, 1H6, J = 7.7 Hz), 5.89 (d, 1H4, J = 7.5 Hz), 7.11 (t, 1H5', J = 7.4 Hz), 7.34 (t, 1H6', J = 7.6 Hz), 7.53 (d, 1H7', J = 8.4 Hz), 7.75 (d, 1H4', J = 8.1 Hz), 8.08 (s, 1H3'), 8.23 (t, 1H5, J = 7.6 Hz), 10.85 (d, 1H7, J = 8.5 Hz), 17.76 (s, 1H1) ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 21, "type": "text", "classification": ["synthesis condition"], "content": "<title>(H<sub>2</sub>trz)[OsCl<sub>5</sub>(Htrz)] (<bold>11</bold>)</title><p>To triazole (15 mg, 0.22 mmol) in water (1.5 mL) was added 12 M hydrochloric acid (0.02 mL, 0.24 mmol). The resulting solution of triazolium chloride was then added to a solution of <bold>8</bold> (48 mg, 0.10 mmol) in water (4.8 mL). The reaction mixture produced red needle-like crystals. Yield: 28 mg, 56%. Anal. Calcd for C<sub>4</sub>H<sub>7</sub>Cl<sub>5</sub>N<sub>6</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 506.63 g/mol): C, 9.48; H, 1.39; N, 16.59. Found: C, 9.49; H, 1.23; N, 16.35. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 436 [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup>, 401 [Os<sup>III</sup>Cl<sub>4</sub>(Htrz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. Solubility in water 4.4 mM at 298 K. IR, cm<sup>\u22121</sup>: 621, 661, 743, 838, 877, 934, 970, 1027, 1058, 1150, 1258, 1300, 1413, 1518, 1560, 1602, 2807, 2848, 2916, 2955, 3124, 3521, 3601. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 212 sh (117 773), 338 sh (4 890), 363 (8 229). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.19 (s, 1H), 8.71 (s, 2H<sub>3,5</sub>\u2032), 8.90 (brs) ppm.</p>", "clean_text": "(H2trz)[OsCl5(Htrz)] (11)\n\nTo triazole (15 mg, 0.22 mmol) in water (1.5 mL) was added 12 M hydrochloric acid (0.02 mL, 0.24 mmol). The resulting solution of triazolium chloride was then added to a solution of 8 (48 mg, 0.10 mmol) in water (4.8 mL). The reaction mixture produced red needle-like crystals. Yield: 28 mg, 56%. Anal. Calcd for C4H7Cl5N6Os (M r = 506.63 g/mol): C, 9.48; H, 1.39; N, 16.59. Found: C, 9.49; H, 1.23; N, 16.35. ESI-MS in MeOH (negative): m/z 436 [OsIVCl5(Htrz)]-, 401 [OsIIICl4(Htrz)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. Solubility in water 4.4 mM at 298 K. IR, cm-1: 621, 661, 743, 838, 877, 934, 970, 1027, 1058, 1150, 1258, 1300, 1413, 1518, 1560, 1602, 2807, 2848, 2916, 2955, 3124, 3521, 3601. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 212 sh (117 773), 338 sh (4 890), 363 (8 229). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.19 (s, 1H), 8.71 (s, 2H3,5'), 8.90 (brs) ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 22, "type": "text", "classification": ["synthesis condition"], "content": "<title>{(Bu<sub>4</sub>N)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>]}<sub>2</sub>\u00b7[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] (<bold>12</bold>)</title><p>To a solution of (H<sub>2</sub>im)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu<sub>4</sub>NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at \u221220 \u00b0C for 2 days. The orange crystals formed were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 80 mg, 58%. Anal. Calcd for C<sub>70</sub>H<sub>152</sub>Cl<sub>16</sub>N<sub>8</sub>Os<sub>3</sub> (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 2243.80 g/mol): C, 37.47; H, 6.83; N, 4.99. Found: C, 37.49; H, 6.70; N, 4.93. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 469 [Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>\u2212H<sup>+</sup>]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 615, 653, 737, 880, 1025, 1065, 1100, 1135, 1259, 1323, 1378, 1474, 1547, 2873, 2958, 3164, 3251. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 254 sh (19 949), 339 (49 763), 371 (45 578), 421 sh (7141). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22120.52 (s, 1H), 0.95 (t, 24H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 16H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 16H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 3.17 (t, 16H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.3 Hz), 7.28 (s, 1H), 7.85 (s, 1H), 12.28 (s, 1H<sub>1</sub>) ppm. X-ray diffraction quality crystals were selected directly from the reaction vessel.</p>", "clean_text": "{(Bu4N)2[OsIVCl6]}2\u22c5[OsIVCl4(Him)2] (12)\n\nTo a solution of (H2im)2[OsCl6] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu4NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at -20 \u00b0C for 2 days. The orange crystals formed were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 80 mg, 58%. Anal. Calcd for C70H152Cl16N8Os3 (M r = 2243.80 g/mol): C, 37.47; H, 6.83; N, 4.99. Found: C, 37.49; H, 6.70; N, 4.93. ESI-MS in MeOH (negative): m/z 469 [OsIVCl4(Him)2-H+]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. IR, cm-1: 615, 653, 737, 880, 1025, 1065, 1100, 1135, 1259, 1323, 1378, 1474, 1547, 2873, 2958, 3164, 3251. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 254 sh (19 949), 339 (49 763), 371 (45 578), 421 sh (7141). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -0.52 (s, 1H), 0.95 (t, 24HD, J = 7.3 Hz), 1.32 (sxt, 16HC, J = 7.3 Hz), 1.58 (qui, 16HB, J = 7.5 Hz), 3.17 (t, 16HA, J = 8.3 Hz), 7.28 (s, 1H), 7.85 (s, 1H), 12.28 (s, 1H1) ppm. X-ray diffraction quality crystals were selected directly from the reaction vessel.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 23, "type": "text", "classification": "error", "content": "<title>Physical Measurements</title><p>Elemental analyses were performed by the Microanalytical Service of the Institute of Physical Chemistry of the University of Vienna. IR spectra were obtained by using an ATR unit with a Perkin-Elmer 370 FTIR 2000 instrument (4000\u2212400 cm<sup>\u22121</sup>). UV\u2212vis spectra were recorded on a Perkin-Elmer Lambda 20 UV\u2212vis spectrophotometer using samples dissolved in water or ethanol. The aqueous solution behavior of <bold>6</bold>, <bold>7</bold>, and <bold>9</bold> with respect to hydrolysis was studied at 294 K over 24 h by UV\u2212vis spectroscopy. Electrospray ionization mass spectrometry (ESI-MS) was carried out with a Bruker Esquire 3000 instrument (Bruker Daltonics, Bremen, Germany) by using methanol, methanol/acetonitrile, or water as solvents. Expected and measured isotope distributions were compared. Cyclic voltammogramms were measured in a three-electrode cell using a 2 mm diameter glassy carbon disk working electrode, a platinum auxiliary electrode and an Ag|Ag<sup>+</sup> reference electrode containing 0.1 M AgNO<sub>3</sub>. Measurements were performed at room temperature using a EG&amp;G PARC potentiostat/galvanostat model 273A. Deaeration of solutions was accomplished by passing a stream of argon through the solution for 5 min prior to the measurement and then maintaining a blanket atmosphere of argon over the solution during the measurement. The potentials were measured in 0.2 M (Bu<sub>4</sub>N)[BF<sub>4</sub>]/DMSO using [Fe(\u03b7<sup>5</sup>-C<sub>5</sub>H<sub>5</sub>)<sub>2</sub>] (<italic toggle=\"yes\">E</italic>\n<sub>1/2</sub>\n<sup>ox</sup> = +0.68 V vs NHE) as internal standard and are quoted relative to NHE. Thermogravimetry was performed under nitrogen atmosphere on a Mettler Toledo TGA/SDTA851<sup>e</sup> instrument. The <sup>1</sup>H, <sup>13</sup>C, and <sup>15</sup>N NMR spectra were recorded at 500.32, 125.81, and 50.68 MHz on a Bruker DPX500 (Ultrashield Magnet) in d<sub>6</sub>-DMSO. 2D <sup>13</sup>C<sup>1</sup>H HSQC, <sup>15</sup>N<sup>1</sup>H HSQC, <sup>13</sup>C<sup>1</sup>H HMBC, <sup>1</sup>H<sup>1</sup>H COSY, and <sup>1</sup>H<sup>1</sup>H NOESY experiments were performed for <bold>1</bold>, <bold>2</bold>, and <bold>9</bold>. Atom labeling with an apostrophe (Y<sub>\n<italic toggle=\"yes\">x</italic>\n</sub>\u2032) was introduced for assignments of azolium ion resonances in NMR spectra (Chart ). Magnetic susceptibility data were collected on powdered samples with a SQUID-based sample magnetometer on a Quantum Design model MPMS instrument. All data were corrected for the diamagnetism of the ligands estimated from Pascal\u2019s constants. Magnetic susceptibility measurements in solution were conducted on a Bruker DPX500 (Ultrashield Magnet) NMR spectrometer in d<sub>6</sub>-DMSO by Evans method. The \u03bc<sub>eff</sub> calculated for 0.023 M Cu(acac)<sub>2</sub> (acac =  acetylacetonate) solution in d<sub>6</sub>-DMSO was 1.74 \u03bc<sub>B</sub>.</p>", "clean_text": "Physical Measurements\n\nElemental analyses were performed by the Microanalytical Service of the Institute of Physical Chemistry of the University of Vienna. IR spectra were obtained by using an ATR unit with a Perkin-Elmer 370 FTIR 2000 instrument (4000-400 cm-1). UV-vis spectra were recorded on a Perkin-Elmer Lambda 20 UV-vis spectrophotometer using samples dissolved in water or ethanol. The aqueous solution behavior of 6, 7, and 9 with respect to hydrolysis was studied at 294 K over 24 h by UV-vis spectroscopy. Electrospray ionization mass spectrometry (ESI-MS) was carried out with a Bruker Esquire 3000 instrument (Bruker Daltonics, Bremen, Germany) by using methanol, methanol/acetonitrile, or water as solvents. Expected and measured isotope distributions were compared. Cyclic voltammogramms were measured in a three-electrode cell using a 2 mm diameter glassy carbon disk working electrode, a platinum auxiliary electrode and an Ag|Ag+ reference electrode containing 0.1 M AgNO3. Measurements were performed at room temperature using a EG&G PARC potentiostat/galvanostat model 273A. Deaeration of solutions was accomplished by passing a stream of argon through the solution for 5 min prior to the measurement and then maintaining a blanket atmosphere of argon over the solution during the measurement. The potentials were measured in 0.2 M (Bu4N)[BF4]/DMSO using [Fe(\u03b75-C5H5)2] (E 1/2 ox = +0.68 V vs NHE) as internal standard and are quoted relative to NHE. Thermogravimetry was performed under nitrogen atmosphere on a Mettler Toledo TGA/SDTA851e instrument. The 1H, 13C, and 15N NMR spectra were recorded at 500.32, 125.81, and 50.68 MHz on a Bruker DPX500 (Ultrashield Magnet) in d6-DMSO. 2D 13C1H HSQC, 15N1H HSQC, 13C1H HMBC, 1H1H COSY, and 1H1H NOESY experiments were performed for 1, 2, and 9. Atom labeling with an apostrophe (Y x ') was introduced for assignments of azolium ion resonances in NMR spectra (Chart ). Magnetic susceptibility data were collected on powdered samples with a SQUID-based sample magnetometer on a Quantum Design model MPMS instrument. All data were corrected for the diamagnetism of the ligands estimated from Pascal's constants. Magnetic susceptibility measurements in solution were conducted on a Bruker DPX500 (Ultrashield Magnet) NMR spectrometer in d6-DMSO by Evans method. The \u03bceff calculated for 0.023 M Cu(acac)2 (acac =  acetylacetonate) solution in d6-DMSO was 1.74 \u03bcB.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 24, "type": "text", "classification": "error", "content": "<title>Crystallographic Structure Determination</title><p>X-ray diffraction measurements were performed on a Bruker X8 APEXII CCD diffractometer. Single crystals were positioned at 35, 40, 40, 40, 35, 35, and 35 mm from the detector, and 1983, 2366, 1789, 1414, 1449, 2620, and 1273 frames were measured, each for 50, 20, 40, 60, 40, 20, and 80 s over 1\u00b0 scan width for <bold>1</bold>\u2212<bold>6</bold> and <bold>12</bold>, correspondingly. The data were processed using SAINT software. Crystal data, data collection parameters, and structure refinement details are given in Tables  and . The structures were solved by direct methods and refined by full-matrix least-squares techniques. Non-H atoms were refined with anisotropic displacement parameters. H atoms were inserted in calculated positions and refined with a riding model. The following software, personal computer and tables were used: structure solution, SHELXS-97; refinement, SHELXL-97; molecular diagrams, ORTEP; Pentium IV; scattering factors.\n</p>", "clean_text": "Crystallographic Structure Determination\n\nX-ray diffraction measurements were performed on a Bruker X8 APEXII CCD diffractometer. Single crystals were positioned at 35, 40, 40, 40, 35, 35, and 35 mm from the detector, and 1983, 2366, 1789, 1414, 1449, 2620, and 1273 frames were measured, each for 50, 20, 40, 60, 40, 20, and 80 s over 1\u00b0 scan width for 1-6 and 12, correspondingly. The data were processed using SAINT software. Crystal data, data collection parameters, and structure refinement details are given in Tables  and . The structures were solved by direct methods and refined by full-matrix least-squares techniques. Non-H atoms were refined with anisotropic displacement parameters. H atoms were inserted in calculated positions and refined with a riding model. The following software, personal computer and tables were used: structure solution, SHELXS-97; refinement, SHELXL-97; molecular diagrams, ORTEP; Pentium IV; scattering factors. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 25, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystal Data and Details of Data Collection for <bold>1</bold>\u2212<bold>5</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>4</bold>\u00b7CH<sub>3</sub>OH</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os</oasis:entry>\n<oasis:entry>C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os</oasis:entry>\n<oasis:entry>C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os</oasis:entry>\n<oasis:entry>C<sub>24</sub>H<sub>46</sub>Cl<sub>5</sub>N<sub>3</sub>OOs</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>45</sub>Cl<sub>5</sub>N<sub>4</sub>OOs</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Fw</oasis:entry>\n<oasis:entry>677.99</oasis:entry>\n<oasis:entry>728.05</oasis:entry>\n<oasis:entry>677.99</oasis:entry>\n<oasis:entry>760.09</oasis:entry>\n<oasis:entry>725.05</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> [\u00c5]</oasis:entry>\n<oasis:entry>10.6292(8)</oasis:entry>\n<oasis:entry>9.8278(8)</oasis:entry>\n<oasis:entry>10.7865(6)</oasis:entry>\n<oasis:entry>10.2229(7)</oasis:entry>\n<oasis:entry>9.6679(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> [\u00c5]</oasis:entry>\n<oasis:entry>11.4265(8)</oasis:entry>\n<oasis:entry>10.9541(8)</oasis:entry>\n<oasis:entry>19.3982(13)</oasis:entry>\n<oasis:entry>11.2755(8)</oasis:entry>\n<oasis:entry>10.4061(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> [\u00c5]</oasis:entry>\n<oasis:entry>11.7079(9)</oasis:entry>\n<oasis:entry>14.7537(12)</oasis:entry>\n<oasis:entry>13.3421(8)</oasis:entry>\n<oasis:entry>14.9270(11)</oasis:entry>\n<oasis:entry>15.1487(6)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 [deg]</oasis:entry>\n<oasis:entry>68.717(4)</oasis:entry>\n<oasis:entry>109.992(5)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>74.902(4)</oasis:entry>\n<oasis:entry>98.195(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 [deg]</oasis:entry>\n<oasis:entry>85.748(4)</oasis:entry>\n<oasis:entry>96.282(6)</oasis:entry>\n<oasis:entry>109.892(3)</oasis:entry>\n<oasis:entry>72.132(4)</oasis:entry>\n<oasis:entry>103.674(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 [deg]</oasis:entry>\n<oasis:entry>83.527(3)</oasis:entry>\n<oasis:entry>91.468(5)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>78.163(4)</oasis:entry>\n<oasis:entry>90.020(1)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> [\u00c5<sup>3</sup>]</oasis:entry>\n<oasis:entry>1315.70(17)</oasis:entry>\n<oasis:entry>1480.3(2)</oasis:entry>\n<oasis:entry>2625.1(3)</oasis:entry>\n<oasis:entry>1566.34(19)</oasis:entry>\n<oasis:entry>1464.80(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bb [\u00c5]</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>]</oasis:entry>\n<oasis:entry>1.711</oasis:entry>\n<oasis:entry>1.633</oasis:entry>\n<oasis:entry>1.715</oasis:entry>\n<oasis:entry>1.612</oasis:entry>\n<oasis:entry>1.644</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size [mm<sup>3</sup>]</oasis:entry>\n<oasis:entry>0.25 \u00d7 0.10 \u00d7 0.10</oasis:entry>\n<oasis:entry>0.10 \u00d7 0.10 \u00d7 0.06</oasis:entry>\n<oasis:entry>0.10 \u00d7 0.07 \u00d7 0.03</oasis:entry>\n<oasis:entry>0.14 \u00d7 0.08 \u00d7 0.02</oasis:entry>\n<oasis:entry>0.30 \u00d7 0.30 \u00d7 0.02</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">T</italic> [K]</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc [mm<sup>\u22121</sup>]</oasis:entry>\n<oasis:entry>5.365</oasis:entry>\n<oasis:entry>4.775</oasis:entry>\n<oasis:entry>5.378</oasis:entry>\n<oasis:entry>4.518</oasis:entry>\n<oasis:entry>4.828</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub>\n<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0314</oasis:entry>\n<oasis:entry>0.0282</oasis:entry>\n<oasis:entry>0.0339</oasis:entry>\n<oasis:entry>0.0377</oasis:entry>\n<oasis:entry>0.0264</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub>\n<xref rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.0742</oasis:entry>\n<oasis:entry>0.0600</oasis:entry>\n<oasis:entry>0.0806</oasis:entry>\n<oasis:entry>0.0787</oasis:entry>\n<oasis:entry>0.0669</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF<xref rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>1.008</oasis:entry>\n<oasis:entry>1.009</oasis:entry>\n<oasis:entry>1.008</oasis:entry>\n<oasis:entry>1.021</oasis:entry>\n<oasis:entry>1.069</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = \u2211\u2223\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223 \u2212 \u2223<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\u2223\u2223/\u2211\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223.</p>\n</fn>\n<fn id=\"t1fn2\">\n<label>b</label>\n<p>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = {\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>/\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.</p>\n</fn>\n<fn id=\"t1fn3\">\n<label>c</label>\n<p>GOF = {\u2211[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/(<italic toggle=\"yes\">n</italic> \u2212 <italic toggle=\"yes\">p</italic>)}<sup>1/2</sup>, where <italic toggle=\"yes\">n</italic> is the number of reflections and <italic toggle=\"yes\">p</italic> is the total number of parameters refined.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Crystal Data and Details of Data Collection for <bold>6</bold> and <bold>12</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"3\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>6</bold>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>12</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>3</sub>H<sub>8</sub>Cl<sub>5</sub>N<sub>2</sub>NaO<sub>2</sub>Os</oasis:entry>\n<oasis:entry>C<sub>70</sub>H<sub>152</sub>Cl<sub>16</sub>N<sub>8</sub>Os<sub>3</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Fw</oasis:entry>\n<oasis:entry>494.55</oasis:entry>\n<oasis:entry>2243.80</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> [\u00c5]</oasis:entry>\n<oasis:entry>6.5037(3)</oasis:entry>\n<oasis:entry>11.1066(7)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> [\u00c5]</oasis:entry>\n<oasis:entry>6.8557(3)</oasis:entry>\n<oasis:entry>16.2484(9)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> [\u00c5]</oasis:entry>\n<oasis:entry>13.5359(6)</oasis:entry>\n<oasis:entry>26.7804(15)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 [deg]</oasis:entry>\n<oasis:entry>96.816(3)</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 [deg]</oasis:entry>\n<oasis:entry>91.235(2)</oasis:entry>\n<oasis:entry>94.799(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 [deg]</oasis:entry>\n<oasis:entry>94.297(3)</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> [\u00c5<sup>3</sup>]</oasis:entry>\n<oasis:entry>597.30(5)</oasis:entry>\n<oasis:entry>4816.0(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bb [\u00c5]</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>]</oasis:entry>\n<oasis:entry>2.750</oasis:entry>\n<oasis:entry>1.547</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size [mm<sup>3</sup>]</oasis:entry>\n<oasis:entry>0.20 \u00d7 0.06 \u00d7 0.03</oasis:entry>\n<oasis:entry>0.10 \u00d7 0.05 \u00d7 0.01</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">T</italic> [K]</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc [mm<sup>\u22121</sup>]</oasis:entry>\n<oasis:entry>11.803</oasis:entry>\n<oasis:entry>4.431</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub>\n<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0203</oasis:entry>\n<oasis:entry>0.0465</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub>\n<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.0547</oasis:entry>\n<oasis:entry>0.0848</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF<xref rid=\"t2fn3\"></xref>\n</oasis:entry>\n<oasis:entry>1.099</oasis:entry>\n<oasis:entry>0.974</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = \u2211\u2223\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223 \u2212 \u2223<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\u2223\u2223/\u2211\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = {\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>/\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.</p>\n</fn>\n<fn id=\"t2fn3\">\n<label>c</label>\n<p>GOF = {\u2211[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/(<italic toggle=\"yes\">n</italic> \u2212 <italic toggle=\"yes\">p</italic>)}<sup>1/2</sup>, where <italic toggle=\"yes\">n</italic> is the number of reflections and <italic toggle=\"yes\">p</italic> is the total number of parameters refined.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "text", "classification": ["else"], "content": "<title>Cell Lines and Culture Conditions</title><p>CH1 (ovarian carcinoma, human) cells were donated by Lloyd R. Kelland (CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, U.K.). A549 (non-small cell lung cancer, human) and SW480 (colon carcinoma, human) cells were kindly provided by Brigitte Marian (Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria). Cells were grown in 75 cm<sup>2</sup> culture flasks (Iwaki/Asahi Technoglass) as adherent monolayer cultures in Minimal Essential Medium (MEM) supplemented with 10% heat-inactivated fetal bovine serum, 1 mM sodium pyruvate, and 2 mM <sc>l</sc>-glutamine (all purchased from Sigma-Aldrich) without antibiotics. Cultures were maintained at 37 \u00b0C in a humidified atmosphere containing 5% CO<sub>2</sub> and 95% air.</p>", "clean_text": "Cell Lines and Culture Conditions\n\nCH1 (ovarian carcinoma, human) cells were donated by Lloyd R. Kelland (CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, U.K.). A549 (non-small cell lung cancer, human) and SW480 (colon carcinoma, human) cells were kindly provided by Brigitte Marian (Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria). Cells were grown in 75 cm2 culture flasks (Iwaki/Asahi Technoglass) as adherent monolayer cultures in Minimal Essential Medium (MEM) supplemented with 10% heat-inactivated fetal bovine serum, 1 mM sodium pyruvate, and 2 mM l-glutamine (all purchased from Sigma-Aldrich) without antibiotics. Cultures were maintained at 37 \u00b0C in a humidified atmosphere containing 5% CO2 and 95% air.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 28, "type": "text", "classification": "error", "content": "<title>Cytotoxicity in Cancer Cell Lines</title><p>Cytotoxicity in the cell lines mentioned above was determined by the colorimetric MTT assay (MTT = 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2<italic toggle=\"yes\">H</italic>-tetrazolium bromide, purchased from Fluka). Cells were harvested from culture flasks by trypsinization and seeded in 100 \u03bcL aliquots in MEM supplemented with 10% heat-inactivated fetal bovine serum, 1 mM sodium pyruvate, 2 mM <sc>l</sc>-glutamine, and 1% non-essential amino acids (100\u00d7) into 96-well microculture plates (Iwaki/Asahi Technoglass) in the following densities, to ensure exponential growth of untreated controls throughout the experiment: 1.5 \u00d7 10<sup>3</sup> (CH1), 4.0 \u00d7 10<sup>3</sup> (A549), and 2.5 \u00d7 10<sup>3</sup> (SW480) viable cells per well. Cells were allowed to settle and resume exponential growth in drug-free complete culture medium for 24 h, followed by the addition of dilutions of the test compounds in 100 \u03bcL/well of the same medium. After continuous exposure for 96 h, the medium was replaced by a 100 \u03bcL/well RPMI 1640 medium (supplemented with 10% heat-inactivated fetal bovine serum and 4 mM <sc>l</sc>-glutamine) plus 20 \u03bcL/well solution of MTT in phosphate-buffered saline (5 mg/mL) (all purchased from Sigma-Aldrich). After incubation for 4 h, medium/MTT mixtures were removed, and the formazan product formed by viable cells was dissolved in DMSO (150 \u03bcL/well). Optical densities at 550 nm were measured with a microplate reader (Tecan Spectra Classic), using a reference wavelength of 690 nm to correct unspecific absorption. The quantity of viable cells was expressed as percentage of untreated controls, and 50% inhibitory concentrations (IC<sub>50</sub>) were calculated from concentration-effect curves by interpolation. Evaluation is based on at least two independent experiments, each comprising three replicates per concentration level.</p>", "clean_text": "Cytotoxicity in Cancer Cell Lines\n\nCytotoxicity in the cell lines mentioned above was determined by the colorimetric MTT assay (MTT = 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide, purchased from Fluka). Cells were harvested from culture flasks by trypsinization and seeded in 100 \u03bcL aliquots in MEM supplemented with 10% heat-inactivated fetal bovine serum, 1 mM sodium pyruvate, 2 mM l-glutamine, and 1% non-essential amino acids (100\u00d7) into 96-well microculture plates (Iwaki/Asahi Technoglass) in the following densities, to ensure exponential growth of untreated controls throughout the experiment: 1.5 \u00d7 103 (CH1), 4.0 \u00d7 103 (A549), and 2.5 \u00d7 103 (SW480) viable cells per well. Cells were allowed to settle and resume exponential growth in drug-free complete culture medium for 24 h, followed by the addition of dilutions of the test compounds in 100 \u03bcL/well of the same medium. After continuous exposure for 96 h, the medium was replaced by a 100 \u03bcL/well RPMI 1640 medium (supplemented with 10% heat-inactivated fetal bovine serum and 4 mM l-glutamine) plus 20 \u03bcL/well solution of MTT in phosphate-buffered saline (5 mg/mL) (all purchased from Sigma-Aldrich). After incubation for 4 h, medium/MTT mixtures were removed, and the formazan product formed by viable cells was dissolved in DMSO (150 \u03bcL/well). Optical densities at 550 nm were measured with a microplate reader (Tecan Spectra Classic), using a reference wavelength of 690 nm to correct unspecific absorption. The quantity of viable cells was expressed as percentage of untreated controls, and 50% inhibitory concentrations (IC50) were calculated from concentration-effect curves by interpolation. Evaluation is based on at least two independent experiments, each comprising three replicates per concentration level.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 29, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><title>Synthesis</title><p>Our previous investigation of the \u201c(H<sub>2</sub>azole)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] \u2212 Hazole\u201d system resulted in osmium(III)chlorido compounds of the general formulas [Os<sup>III</sup>Cl<sub>2</sub>(Hazole)<sub>4</sub>]Cl and [Os<sup>III</sup>Cl<sub>3</sub>(Hazole)<sub>3</sub>]. The reduction occurred in boiling isoamyl alcohol or hexanol in the absence of any other reducing agent. In the case of the benzimidazole system we observed the formation of an intermediate species, namely, [Os<sup>IV</sup>Cl<sub>4</sub>(Hbzim)<sub>2</sub>]. This result prompted us to explore the following scheme for the synthesis of azolepentachloridoosmate(IV) complexes:<disp-formula id=\"ueq1\">\n<mml:math altimg=\"ic-2009-01671j_m001.gif\" display=\"block\" overflow=\"scroll\">\n<mml:msub>\n<mml:mrow>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:msub>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">H</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>2</mml:mn>\n</mml:mrow>\n</mml:msub>\n<mml:mtext>azole</mml:mtext>\n<mml:mo stretchy=\"false\">)</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>2</mml:mn>\n</mml:mrow>\n</mml:msub>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:msup>\n<mml:mrow>\n<mml:mtext>Os</mml:mtext>\n</mml:mrow>\n<mml:mrow>\n<mml:mtext>IV</mml:mtext>\n</mml:mrow>\n</mml:msup>\n<mml:msub>\n<mml:mrow>\n<mml:mtext>Cl</mml:mtext>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>6</mml:mn>\n</mml:mrow>\n</mml:msub>\n<mml:mo stretchy=\"false\">]</mml:mo>\n<mml:munder>\n<mml:mrow>\n<mml:mo>\u2192</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mo>\u2212</mml:mo>\n<mml:mi>H</mml:mi>\n<mml:mi>C</mml:mi>\n<mml:mi>l</mml:mi>\n</mml:mrow>\n</mml:munder>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:msub>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">H</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>2</mml:mn>\n</mml:mrow>\n</mml:msub>\n<mml:mtext>azole</mml:mtext>\n<mml:mo stretchy=\"false\">)</mml:mo>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:msup>\n<mml:mrow>\n<mml:mtext>Os</mml:mtext>\n</mml:mrow>\n<mml:mrow>\n<mml:mtext>IV</mml:mtext>\n</mml:mrow>\n</mml:msup>\n<mml:msub>\n<mml:mrow>\n<mml:mtext>Cl</mml:mtext>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>5</mml:mn>\n</mml:mrow>\n</mml:msub>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:mtext>Hazole</mml:mtext>\n<mml:mo stretchy=\"false\">)</mml:mo>\n<mml:mo stretchy=\"false\">]</mml:mo>\n<mml:munder>\n<mml:mrow>\n<mml:mo>\u2192</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mo>\u2212</mml:mo>\n<mml:mi>H</mml:mi>\n<mml:mi>C</mml:mi>\n<mml:mi>l</mml:mi>\n</mml:mrow>\n</mml:munder>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:msup>\n<mml:mrow>\n<mml:mtext>Os</mml:mtext>\n</mml:mrow>\n<mml:mrow>\n<mml:mtext>IV</mml:mtext>\n</mml:mrow>\n</mml:msup>\n<mml:msub>\n<mml:mrow>\n<mml:mtext>Cl</mml:mtext>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>4</mml:mn>\n</mml:mrow>\n</mml:msub>\n<mml:msub>\n<mml:mrow>\n<mml:mo stretchy=\"false\">(</mml:mo>\n<mml:mtext>Hazole</mml:mtext>\n<mml:mo stretchy=\"false\">)</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>2</mml:mn>\n</mml:mrow>\n</mml:msub>\n<mml:mo stretchy=\"false\">]</mml:mo>\n</mml:math>\n</disp-formula>\n</p>", "clean_text": "Results and Discussion\n\nSynthesis\n\nOur previous investigation of the \"(H2azole)2[OsIVCl6] - Hazole\" system resulted in osmium(III)chlorido compounds of the general formulas [OsIIICl2(Hazole)4]Cl and [OsIIICl3(Hazole)3]. The reduction occurred in boiling isoamyl alcohol or hexanol in the absence of any other reducing agent. In the case of the benzimidazole system we observed the formation of an intermediate species, namely, [OsIVCl4(Hbzim)2]. This result prompted us to explore the following scheme for the synthesis of azolepentachloridoosmate(IV) complexes:    (   H   2   azole )   2   [   Os   IV     Cl   6   ]   \u2192   - H C l   (   H   2   azole ) [   Os   IV     Cl   5   ( Hazole ) ]   \u2192   - H C l   [   Os   IV     Cl   4     ( Hazole )   2   ]   ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 30, "type": "text", "classification": ["else"], "content": "<p>Such transformations are known as Anderson rearrangements and can be performed both in the solid state and in solution. As starting materials the (H<sub>2</sub>azole)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] (Hazole = Him, Hpz, Hind, Hbzim) compounds were used. By following the reported protocol the triazole analogue (H<sub>2</sub>trz)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] was synthesized in 94% yield (see ).</p>", "clean_text": "Such transformations are known as Anderson rearrangements and can be performed both in the solid state and in solution. As starting materials the (H2azole)2[OsIVCl6] (Hazole = Him, Hpz, Hind, Hbzim) compounds were used. By following the reported protocol the triazole analogue (H2trz)2[OsIVCl6] was synthesized in 94% yield (see ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 31, "type": "text", "classification": ["else"], "content": "<p>The performed thermogravimetric analyses for (H<sub>2</sub>azole)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] did not confirm the expected stepwise liberation of one and then another molecule of HCl, which would have allowed the isolation of the reaction product after elimination of the first molecule of HCl. However, this approach proved to be more appropriate for the production of [Os<sup>IV</sup>Cl<sub>4</sub>(Hazole)<sub>2</sub>]. These latter compounds are of non-electrolytic type, insoluble in aqueous and other biocompatible media. Since we are primarily interested in water-soluble versions of compounds for the investigation of their biological properties, our research was focused on the synthesis of [Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup> species.</p>", "clean_text": "The performed thermogravimetric analyses for (H2azole)2[OsIVCl6] did not confirm the expected stepwise liberation of one and then another molecule of HCl, which would have allowed the isolation of the reaction product after elimination of the first molecule of HCl. However, this approach proved to be more appropriate for the production of [OsIVCl4(Hazole)2]. These latter compounds are of non-electrolytic type, insoluble in aqueous and other biocompatible media. Since we are primarily interested in water-soluble versions of compounds for the investigation of their biological properties, our research was focused on the synthesis of [OsIVCl5(Hazole)]- species.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 32, "type": "text", "classification": ["else"], "content": "<p>To quench the Anderson rearrangement after the first step, we performed the reaction in the presence of tetrabutylammonium chloride, thereby inducing the precipitation of [Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup> complexes as tetrabutylammonium salts. The reactions were carried out in boiling ethanol. As a result the complexes <bold>1</bold>, <bold>2</bold>, <bold>4</bold>, and <bold>5</bold> were synthesized in 24\u221279% yields. The synthesis of <bold>4</bold> was accompanied by concurrent formation of <italic toggle=\"yes\">trans</italic>\u2212[Os<sup>IV</sup>Cl<sub>4</sub>(Hbzim)<sub>2</sub>]. The reaction with (H<sub>2</sub>im)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] ended up by precipitation of {(Bu<sub>4</sub>N)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>]}<sub>2</sub>[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] (<bold>12</bold>) in 58% yield. The reaction of the imidazole system carried out in isoamyl alcohol at 100 \u00b0C afforded <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] and a minor amount of <bold>3</bold>. These results indicate that the [Os<sup>IV</sup>Cl<sub>5</sub>(Him)]<sup>\u2212</sup> species is formed as an intermediate, which is immediately converted into <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>]. The transformations in isoamyl alcohol are slower, allowing the isolation of the [Os<sup>IV</sup>Cl<sub>5</sub>(Him)]<sup>\u2212</sup> species.</p>", "clean_text": "To quench the Anderson rearrangement after the first step, we performed the reaction in the presence of tetrabutylammonium chloride, thereby inducing the precipitation of [OsIVCl5(Hazole)]- complexes as tetrabutylammonium salts. The reactions were carried out in boiling ethanol. As a result the complexes 1, 2, 4, and 5 were synthesized in 24-79% yields. The synthesis of 4 was accompanied by concurrent formation of trans-[OsIVCl4(Hbzim)2]. The reaction with (H2im)2[OsIVCl6] ended up by precipitation of {(Bu4N)2[OsIVCl6]}2[OsIVCl4(Him)2] (12) in 58% yield. The reaction of the imidazole system carried out in isoamyl alcohol at 100 \u00b0C afforded trans-[OsIVCl4(Him)2] and a minor amount of 3. These results indicate that the [OsIVCl5(Him)]- species is formed as an intermediate, which is immediately converted into trans-[OsIVCl4(Him)2]. The transformations in isoamyl alcohol are slower, allowing the isolation of the [OsIVCl5(Him)]- species.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 33, "type": "text", "classification": ["else"], "content": "<p>The observed reactivity of (H<sub>2</sub>azole)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] complexes in boiling ethanol agrees well with the electron donating properties of the azole ligands (Him &gt; Hbzim &gt; Htrz &gt; Hpz &gt; Hind), which account for the deeper substitution for imidazole and benzimidazole systems resulting in the formation of single and double substituted products. In the case of indazole and benzimidazole the corresponding complexes (Bu<sub>4</sub>N)[Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)] were isolated in higher yields because of poorer solubility of these compounds.</p>", "clean_text": "The observed reactivity of (H2azole)2[OsIVCl6] complexes in boiling ethanol agrees well with the electron donating properties of the azole ligands (Him > Hbzim > Htrz > Hpz > Hind), which account for the deeper substitution for imidazole and benzimidazole systems resulting in the formation of single and double substituted products. In the case of indazole and benzimidazole the corresponding complexes (Bu4N)[OsIVCl5(Hazole)] were isolated in higher yields because of poorer solubility of these compounds.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 34, "type": "text", "classification": ["else"], "content": "<p>To improve the aqueous solubility of (Bu<sub>4</sub>N)[Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)] compounds (Hazole = Hpz, Htrz, Hind) and to avoid the toxicity caused by the tetrabutylammonium cation, they were converted into their sodium (<bold>6</bold>\u2212<bold>8</bold>) and azolium salts (<bold>9</bold>\u2212<bold>11</bold>). The sodium salts were obtained in 91\u221298% yields by stirring the aqueous or aqueous/ethanolic solutions of <bold>1</bold>, <bold>2</bold>, and <bold>5</bold> with DOWEX Marathon C ion exchanger resin (1 g for 10 mg of the corresponding complex) for 30 min. These were further reacted with the in situ prepared azolium chloride in 1:1 or 1:2 molar ratio in water to give (H<sub>2</sub>azole)[Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)] (<bold>9</bold>\u2212<bold>11</bold>) in 52\u221278% yields.</p>", "clean_text": "To improve the aqueous solubility of (Bu4N)[OsIVCl5(Hazole)] compounds (Hazole = Hpz, Htrz, Hind) and to avoid the toxicity caused by the tetrabutylammonium cation, they were converted into their sodium (6-8) and azolium salts (9-11). The sodium salts were obtained in 91-98% yields by stirring the aqueous or aqueous/ethanolic solutions of 1, 2, and 5 with DOWEX Marathon C ion exchanger resin (1 g for 10 mg of the corresponding complex) for 30 min. These were further reacted with the in situ prepared azolium chloride in 1:1 or 1:2 molar ratio in water to give (H2azole)[OsIVCl5(Hazole)] (9-11) in 52-78% yields.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 35, "type": "text", "classification": ["else"], "content": "<title>Crystal Structures</title><p>The crystal structures of <bold>1</bold>\u2212<bold>5</bold> contain essentially octahedral complexes of the general formula [Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup> (Figures \n\n\u2212). Table  quotes some geometrical details of the complexes studied. Complexes <bold>1</bold>, <bold>2</bold>, and <bold>4</bold> crystallized in the triclinic space group <italic toggle=\"yes\">P</italic>1\u0305, while <bold>3</bold> and <bold>5</bold> in the monoclinic space group <italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic> and triclinic noncentrosymmetric space group <italic toggle=\"yes\">P</italic>1, respectively. The asymmetric unit of <bold>5</bold>, in contrast to those of <bold>1</bold>\u2212<bold>4</bold>, consists of two crystallographically independent complex anions, (see Figure c, Table ) with well-comparable metric parameters.</p>", "clean_text": "Crystal Structures\n\nThe crystal structures of 1-5 contain essentially octahedral complexes of the general formula [OsIVCl5(Hazole)]- (Figures   -). Table  quotes some geometrical details of the complexes studied. Complexes 1, 2, and 4 crystallized in the triclinic space group P1\u0305, while 3 and 5 in the monoclinic space group P21/n and triclinic noncentrosymmetric space group P1, respectively. The asymmetric unit of 5, in contrast to those of 1-4, consists of two crystallographically independent complex anions, (see Figure c, Table ) with well-comparable metric parameters.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 36, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Selected Bond Distances (\u00c5) in <bold>1</bold>\u2212<bold>5</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>4</bold>\u00b7CH<sub>3</sub>OH</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Os\u2212N1 [Os1\u2212N1, Os2\u2212N4]</oasis:entry>\n<oasis:entry>2.094(3)</oasis:entry>\n<oasis:entry>2.068(3)</oasis:entry>\n<oasis:entry>2.084(4)</oasis:entry>\n<oasis:entry>2.076(4)</oasis:entry>\n<oasis:entry>[2.086(4), 2.081(4)]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Os\u2212Cl<sub>axial</sub> [Os1\u2212Cl5, Os2\u2212Cl10]</oasis:entry>\n<oasis:entry>2.3132(9)</oasis:entry>\n<oasis:entry>2.3332(10)</oasis:entry>\n<oasis:entry>2.3445(13)</oasis:entry>\n<oasis:entry>2.3549(12)</oasis:entry>\n<oasis:entry>[2.3270(11), 2.3136(12)]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Os\u2212Cl<sub>equatorial</sub>(av) [Os1\u2212Cl1\u22124, Os2\u2212Cl6\u22129]</oasis:entry>\n<oasis:entry>2.333(11)</oasis:entry>\n<oasis:entry>2.325(11)</oasis:entry>\n<oasis:entry>2.331(21)</oasis:entry>\n<oasis:entry>2.332(4)</oasis:entry>\n<oasis:entry>[2.326(10), 2.328(11)]</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 37, "type": "text", "classification": ["else"], "content": "<p>The Os\u2212Cl bonds in <bold>1</bold>\u2212<bold>5</bold> are commonly significantly longer than in (Ph<sub>4</sub>P)[Os<sup>V</sup>Cl<sub>6</sub>] at 2.252(4)\u22122.295(2) or (Et<sub>4</sub>N)[Os<sup>V</sup>Cl<sub>6</sub>] at 2.295(3)\u22122.308(2) \u00c5 and well-comparable to those in (HPPh<sub>3</sub>)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>]\u00b7DMF at 2.330(5)\u22122.340(5) \u00c5.</p>", "clean_text": "The Os-Cl bonds in 1-5 are commonly significantly longer than in (Ph4P)[OsVCl6] at 2.252(4)-2.295(2) or (Et4N)[OsVCl6] at 2.295(3)-2.308(2) \u00c5 and well-comparable to those in (HPPh3)2[OsIVCl6]\u22c5DMF at 2.330(5)-2.340(5) \u00c5.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 38, "type": "text", "classification": ["else"], "content": "<p>Intra- and intermolecular hydrogen bonding interactions are evident in the crystal structure of <bold>1</bold> (Figure ).</p><p>The azole ligand coordinated to osmium(IV) via N1 is tilted relative to the mean plane through OsN1Cl3Cl5Cl1, OsN1Cl2Cl4Cl5, OsN1Cl2Cl5Cl4 and Os1N1Cl3Cl5Cl1, the corresponding dihedral angles being at 19.3(2), 38.89(6), 39.6(2), and 41.23(9)\u00b0 in <bold>1</bold>\u2212<bold>4</bold>, respectively (Figures \u2212). The triazole ligands in two crystallographically independent complex anions in <bold>5</bold>, which are bonded to osmium atoms via N1 and N4, are tilted relative to the mean planes through Os1N1Cl1Cl3Cl5 and Os2N4Cl7Cl9Cl10 at 45.5(2) and 38.5(1)\u00b0, respectively (Figure ).</p>", "clean_text": "Intra- and intermolecular hydrogen bonding interactions are evident in the crystal structure of 1 (Figure ).\n\nThe azole ligand coordinated to osmium(IV) via N1 is tilted relative to the mean plane through OsN1Cl3Cl5Cl1, OsN1Cl2Cl4Cl5, OsN1Cl2Cl5Cl4 and Os1N1Cl3Cl5Cl1, the corresponding dihedral angles being at 19.3(2), 38.89(6), 39.6(2), and 41.23(9)\u00b0 in 1-4, respectively (Figures -). The triazole ligands in two crystallographically independent complex anions in 5, which are bonded to osmium atoms via N1 and N4, are tilted relative to the mean planes through Os1N1Cl1Cl3Cl5 and Os2N4Cl7Cl9Cl10 at 45.5(2) and 38.5(1)\u00b0, respectively (Figure ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 39, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>ORTEP view of the [Os<sup>IV</sup>Cl<sub>5</sub>(Hpz)]<sup>\u2212</sup> anion involved in hydrogen bonding interactions with the adjacent complex anion in <bold>1</bold>, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (\u2212<italic toggle=\"yes\">x</italic> + 2, \u2212<italic toggle=\"yes\">y</italic> + 2, \u2212<italic toggle=\"yes\">z</italic> + 1). Hydrogen bonding parameters: N2\u2212H\u00b7\u00b7\u00b7Cl3 and N2\u2212H\u00b7\u00b7\u00b7Cl4<sup>i</sup> (N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl3 2.580, N2\u00b7\u00b7\u00b7Cl3 3.093 \u00c5, N2HCl3 118.04\u00b0, H\u00b7\u00b7\u00b7Cl4<sup>i</sup> 2.693, N2\u00b7\u00b7\u00b7Cl4<sup>i</sup> 3.296 \u00c5, N2HCl4<sup>i</sup> 126.71\u00b0).</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0003.tif\"></graphic>\n</fig>", "clean_text": " 1  ORTEP view of the [OsIVCl5(Hpz)]- anion involved in hydrogen bonding interactions with the adjacent complex anion in 1, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (-x + 2, -y + 2, -z + 1). Hydrogen bonding parameters: N2-H\u22c5\u22c5\u22c5Cl3 and N2-H\u22c5\u22c5\u22c5Cl4i (N2-H 0.88, H\u22c5\u22c5\u22c5Cl3 2.580, N2\u22c5\u22c5\u22c5Cl3 3.093 \u00c5, N2HCl3 118.04\u00b0, H\u22c5\u22c5\u22c5Cl4i 2.693, N2\u22c5\u22c5\u22c5Cl4i 3.296 \u00c5, N2HCl4i 126.71\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 40, "type": "text", "classification": ["else"], "content": "<p>Intermolecular hydrogen bonding interactions in <bold>2</bold> are shown in Figure .</p><p>The complex anions [Os<sup>IV</sup>Cl<sub>5</sub>(Him)]<sup>\u2212</sup> in <bold>3</bold> form a 1D chain via intermolecular hydrogen bonding interactions of the type N\u2212H\u00b7\u00b7\u00b7Cl (Figure ).</p><p>The molecule of CH<sub>3</sub>OH in the crystal structure of <bold>4</bold>\u00b7CH<sub>3</sub>OH, acts as proton donor in a bifurcated hydrogen bond to chloride ligands Cl2<sup>i</sup> and Cl5<sup>i</sup> and as proton acceptor in the hydrogen bond N2\u2212H\u00b7\u00b7\u00b7O1 (Figure ).</p>", "clean_text": "Intermolecular hydrogen bonding interactions in 2 are shown in Figure .\n\nThe complex anions [OsIVCl5(Him)]- in 3 form a 1D chain via intermolecular hydrogen bonding interactions of the type N-H\u22c5\u22c5\u22c5Cl (Figure ).\n\nThe molecule of CH3OH in the crystal structure of 4\u22c5CH3OH, acts as proton donor in a bifurcated hydrogen bond to chloride ligands Cl2i and Cl5i and as proton acceptor in the hydrogen bond N2-H\u22c5\u22c5\u22c5O1 (Figure ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 41, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>ORTEP view of the [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup> anion involved in hydrogen bonding interactions with the adjacent complex anion in <bold>2</bold>, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (\u2212<italic toggle=\"yes\">x</italic> + 1, \u2212<italic toggle=\"yes\">y</italic> + 1, \u2212<italic toggle=\"yes\">z</italic> + 1). Hydrogen bonding parameters: N2\u2212H\u00b7\u00b7\u00b7Cl1<sup>i</sup> (N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl1<sup>i</sup> 2.611, N2\u00b7\u00b7\u00b7Cl1<sup>i</sup> 3.354 \u00c5, N2HCl1<sup>i</sup> 142.81\u00b0).</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0004.tif\"></graphic>\n</fig>", "clean_text": " 2  ORTEP view of the [OsIVCl5(Hind)]- anion involved in hydrogen bonding interactions with the adjacent complex anion in 2, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (-x + 1, -y + 1, -z + 1). Hydrogen bonding parameters: N2-H\u22c5\u22c5\u22c5Cl1i (N2-H 0.88, H\u22c5\u22c5\u22c5Cl1i 2.611, N2\u22c5\u22c5\u22c5Cl1i 3.354 \u00c5, N2HCl1i 142.81\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 42, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>ORTEP view of the [Os<sup>IV</sup>Cl<sub>5</sub>(Him)]<sup>\u2212</sup> anion (a) in <bold>3</bold>, the [Os<sup>IV</sup>Cl<sub>5</sub>(Hbzim)]<sup>\u2212</sup> anion (b) in <bold>4</bold>\u00b7CH<sub>3</sub>OH, and of the two crystallographically independent [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup> anions (c) in <bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0005.tif\"></graphic>\n</fig>", "clean_text": " 3  ORTEP view of the [OsIVCl5(Him)]- anion (a) in 3, the [OsIVCl5(Hbzim)]- anion (b) in 4\u22c5CH3OH, and of the two crystallographically independent [OsIVCl5(Htrz)]- anions (c) in 5\u22c5C2H5OH, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 43, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Part of the crystal structure of <bold>3</bold>, showing the 1D arrangement of osmium(IV) complexes via intermolecular hydrogen-bonding interactions. Atoms marked i are at the symmetry positions (<italic toggle=\"yes\">x</italic> \u2212 0.5, \u2212<italic toggle=\"yes\">y</italic> + 0.5, <italic toggle=\"yes\">z</italic> \u2212 0.5). Hydrogen-bonding parameters: N2\u2212H\u00b7\u00b7\u00b7Cl1<sup>i</sup> and N2\u2212H\u00b7\u00b7\u00b7Cl5<sup>i</sup> (N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl1<sup>i</sup> 2.652, N2\u00b7\u00b7\u00b7Cl1<sup>i</sup> 3.340 \u00c5, N2HCl1<sup>i</sup> 135.78; H\u00b7\u00b7\u00b7Cl5<sup>i</sup> 2.679, N2\u00b7\u00b7\u00b7Cl5<sup>i</sup> 3.380 \u00c5, N2HCl5<sup>i</sup> 137.44\u00b0).</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0006.tif\"></graphic>\n</fig>", "clean_text": " 4  Part of the crystal structure of 3, showing the 1D arrangement of osmium(IV) complexes via intermolecular hydrogen-bonding interactions. Atoms marked i are at the symmetry positions (x - 0.5, -y + 0.5, z - 0.5). Hydrogen-bonding parameters: N2-H\u22c5\u22c5\u22c5Cl1i and N2-H\u22c5\u22c5\u22c5Cl5i (N2-H 0.88, H\u22c5\u22c5\u22c5Cl1i 2.652, N2\u22c5\u22c5\u22c5Cl1i 3.340 \u00c5, N2HCl1i 135.78; H\u22c5\u22c5\u22c5Cl5i 2.679, N2\u22c5\u22c5\u22c5Cl5i 3.380 \u00c5, N2HCl5i 137.44\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 44, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Part of the crystal structure of <bold>4</bold>\u00b7CH<sub>3</sub>OH,, showing the intermolecular hydrogen-bonding interactions between complex anions and solvent molecules. Atoms marked i are at the symmetry positions (\u2212<italic toggle=\"yes\">x +</italic> 1, \u2212<italic toggle=\"yes\">y</italic> + 2, \u2212<italic toggle=\"yes\">z</italic> + 1). Hydrogen-bonding parameters: N2\u2212H\u00b7\u00b7\u00b7O1 (N2\u2212H 0.88, H\u00b7\u00b7\u00b7O1 1.886, N2\u00b7\u00b7\u00b7O1 2.763 \u00c5, N2HO1 174.08\u00b0) and O1\u2212H\u00b7\u00b7\u00b7Cl2<sup>i</sup> and O1\u2212H\u00b7\u00b7\u00b7Cl5<sup>i</sup> (O1\u2212H 0.84, H\u00b7\u00b7\u00b7Cl2<sup>i</sup> 2.829, O1\u00b7\u00b7\u00b7Cl2<sup>i</sup> 3.473 \u00c5, O1HCl2<sup>i</sup> 134.90; H\u00b7\u00b7\u00b7Cl5<sup>i</sup> 2.507, O1\u00b7\u00b7\u00b7Cl5<sup>i</sup> 3.235 \u00c5, O1HCl5<sup>i</sup> 145.44\u00b0).</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0007.tif\"></graphic>\n</fig>", "clean_text": " 5  Part of the crystal structure of 4\u22c5CH3OH,, showing the intermolecular hydrogen-bonding interactions between complex anions and solvent molecules. Atoms marked i are at the symmetry positions (-x + 1, -y + 2, -z + 1). Hydrogen-bonding parameters: N2-H\u22c5\u22c5\u22c5O1 (N2-H 0.88, H\u22c5\u22c5\u22c5O1 1.886, N2\u22c5\u22c5\u22c5O1 2.763 \u00c5, N2HO1 174.08\u00b0) and O1-H\u22c5\u22c5\u22c5Cl2i and O1-H\u22c5\u22c5\u22c5Cl5i (O1-H 0.84, H\u22c5\u22c5\u22c5Cl2i 2.829, O1\u22c5\u22c5\u22c5Cl2i 3.473 \u00c5, O1HCl2i 134.90; H\u22c5\u22c5\u22c5Cl5i 2.507, O1\u22c5\u22c5\u22c5Cl5i 3.235 \u00c5, O1HCl5i 145.44\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 45, "type": "text", "classification": ["else"], "content": "<p>An interesting feature is the stabilization of the 4<italic toggle=\"yes\">H</italic> tautomeric form of the 1,2,4-triazole in <bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH through bonding of the ligand via N2 in the nomenclature used for 1<italic toggle=\"yes\">H</italic>- or 4<italic toggle=\"yes\">H</italic>-1,2,4-triazole. Note that in the solid Htrz crystallizes exclusively as a 1<italic toggle=\"yes\">H</italic>-tautomer. This rare behavior was also documented recently for (H<sub>2</sub>trz)[<italic toggle=\"yes\">cis</italic>-Ru<sup>III</sup>Cl<sub>4</sub>(Htrz)<sub>2</sub>]\u00b7H<sub>2</sub>O, (Ph<sub>3</sub>PCH<sub>2</sub>Ph)[<italic toggle=\"yes\">trans</italic>-Ru<sup>III</sup>Cl<sub>4</sub>(Htrz)<sub>2</sub>], and <italic toggle=\"yes\">mer</italic>-[Ru<sup>III</sup>Cl<sub>3</sub>(Htrz)<sub>3</sub>]. The established mode of coordination of 1,2,4-triazole is also corroborated by participation of all non-coordinated nitrogen atoms in strong hydrogen bonding interactions, as shown in Figure . The atoms N3 and N6 act as proton donors to N5 and N2, Cl2, correspondingly.</p>", "clean_text": "An interesting feature is the stabilization of the 4H tautomeric form of the 1,2,4-triazole in 5\u22c5C2H5OH through bonding of the ligand via N2 in the nomenclature used for 1H- or 4H-1,2,4-triazole. Note that in the solid Htrz crystallizes exclusively as a 1H-tautomer. This rare behavior was also documented recently for (H2trz)[cis-RuIIICl4(Htrz)2]\u22c5H2O, (Ph3PCH2Ph)[trans-RuIIICl4(Htrz)2], and mer-[RuIIICl3(Htrz)3]. The established mode of coordination of 1,2,4-triazole is also corroborated by participation of all non-coordinated nitrogen atoms in strong hydrogen bonding interactions, as shown in Figure . The atoms N3 and N6 act as proton donors to N5 and N2, Cl2, correspondingly.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 46, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Part of the crystal structure of <bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH, showing the 1D arrangement of osmium(IV) complexes via strong intermolecular hydrogen-bonding interactions. Atoms marked i and ii are at the symmetry positions (<italic toggle=\"yes\">x</italic>, <italic toggle=\"yes\">y</italic> + 1, <italic toggle=\"yes\">z</italic>) and (<italic toggle=\"yes\">x</italic> + 1, <italic toggle=\"yes\">y</italic> \u2212 1, <italic toggle=\"yes\">z</italic>), respectively. Hydrogen-bonding parameters: N3\u2212H\u00b7\u00b7\u00b7N5<sup>i</sup> (N3\u2212H 0.88, H\u00b7\u00b7\u00b7N5<sup>i</sup> 1.920, N3\u00b7\u00b7\u00b7N5<sup>i</sup> 2.792 \u00c5, N3HN5 170.39\u00b0), N6<sup>ii</sup>\u2212H\u00b7\u00b7\u00b7N2, and N6<sup>ii</sup>\u2212H\u00b7\u00b7\u00b7Cl2 (N6<sup>ii</sup>\u2212H 0.88, H\u00b7\u00b7\u00b7N2 1.918, N6<sup>ii</sup>\u00b7\u00b7\u00b7N2 2.785 \u00c5, N6<sup>ii</sup>HN2 168.0\u00b0; H\u00b7\u00b7\u00b7Cl2 2.926, N6<sup>ii</sup>\u00b7\u00b7\u00b7Cl2 3.344 \u00c5, N6<sup>ii</sup>HCl2 111.03\u00b0).</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0008.tif\"></graphic>\n</fig>", "clean_text": " 6  Part of the crystal structure of 5\u22c5C2H5OH, showing the 1D arrangement of osmium(IV) complexes via strong intermolecular hydrogen-bonding interactions. Atoms marked i and ii are at the symmetry positions (x, y + 1, z) and (x + 1, y - 1, z), respectively. Hydrogen-bonding parameters: N3-H\u22c5\u22c5\u22c5N5i (N3-H 0.88, H\u22c5\u22c5\u22c5N5i 1.920, N3\u22c5\u22c5\u22c5N5i 2.792 \u00c5, N3HN5 170.39\u00b0), N6ii-H\u22c5\u22c5\u22c5N2, and N6ii-H\u22c5\u22c5\u22c5Cl2 (N6ii-H 0.88, H\u22c5\u22c5\u22c5N2 1.918, N6ii\u22c5\u22c5\u22c5N2 2.785 \u00c5, N6iiHN2 168.0\u00b0; H\u22c5\u22c5\u22c5Cl2 2.926, N6ii\u22c5\u22c5\u22c5Cl2 3.344 \u00c5, N6iiHCl2 111.03\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 47, "type": "text", "classification": ["else"], "content": "<p>Complex <bold>6</bold> crystallized in the triclinic centrosymmetric space group <italic toggle=\"yes\">P</italic>1\u0305. The crystal structure (Figure ) shows that it is an infinite 1D chain consisting of centrosymmetric dimers of heterometallic (Os\u2212Na) entities running along <italic toggle=\"yes\">a</italic> axis. The octahedral osmium(IV) atom is bound to five chlorido ligands and a pyrazole molecule through nitrogen atom N1. The Cl1 and Cl5 atoms act as bridging ligands between osmium(IV) and the neighboring sodium cation, which is six-coordinate. The latter is also bound with two water molecules via O1 and O2, which act as bridging ligands to two other centrosymmetry related sodium cations. The inversion center resides in the middle of the vector connecting the two atoms Na and Na<sup>i</sup> (<italic toggle=\"yes\">x</italic> + 1, <italic toggle=\"yes\">y</italic> + 1, <italic toggle=\"yes\">z</italic> + 1). The Na\u2212O1 and Na\u2212O2 distances of 2.346(4) and 2.340(4) \u00c5, respectively, are well comparable with those found in penta-\u03bc-aqua-disodium(I) bis(dimethylarsenate), {[Na<sub>2</sub>(H<sub>2</sub>O)<sub>5</sub>](C<sub>2</sub>H<sub>6</sub>AsO<sub>2</sub>)<sub>2</sub>}<sub>\n<italic toggle=\"yes\">n</italic>\n</sub> at 2.317(3)\u22122.422(2) \u00c5.\n</p>", "clean_text": "Complex 6 crystallized in the triclinic centrosymmetric space group P1\u0305. The crystal structure (Figure ) shows that it is an infinite 1D chain consisting of centrosymmetric dimers of heterometallic (Os-Na) entities running along a axis. The octahedral osmium(IV) atom is bound to five chlorido ligands and a pyrazole molecule through nitrogen atom N1. The Cl1 and Cl5 atoms act as bridging ligands between osmium(IV) and the neighboring sodium cation, which is six-coordinate. The latter is also bound with two water molecules via O1 and O2, which act as bridging ligands to two other centrosymmetry related sodium cations. The inversion center resides in the middle of the vector connecting the two atoms Na and Nai (x + 1, y + 1, z + 1). The Na-O1 and Na-O2 distances of 2.346(4) and 2.340(4) \u00c5, respectively, are well comparable with those found in penta-\u03bc-aqua-disodium(I) bis(dimethylarsenate), {[Na2(H2O)5](C2H6AsO2)2} n  at 2.317(3)-2.422(2) \u00c5. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 48, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<caption>\n<p>Projection of a part of the crystal structure of [Na(H<sub>2</sub>O)<sub>2</sub>OsCl<sub>5</sub>(Hpz)]<sub>\n<italic toggle=\"yes\">n</italic>\n</sub> on the <italic toggle=\"yes\">ac</italic> plane of the unit cell, showing the formation of an infinite 1D chain in <bold>6</bold>\u00b72H<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0009.tif\"></graphic>\n</fig>", "clean_text": " 7  Projection of a part of the crystal structure of [Na(H2O)2OsCl5(Hpz)] n  on the ac plane of the unit cell, showing the formation of an infinite 1D chain in 6\u22c52H2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 49, "type": "text", "classification": "error", "content": "<p>Complex <bold>12</bold> crystallized in the monoclinic space group <italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic>. The crystal structure of <bold>12</bold> consists of neutral complexes <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] and ionic complexes (Bu<sub>4</sub>N)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] in 1:2 molar ratio. The neutral complex is octahedral (Figure ). The osmium(IV) atom is bound to four chlorido ligands in the equatorial plane and to two monodentate imidazole ligands in axial positions. The Os\u2212N1 bond of 2.058(6) \u00c5 is significantly shorter than the Ru\u2212N3 bond of 2.081(5) \u00c5 in [P(C<sub>6</sub>H<sub>5</sub>)<sub>4</sub>][Ru<sup>III</sup>Cl<sub>4</sub>(5-NO<sub>2</sub>Him)<sub>2</sub>] as well as the Ru\u2212N1 and Ru\u2212N3 bonds of 2.0687(12) and 2.0682(12) \u00c5, respectively, in <italic toggle=\"yes\">trans</italic>-[Ru<sup>III</sup>Cl<sub>2</sub>(Him)<sub>4</sub>]Cl. The Os\u2212Cl1 bond of 2.3354(19) \u00c5 is significantly longer than the Os\u2212Cl2 bond of 2.310(2) \u00c5 because of partake of Cl1 as a proton acceptor in two intramolecular hydrogen bonding interactions of the type Cl1\u00b7\u00b7\u00b7H\u2212C1 and Cl1\u00b7\u00b7\u00b7H\u2212C3<sup>i</sup>(\u2212<italic toggle=\"yes\">x</italic> + 2, \u2212<italic toggle=\"yes\">y</italic> + 1, \u2212<italic toggle=\"yes\">z</italic> + 2). At the same time C1 acts as a proton donor in intermolecular hydrogen bonding of the complex <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] with [Os<sup>IV</sup>Cl<sub>6</sub>]<sup>2\u2212</sup> (Figure ), where Cl6<sup>ii</sup> acts as a proton acceptor. In addition, N2 acts as a proton donor and Cl3<sup>ii</sup> and Cl8<sup>ii</sup> as proton acceptors in an intermolecular bifurcated hydrogen bond between the two species (Figure ). The elongation of the bonds Os2\u2212Cl3 and Os2\u2212Cl6 of 2.3685(18) and 2.3487(19), correspondingly, as compared to Os2\u2212Cl4, Os2\u2212Cl5, and Os2\u2212Cl7 of 2.3299(19), 2.3291(18), and 2.3350(19) \u00c5, respectively, is obvious.</p>", "clean_text": "Complex 12 crystallized in the monoclinic space group P21/n. The crystal structure of 12 consists of neutral complexes trans-[OsIVCl4(Him)2] and ionic complexes (Bu4N)2[OsIVCl6] in 1:2 molar ratio. The neutral complex is octahedral (Figure ). The osmium(IV) atom is bound to four chlorido ligands in the equatorial plane and to two monodentate imidazole ligands in axial positions. The Os-N1 bond of 2.058(6) \u00c5 is significantly shorter than the Ru-N3 bond of 2.081(5) \u00c5 in [P(C6H5)4][RuIIICl4(5-NO2Him)2] as well as the Ru-N1 and Ru-N3 bonds of 2.0687(12) and 2.0682(12) \u00c5, respectively, in trans-[RuIIICl2(Him)4]Cl. The Os-Cl1 bond of 2.3354(19) \u00c5 is significantly longer than the Os-Cl2 bond of 2.310(2) \u00c5 because of partake of Cl1 as a proton acceptor in two intramolecular hydrogen bonding interactions of the type Cl1\u22c5\u22c5\u22c5H-C1 and Cl1\u22c5\u22c5\u22c5H-C3i(-x + 2, -y + 1, -z + 2). At the same time C1 acts as a proton donor in intermolecular hydrogen bonding of the complex trans-[OsIVCl4(Him)2] with [OsIVCl6]2- (Figure ), where Cl6ii acts as a proton acceptor. In addition, N2 acts as a proton donor and Cl3ii and Cl8ii as proton acceptors in an intermolecular bifurcated hydrogen bond between the two species (Figure ). The elongation of the bonds Os2-Cl3 and Os2-Cl6 of 2.3685(18) and 2.3487(19), correspondingly, as compared to Os2-Cl4, Os2-Cl5, and Os2-Cl7 of 2.3299(19), 2.3291(18), and 2.3350(19) \u00c5, respectively, is obvious.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 50, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" orientation=\"portrait\" position=\"float\">\n<label>8</label>\n<caption>\n<p>ORTEP view of the fragment of the crystal structure of <bold>12</bold>, showing intra- and intermolecular hydrogen bonding interactions between the complex <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] and the complex anion [Os<sup>IV</sup>Cl<sub>6</sub>]<sup>2\u2212</sup> with atom-numbering scheme. The thermal displacement ellipsoids are drawn at 50% probability level. Hydrogen bonding parameters: Cl1\u00b7\u00b7\u00b7H\u2212C1 [Cl1\u00b7\u00b7\u00b7H 2.565, Cl1\u00b7\u00b7\u00b7C1 3.117, H\u2212C1 0.95 \u00c5, Cl1HC1 117.2\u00b0], Cl1\u00b7\u00b7\u00b7H\u2212C3<sup>i</sup> [Cl1\u00b7\u00b7\u00b7H 2.737, Cl1\u00b7\u00b7\u00b7C3<sup>i</sup> 3.216, H\u2212C3<sup>i</sup> 0.95 \u00c5, Cl1HC3<sup>i</sup> 112.1\u00b0], C1\u2212H\u00b7\u00b7\u00b7Cl6<sup>ii</sup> [C1\u2212H 0.95, H\u00b7\u00b7\u00b7Cl6<sup>ii</sup> 2.671, C1\u00b7\u00b7\u00b7Cl6<sup>ii</sup> 3.395 \u00c5, C1HCl6<sup>ii</sup> 133.4\u00b0], N2\u2212H\u00b7\u00b7\u00b7Cl3<sup>ii</sup> and N2\u2212H\u00b7\u00b7\u00b7Cl8<sup>ii</sup> [N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl3<sup>ii</sup> 2.471, N2\u00b7\u00b7\u00b7Cl3<sup>ii</sup> 3.314 \u00c5, N2HCl3<sup>ii</sup> 160.64\u00b0; H\u00b7\u00b7\u00b7Cl8<sup>ii</sup> 2.925, N2\u00b7\u00b7\u00b7Cl8<sup>ii</sup> 3.491 \u00c5, N2HCl8<sup>ii</sup> 123.77\u00b0]. Atoms marked i are at the symmetry positions <italic toggle=\"yes\">x</italic> + 2, <italic toggle=\"yes\">y</italic> + 1, <italic toggle=\"yes\">z</italic> + 2, and those marked ii at the symmetry positions <italic toggle=\"yes\">x</italic> + 1, <italic toggle=\"yes\">y</italic> + 1, <italic toggle=\"yes\">z</italic> + 1.</p>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0010.tif\"></graphic>\n</fig>", "clean_text": " 8  ORTEP view of the fragment of the crystal structure of 12, showing intra- and intermolecular hydrogen bonding interactions between the complex trans-[OsIVCl4(Him)2] and the complex anion [OsIVCl6]2- with atom-numbering scheme. The thermal displacement ellipsoids are drawn at 50% probability level. Hydrogen bonding parameters: Cl1\u22c5\u22c5\u22c5H-C1 [Cl1\u22c5\u22c5\u22c5H 2.565, Cl1\u22c5\u22c5\u22c5C1 3.117, H-C1 0.95 \u00c5, Cl1HC1 117.2\u00b0], Cl1\u22c5\u22c5\u22c5H-C3i [Cl1\u22c5\u22c5\u22c5H 2.737, Cl1\u22c5\u22c5\u22c5C3i 3.216, H-C3i 0.95 \u00c5, Cl1HC3i 112.1\u00b0], C1-H\u22c5\u22c5\u22c5Cl6ii [C1-H 0.95, H\u22c5\u22c5\u22c5Cl6ii 2.671, C1\u22c5\u22c5\u22c5Cl6ii 3.395 \u00c5, C1HCl6ii 133.4\u00b0], N2-H\u22c5\u22c5\u22c5Cl3ii and N2-H\u22c5\u22c5\u22c5Cl8ii [N2-H 0.88, H\u22c5\u22c5\u22c5Cl3ii 2.471, N2\u22c5\u22c5\u22c5Cl3ii 3.314 \u00c5, N2HCl3ii 160.64\u00b0; H\u22c5\u22c5\u22c5Cl8ii 2.925, N2\u22c5\u22c5\u22c5Cl8ii 3.491 \u00c5, N2HCl8ii 123.77\u00b0]. Atoms marked i are at the symmetry positions x + 2, y + 1, z + 2, and those marked ii at the symmetry positions x + 1, y + 1, z + 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 51, "type": "text", "classification": "error", "content": "<title>NMR Spectra</title><p>The <sup>1</sup>H and <sup>13</sup>C NMR spectra of the reported compounds show signals due to (Bu<sub>4</sub>N)<sup>+</sup> (<bold>1</bold>, <bold>2</bold>, <bold>4</bold>, <bold>5</bold>, <bold>12</bold>) or (H<sub>2</sub>azole)<sup>+</sup> (<bold>9</bold>\u2212<bold>11</bold>) cations and coordinated azole heterocycles (<bold>1</bold>\u2212<bold>12</bold>, but not <bold>3</bold>).</p><p>The <sup>1</sup>H NMR spectrum of (Bu<sub>4</sub>N)<sup>+</sup> (<bold>1</bold>, <bold>2</bold>, <bold>4</bold>, <bold>5</bold>, <bold>12</bold>) is well resolved and displays, as expected, a triplet for the C<italic toggle=\"yes\">H</italic>\n<sub>3</sub> group (D) at 0.95 ppm, a sextet for the C<italic toggle=\"yes\">H</italic>\n<sub>2</sub> group (C) at 1.32 ppm, a quintet for the C<italic toggle=\"yes\">H</italic>\n<sub>2</sub> group (B) at 1.58 ppm, and a triplet for the C<italic toggle=\"yes\">H</italic>\n<sub>2</sub> group (A) at 3.17 ppm with integration ratio 3:2:2:2 (for atom labeling see Chart ). The <sup>13</sup>C{<sup>1</sup>H} NMR spectra of the (Bu<sub>4</sub>N)<sup>+</sup> cation (<bold>1</bold>, <bold>2</bold>) show four signals: one for CH<sub>3</sub> at 14.1 (C<sub>D</sub>) ppm and three for CH<sub>2</sub> at 19.8 (C<sub>C</sub>), 23.7 (C<sub>B</sub>), and 58.4 (C<sub>A</sub>) ppm.</p>", "clean_text": "NMR Spectra\n\nThe 1H and 13C NMR spectra of the reported compounds show signals due to (Bu4N)+ (1, 2, 4, 5, 12) or (H2azole)+ (9-11) cations and coordinated azole heterocycles (1-12, but not 3).\n\nThe 1H NMR spectrum of (Bu4N)+ (1, 2, 4, 5, 12) is well resolved and displays, as expected, a triplet for the CH 3 group (D) at 0.95 ppm, a sextet for the CH 2 group (C) at 1.32 ppm, a quintet for the CH 2 group (B) at 1.58 ppm, and a triplet for the CH 2 group (A) at 3.17 ppm with integration ratio 3:2:2:2 (for atom labeling see Chart ). The 13C{1H} NMR spectra of the (Bu4N)+ cation (1, 2) show four signals: one for CH3 at 14.1 (CD) ppm and three for CH2 at 19.8 (CC), 23.7 (CB), and 58.4 (CA) ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 52, "type": "text", "classification": "error", "content": "<p>\n<sup>1</sup>H NMR spectra of azolium cations reveal a set of split signals which is typical for a protonated azole heterocycle: two singlets for the pyrazolium cation in <bold>9</bold> at 6.31 and 7.68 ppm with relative intensities 1:2 (1H<sub>4</sub>\u2032, 2H<sub>3,5</sub>\u2032), in accord with <italic toggle=\"yes\">C</italic>\n<sub>2</sub> molecular symmetry for this cation; two triplets at 7.11 (1H<sub>5</sub>\u2032) and 7.34 (1H<sub>6</sub>\u2032) ppm, two doublets at 7.53 (1H<sub>7</sub>\u2032) and 7.75 ppm (1H<sub>4</sub>\u2032), and one singlet at 8.08 ppm (1H<sub>3</sub>\u2032) for the indazolium cation in <bold>10</bold>; one singlet at 8.71 ppm (H<sub>3,5</sub>\u2032) for the triazolium cation in <bold>11</bold>, in line with its <italic toggle=\"yes\">C</italic>\n<sub>2</sub> own symmetry.</p>", "clean_text": " 1H NMR spectra of azolium cations reveal a set of split signals which is typical for a protonated azole heterocycle: two singlets for the pyrazolium cation in 9 at 6.31 and 7.68 ppm with relative intensities 1:2 (1H4', 2H3,5'), in accord with C 2 molecular symmetry for this cation; two triplets at 7.11 (1H5') and 7.34 (1H6') ppm, two doublets at 7.53 (1H7') and 7.75 ppm (1H4'), and one singlet at 8.08 ppm (1H3') for the indazolium cation in 10; one singlet at 8.71 ppm (H3,5') for the triazolium cation in 11, in line with its C 2 own symmetry.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 53, "type": "text", "classification": ["else"], "content": "<p>The assignment of the protons and carbon atoms in coordinated azoles is hindered because of their coordination to paramagnetic (low-spin d<sup>4</sup>) osmium(IV). The paramagnetism causes broadening of the signals and shift to negative values, especially for the protons which are closer to the metal center. It should, however, be noted that the effect of the paramagnetic center is not the same for complexes with different azole heterocycles. Some of them have <sup>1</sup>H NMR spectra with resonances as sharp as those observed in diamagnetic compounds and shifted very little as compared with diamagnetic complexes. We succeeded to obtain two-dimensional NMR spectra for the pyrazole compounds <bold>1</bold> (<sup>15</sup>N,<sup>1</sup>H HSQC, <sup>13</sup>C,<sup>1</sup>H HSQC) and <bold>9</bold> (<sup>15</sup>N,<sup>1</sup>H HSQC, <sup>13</sup>C,<sup>1</sup>H HSQC, <sup>13</sup>C,<sup>1</sup>H HMBC) and for the indazole species <bold>2</bold> (<sup>15</sup>N,<sup>1</sup>H HSQC, <sup>13</sup>C,<sup>1</sup>H HSQC, <sup>13</sup>C,<sup>1</sup>H HMBC, <sup>1</sup>H,<sup>1</sup>H NOESY, <sup>1</sup>H,<sup>1</sup>H COSY) (see ).</p>", "clean_text": "The assignment of the protons and carbon atoms in coordinated azoles is hindered because of their coordination to paramagnetic (low-spin d4) osmium(IV). The paramagnetism causes broadening of the signals and shift to negative values, especially for the protons which are closer to the metal center. It should, however, be noted that the effect of the paramagnetic center is not the same for complexes with different azole heterocycles. Some of them have 1H NMR spectra with resonances as sharp as those observed in diamagnetic compounds and shifted very little as compared with diamagnetic complexes. We succeeded to obtain two-dimensional NMR spectra for the pyrazole compounds 1 (15N,1H HSQC, 13C,1H HSQC) and 9 (15N,1H HSQC, 13C,1H HSQC, 13C,1H HMBC) and for the indazole species 2 (15N,1H HSQC, 13C,1H HSQC, 13C,1H HMBC, 1H,1H NOESY, 1H,1H COSY) (see ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 54, "type": "text", "classification": "error", "content": "<title>\n<italic toggle=\"yes\">Pyrazole Compounds</italic>\n</title><p>The H<sub>1</sub> proton of the ligand was identified at 15.71 ppm from the <sup>15</sup>N,<sup>1</sup>H HSQC plot (<bold>1</bold>, <bold>9</bold>). Because of the <italic toggle=\"yes\">C</italic>\n<sub>\n<italic toggle=\"yes\">s</italic>\n</sub> own symmetry of the coordinated pyrazole, the H<sub>3</sub> and H<sub>5</sub> signals in the <sup>1</sup>H NMR spectra of <bold>1</bold>, <bold>6</bold>, and <bold>9</bold> do not overlap, as it is the case for the pyrazolium cation. The resonance signals H<sub>3</sub>, H<sub>4</sub>, and H<sub>5</sub> are observed as singlets at \u22122.75, \u22122.48, and 6.34 ppm for <bold>6</bold> and at \u22122.71, \u22122.44, and 6.39 ppm for <bold>1</bold> and <bold>9</bold>. In the <sup>13</sup>C{<sup>1</sup>H} NMR spectra of <bold>1</bold> and <bold>9</bold> the carbon resonances for C<sub>3</sub>, C<sub>4</sub>, and C<sub>5</sub> are displayed at 71.08 {6.39}, 180.92 {\u22122.71}, 191.31 {\u22122.44} and 71.18 {6.39}, 181.33 {\u22122.71}, 191.99 {\u22122.44} ppm, respectively. In addition, the pyrazolium cation in <bold>9</bold> gives two C<italic toggle=\"yes\">H</italic> signals at 106.16 (C<sub>4</sub>\u2032) and 134.25 (C<sub>3,5</sub>\u2032) ppm. The <sup>13</sup>C,<sup>1</sup>H HMBC plot of <bold>9</bold> does not clarify the assignment of C<sub>3</sub>, C<sub>4</sub>, C<sub>5</sub> and H<sub>3</sub>, H<sub>4</sub>, H<sub>5</sub> because of the same number of cross-signals for these carbon atoms and protons (two cross-peaks for every atom). H<sub>1</sub> has C<italic toggle=\"yes\">H</italic> couplings with C<sub>3</sub>, C<sub>4</sub>, and C<sub>5</sub>.</p>", "clean_text": " Pyrazole Compounds \n\nThe H1 proton of the ligand was identified at 15.71 ppm from the 15N,1H HSQC plot (1, 9). Because of the C  s  own symmetry of the coordinated pyrazole, the H3 and H5 signals in the 1H NMR spectra of 1, 6, and 9 do not overlap, as it is the case for the pyrazolium cation. The resonance signals H3, H4, and H5 are observed as singlets at -2.75, -2.48, and 6.34 ppm for 6 and at -2.71, -2.44, and 6.39 ppm for 1 and 9. In the 13C{1H} NMR spectra of 1 and 9 the carbon resonances for C3, C4, and C5 are displayed at 71.08 {6.39}, 180.92 {-2.71}, 191.31 {-2.44} and 71.18 {6.39}, 181.33 {-2.71}, 191.99 {-2.44} ppm, respectively. In addition, the pyrazolium cation in 9 gives two CH signals at 106.16 (C4') and 134.25 (C3,5') ppm. The 13C,1H HMBC plot of 9 does not clarify the assignment of C3, C4, C5 and H3, H4, H5 because of the same number of cross-signals for these carbon atoms and protons (two cross-peaks for every atom). H1 has CH couplings with C3, C4, and C5.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 55, "type": "text", "classification": "error", "content": "<title>\n<italic toggle=\"yes\">Indazole Compounds</italic>\n</title><p>The <sup>1</sup>H NMR signals of the coordinated indazole in <bold>2</bold>, <bold>7</bold>, and <bold>10</bold> have the same chemical shifts. Therefore, 2D NMR experiments were performed for <bold>2</bold>, and the assignments made were also applied to <bold>7</bold> and <bold>10</bold>. The multiplicity of ligand <sup>1</sup>H signals in the <sup>1</sup>H NMR spectrum is the same as for the metal-free indazole. From the <sup>15</sup>N,<sup>1</sup>H HSQC plot H<sub>1</sub> is seen at 17.76 ppm. Another singlet, H<sub>3</sub>, is observed at \u22124.54 ppm. The <sup>1</sup>H,<sup>1</sup>H NOESY plot shows a cross-peak of H<sub>7</sub> with H<sub>1</sub>, and another resulting from coupling of H<sub>4</sub> with H<sub>3</sub>. The cross-peaks in the <sup>1</sup>H,<sup>1</sup>H COSY plot indicate H<sub>4</sub>\u2212H<sub>5</sub> and H<sub>6</sub>\u2212H<sub>7</sub> couplings. Therefore two doublets are due to H<sub>7</sub> (10.84 ppm) and H<sub>4</sub> (5.89 ppm) protons, while two triplets are due to H<sub>6</sub> (3.08 ppm) and H<sub>5</sub> (8.24 ppm). In the <sup>13</sup>C{<sup>1</sup>H} NMR spectrum four C<italic toggle=\"yes\">H</italic> signals for C<sub>7</sub>, C<sub>5</sub>, C<sub>4</sub>, C<sub>6</sub> are seen at 81.88, 106.16, 139.58, and 163.74 ppm, correspondingly. The unresolved C<sub>3</sub> signal is detected at 200.66 ppm from the <sup>13</sup>C,<sup>1</sup>H HSQC plot. In addition, two carbon signals originate from the quaternary carbons C<sub>9</sub> and C<sub>8</sub>. In the <sup>13</sup>C,<sup>1</sup>H HMBC plot one of them at 75.94 ppm shows five cross-peaks with all protons but H<sub>6</sub>, whereas the second at 173.67 ppm reveals four cross-peaks, but no cross-peaks with H<sub>5</sub> and H<sub>7</sub>. Taking into account that the couplings through four bonds, such as C<sub>9</sub>\u2212H<sub>6</sub> and C<sub>8</sub>\u2212H<sub>5</sub>, are most likely undetectable, we can suppose that C<sub>9</sub> displays a signal at 75.94 ppm, while C<sub>8</sub> at 173.67 ppm.</p>", "clean_text": " Indazole Compounds \n\nThe 1H NMR signals of the coordinated indazole in 2, 7, and 10 have the same chemical shifts. Therefore, 2D NMR experiments were performed for 2, and the assignments made were also applied to 7 and 10. The multiplicity of ligand 1H signals in the 1H NMR spectrum is the same as for the metal-free indazole. From the 15N,1H HSQC plot H1 is seen at 17.76 ppm. Another singlet, H3, is observed at -4.54 ppm. The 1H,1H NOESY plot shows a cross-peak of H7 with H1, and another resulting from coupling of H4 with H3. The cross-peaks in the 1H,1H COSY plot indicate H4-H5 and H6-H7 couplings. Therefore two doublets are due to H7 (10.84 ppm) and H4 (5.89 ppm) protons, while two triplets are due to H6 (3.08 ppm) and H5 (8.24 ppm). In the 13C{1H} NMR spectrum four CH signals for C7, C5, C4, C6 are seen at 81.88, 106.16, 139.58, and 163.74 ppm, correspondingly. The unresolved C3 signal is detected at 200.66 ppm from the 13C,1H HSQC plot. In addition, two carbon signals originate from the quaternary carbons C9 and C8. In the 13C,1H HMBC plot one of them at 75.94 ppm shows five cross-peaks with all protons but H6, whereas the second at 173.67 ppm reveals four cross-peaks, but no cross-peaks with H5 and H7. Taking into account that the couplings through four bonds, such as C9-H6 and C8-H5, are most likely undetectable, we can suppose that C9 displays a signal at 75.94 ppm, while C8 at 173.67 ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 56, "type": "text", "classification": ["property"], "content": "<title>Magnetic Properties</title><p>Complex <bold>5</bold> is paramagnetic at 300 K in the solid state (\u03bc<sub>eff</sub> = 1.86 \u03bc<sub>B</sub>). The magnetic moment is temperature-dependent, decreasing continuously with temperature and reaching the value of 0.40 \u03bc<sub>B</sub> at 2 K (). This behavior indicates a non-magnetic ground state resulting from antiparallel coupling of the effective orbital moment <italic toggle=\"yes\">L</italic> = 1 of the t<sub>2</sub> shell with the total spin <italic toggle=\"yes\">S</italic> = 1 of the ground t<sub arrange=\"stack\">2</sub>\n<sup arrange=\"stack\">4</sup> configuration, induced by spin\u2212orbit coupling on Os(IV) in octahedral geometry. Given a very large spin\u2212orbit coupling constant on the osmium ion (&gt;5000 cm<sup>\u22121</sup>), the reduction of symmetry caused by axial ligands will not affect the character of the ground state, which thus will remain non-degenerate (non-magnetic) in the real geometry too (Figure ). Measurement of the same complex in DMSO by Evans method resulted in an increase of the effective magnetic moment (3.18 \u03bc<sub>B</sub> at 297 K). Similar behavior has been also documented in the literature for magnetically diluted hexahalogenidoosmates(IV). Detailed magnetic studies are underway in our laboratory and will be reported in due course.</p>", "clean_text": "Magnetic Properties\n\nComplex 5 is paramagnetic at 300 K in the solid state (\u03bceff = 1.86 \u03bcB). The magnetic moment is temperature-dependent, decreasing continuously with temperature and reaching the value of 0.40 \u03bcB at 2 K (). This behavior indicates a non-magnetic ground state resulting from antiparallel coupling of the effective orbital moment L = 1 of the t2 shell with the total spin S = 1 of the ground t2 4 configuration, induced by spin-orbit coupling on Os(IV) in octahedral geometry. Given a very large spin-orbit coupling constant on the osmium ion (>5000 cm-1), the reduction of symmetry caused by axial ligands will not affect the character of the ground state, which thus will remain non-degenerate (non-magnetic) in the real geometry too (Figure ). Measurement of the same complex in DMSO by Evans method resulted in an increase of the effective magnetic moment (3.18 \u03bcB at 297 K). Similar behavior has been also documented in the literature for magnetically diluted hexahalogenidoosmates(IV). Detailed magnetic studies are underway in our laboratory and will be reported in due course.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 57, "type": "text", "classification": "error", "content": "<title>Electrochemical Behavior</title><p>The cyclic voltammograms (CVs) of the complexes <bold>1</bold>, <bold>2</bold>, <bold>4</bold>, and <bold>5</bold> in DMSO (0.2 M (<italic toggle=\"yes\">n</italic>-Bu<sub>4</sub>N)[BF<sub>4</sub>]/DMSO) at a carbon disk working electrode, recorded with a scan rate of 0.2 V/s, display a reversible one-electron reduction wave attributed to the Os<sup>IV</sup> \u2192 Os<sup>III</sup> process with potential values ranging from \u22120.03 to 0.12 V and an irreversible single electron reduction wave (I<sup>red</sup>) attributed to the Os<sup>III</sup> \u2192 Os<sup>II</sup> process with <italic toggle=\"yes\">E</italic>\n<sub>p</sub> potential values between \u22121.78 and \u22121.39 V versus NHE (Figure , Table  and , Figures S16 and S18). The redox waves Os<sup>IV</sup>/Os<sup>III</sup> are characterized by a peak-to-peak separation (\u0394<italic toggle=\"yes\">E</italic>\n<sub>p</sub>) of 69\u221287 mV and an anodic peak current (<italic toggle=\"yes\">i</italic>\n<sub>pa</sub>) that is almost equal to the cathodic peak current (<italic toggle=\"yes\">i</italic>\n<sub>pc</sub>), as expected for reversible electron transfer processes. The one-electron nature of the electron transfer processes was verified by comparing the peak current height (<italic toggle=\"yes\">i</italic>\n<sub>p</sub>) with that of standard ferrocene/ferrocenium couples under identical experimental conditions. The reduction potentials Os<sup>IV</sup>/Os<sup>III</sup> are in the following order: <italic toggle=\"yes\">E</italic>\n<sub>1/2</sub>(<bold>2</bold>) &gt; <italic toggle=\"yes\">E</italic>\n<sub>1/2</sub>(<bold>5</bold>) &gt; <italic toggle=\"yes\">E</italic>\n<sub>1/2</sub>(<bold>1</bold>) &gt; <italic toggle=\"yes\">E</italic>\n<sub>1/2</sub>(<bold>4</bold>), which agrees quite well with the relative electron-donating character of the azole ligands [<italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Hind) &gt; <italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Hpz) &gt; <italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Htrz)&gt; <italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Hbzim)] and their basicity [p<italic toggle=\"yes\">K</italic>\n<sub>a</sub>(H<sub>2</sub>ind<sup>+</sup>) &lt; p<italic toggle=\"yes\">K</italic>\n<sub>a</sub>(H<sub>2</sub>trz<sup>+</sup>) &lt; p<italic toggle=\"yes\">K</italic>\n<sub>a</sub>(H<sub>2</sub>pz<sup>+</sup>) &lt; p<italic toggle=\"yes\">K</italic>\n<sub>a</sub>(H<sub>2</sub>bzim<sup>+</sup>)] (Table ). The reduction potential for Os<sup>III</sup> \u2192 Os<sup>II</sup> was calculated using Lever\u2019s equation (eq ) [<italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Cl) = \u22120.24,\n<italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Hpz) = 0.20,\n<italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Hbzim) = 0.1,\n<italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Hind) = 0.26,\n<italic toggle=\"yes\">E</italic>\n<sub>L</sub>(Htrz) = 0.18,\n<italic toggle=\"yes\">S</italic>\n<sub>M</sub>(Os<sup>III</sup>/Os<sup>II</sup>) = 1.01,\n<italic toggle=\"yes\">I</italic>\n<sub>M</sub>(Os<sup>III</sup>/Os<sup>II</sup>) = \u22120.40].<disp-formula id=\"eq1\">\n<label>1</label>\n<mml:math altimg=\"ic-2009-01671j_m002.gif\" display=\"block\" overflow=\"scroll\">\n<mml:mi>E</mml:mi>\n<mml:mspace width=\"-2pt\"></mml:mspace>\n<mml:mo>=</mml:mo>\n<mml:msub>\n<mml:mrow>\n<mml:mi>S</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">M</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mo>\u2211</mml:mo>\n<mml:mrow>\n<mml:msub>\n<mml:mrow>\n<mml:mi>E</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">L</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mspace width=\"2pt\"></mml:mspace>\n<mml:mo>+</mml:mo>\n<mml:mspace width=\"2pt\"></mml:mspace>\n<mml:msub>\n<mml:mrow>\n<mml:mi>I</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">M</mml:mi>\n</mml:mrow>\n</mml:msub>\n</mml:mrow>\n</mml:math>\n</disp-formula>\n</p>", "clean_text": "Electrochemical Behavior\n\nThe cyclic voltammograms (CVs) of the complexes 1, 2, 4, and 5 in DMSO (0.2 M (n-Bu4N)[BF4]/DMSO) at a carbon disk working electrode, recorded with a scan rate of 0.2 V/s, display a reversible one-electron reduction wave attributed to the OsIV \u2192 OsIII process with potential values ranging from -0.03 to 0.12 V and an irreversible single electron reduction wave (Ired) attributed to the OsIII \u2192 OsII process with E p potential values between -1.78 and -1.39 V versus NHE (Figure , Table  and , Figures S16 and S18). The redox waves OsIV/OsIII are characterized by a peak-to-peak separation (\u0394E p) of 69-87 mV and an anodic peak current (i pa) that is almost equal to the cathodic peak current (i pc), as expected for reversible electron transfer processes. The one-electron nature of the electron transfer processes was verified by comparing the peak current height (i p) with that of standard ferrocene/ferrocenium couples under identical experimental conditions. The reduction potentials OsIV/OsIII are in the following order: E 1/2(2) > E 1/2(5) > E 1/2(1) > E 1/2(4), which agrees quite well with the relative electron-donating character of the azole ligands [E L(Hind) > E L(Hpz) > E L(Htrz)> E L(Hbzim)] and their basicity [pK a(H2ind+) < pK a(H2trz+) < pK a(H2pz+) < pK a(H2bzim+)] (Table ). The reduction potential for OsIII \u2192 OsII was calculated using Lever's equation (eq ) [E L(Cl) = -0.24, E L(Hpz) = 0.20, E L(Hbzim) = 0.1, E L(Hind) = 0.26, E L(Htrz) = 0.18, S M(OsIII/OsII) = 1.01, I M(OsIII/OsII) = -0.40]. 1  E  =   S   M   \u2211    E   L    +    I   M      ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 58, "type": "text", "classification": "error", "content": "<p>The values of <italic toggle=\"yes\">E</italic>\n<sub>calc</sub> for Os<sup>III</sup>/Os<sup>II</sup> using this formula agree quite well with the <italic toggle=\"yes\">E</italic>\n<sub>p</sub> values measured for Os<sup>III</sup>/Os<sup>II</sup> (Table ).</p><title>Aqueous Solubility and Resistance to Hydrolysis</title><p>The aqueous solubility of the complexes <bold>6</bold>\u2212<bold>11</bold> at 298 K varies from 1.3 mM (<bold>10</bold>) to 34.3 mM (<bold>6</bold>), depending on the coordinated azole heterocycle and cation identity. The sodium salts showed higher aqueous solubility than the analogous azolium salts. The aqueous solution behavior of <bold>6</bold>, <bold>7</bold>, and <bold>9</bold> with respect to hydrolysis was studied at 294 K over 24 h by UV\u2212vis spectroscopy. The complexes remain intact in aqueous solution, as can be seen from their electronic absorption spectra (Figure  and , Figures S1 and S2).</p>", "clean_text": "The values of E calc for OsIII/OsII using this formula agree quite well with the E p values measured for OsIII/OsII (Table ).\n\nAqueous Solubility and Resistance to Hydrolysis\n\nThe aqueous solubility of the complexes 6-11 at 298 K varies from 1.3 mM (10) to 34.3 mM (6), depending on the coordinated azole heterocycle and cation identity. The sodium salts showed higher aqueous solubility than the analogous azolium salts. The aqueous solution behavior of 6, 7, and 9 with respect to hydrolysis was studied at 294 K over 24 h by UV-vis spectroscopy. The complexes remain intact in aqueous solution, as can be seen from their electronic absorption spectra (Figure  and , Figures S1 and S2).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 59, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<title>Cyclic Voltammetric Data for <bold>1</bold>, <bold>2</bold>, <bold>4</bold>, and <bold>5</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">complex</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">E</italic>\n<sub>p</sub> Os(III/II)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">E</italic>\n<sub>1/2</sub> Os(IV/III)<xref rid=\"t4fn1\"></xref>, (\u0394<italic toggle=\"yes\">E</italic>\n<sub>p</sub>)<xref rid=\"t4fn2\"></xref>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">E</italic>\n<sub>calc</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">p<italic toggle=\"yes\">K</italic>\n<sub>a</sub> (H<sub>2</sub>azole<sup>+</sup>)</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>\u22121.66</oasis:entry>\n<oasis:entry>0.03 (75)</oasis:entry>\n<oasis:entry>\u22121.41</oasis:entry>\n<oasis:entry>2.64</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry>\u22121.39</oasis:entry>\n<oasis:entry>0.12 (69)</oasis:entry>\n<oasis:entry>\u22121.35</oasis:entry>\n<oasis:entry>1.25</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>\u22121.78</oasis:entry>\n<oasis:entry>\u22120.03 (72)</oasis:entry>\n<oasis:entry>\u22121.51</oasis:entry>\n<oasis:entry>5.63</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>5</bold>\n</oasis:entry>\n<oasis:entry>\u22121.50</oasis:entry>\n<oasis:entry>0.05 (87)</oasis:entry>\n<oasis:entry>\u22121.43</oasis:entry>\n<oasis:entry>2.55</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t4fn1\">\n<label>a</label>\n<p>Potentials <italic toggle=\"yes\">E</italic>\n<sub>1/2</sub> (<italic toggle=\"yes\">E</italic>\n<sub>1/2</sub> = (<italic toggle=\"yes\">E</italic>\n<sub>pa</sub> + <italic toggle=\"yes\">E</italic>\n<sub>pc</sub>)/2, where <italic toggle=\"yes\">E</italic>\n<sub>pa</sub> and <italic toggle=\"yes\">E</italic>\n<sub>pc</sub> are the anodic and cathodic peak potentials, are given in V and measured at a scan rate of 0.2 V/s in DMSO, using ferrocene as internal standard, and are quoted relative to NHE.</p>\n</fn>\n<fn id=\"t4fn2\">\n<label>b</label>\n<p>\u0394<italic toggle=\"yes\">E</italic>\n<sub>p</sub> values (\u0394<italic toggle=\"yes\">E</italic>\n<sub>p</sub> = <italic toggle=\"yes\">E</italic>\n<sub>pa</sub> \u2212 <italic toggle=\"yes\">E</italic>\n<sub>pc</sub>) are given in mV.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 60, "type": "figure", "classification": null, "content": "<fig id=\"fig9\" orientation=\"portrait\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Cyclic voltammogram of 0.2 M <bold>1</bold> in DMSO at a carbon disk working electrode and a scan rate of 0.2 V/s, starting the scan in cathodic direction.</p>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0011.tif\"></graphic>\n</fig>", "clean_text": " 9  Cyclic voltammogram of 0.2 M 1 in DMSO at a carbon disk working electrode and a scan rate of 0.2 V/s, starting the scan in cathodic direction.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 61, "type": "figure", "classification": null, "content": "<fig id=\"fig10\" orientation=\"portrait\" position=\"float\">\n<label>10</label>\n<caption>\n<p>UV\u2212vis spectra of an aqueous solution of <bold>9</bold>, measured immediately after dissolution of the sample and 24 h thereafter.</p>\n</caption>\n<graphic id=\"gr11\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0014.tif\"></graphic>\n</fig>", "clean_text": " 10  UV-vis spectra of an aqueous solution of 9, measured immediately after dissolution of the sample and 24 h thereafter.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 62, "type": "text", "classification": "error", "content": "<p>Immediate hydrolysis was excluded, since the parent peak at <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 434 for [Os<sup>IV</sup>Cl<sub>5</sub>(Hpz)]<sup>\u2212</sup> was observed in the negative ion ESI mass spectrum of the aqueous solution of <bold>9</bold> after 24 h.</p><title>Cytotoxicity in Cancer Cell Lines</title><p>Cytotoxicity of compounds <bold>6</bold>\u2212<bold>11</bold> was assessed by means of a colorimetric microculture assay (MTT assay) in three human cancer cell lines. The generally more chemosensitive CH1 (ovarian carcinoma) cells are somewhat, but not more than 3.4 times, more sensitive to these compounds than the least sensitive A549 (non-small cell lung cancer) cells, based on comparison of IC<sub>50</sub> levels (Table ).</p>", "clean_text": "Immediate hydrolysis was excluded, since the parent peak at m/z 434 for [OsIVCl5(Hpz)]- was observed in the negative ion ESI mass spectrum of the aqueous solution of 9 after 24 h.\n\nCytotoxicity in Cancer Cell Lines\n\nCytotoxicity of compounds 6-11 was assessed by means of a colorimetric microculture assay (MTT assay) in three human cancer cell lines. The generally more chemosensitive CH1 (ovarian carcinoma) cells are somewhat, but not more than 3.4 times, more sensitive to these compounds than the least sensitive A549 (non-small cell lung cancer) cells, based on comparison of IC50 levels (Table ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 63, "type": "text", "classification": "error", "content": "<p>The following structure\u2212activity relationships can be inferred from the concentration-effect curves depicted in Figure : Variation of the azole ligand has marked consequences for biological activity within the series of complexes with a sodium counterion. Cytotoxic potency decreases in the following rank order, depending on the azole ligand: pyrazole (<bold>6</bold>) &gt; indazole (<bold>7</bold>) &gt; triazole (<bold>8</bold>), whereas the differences are much less pronounced within the series of azolium analogues (<bold>9</bold>, <bold>10</bold>, <bold>11</bold>), which generally have modest cytotoxic potencies, with IC<sub>50</sub> values varying only in a small range of 10<sup>\u22124</sup> M concentrations in all three cell lines. This implies that exchange of the counterion influences biological activity to a different extent. In the case of the pyrazole complexes (<bold>6</bold> vs <bold>9</bold>), formal replacement of the azolium cation with sodium results in a 3.0- to 5.8-fold enhancement of cytotoxicity to IC<sub>50</sub> values in the 10<sup>\u22125</sup> M range, while the difference is reduced to factors of 1.3\u22122.0 in the indazole complexes (<bold>7</bold> vs <bold>10</bold>) and completely abolished in the triazole complexes (<bold>8</bold> vs <bold>11</bold>). These findings are remarkable because they contrast with observations made with [Ru<sup>III</sup>Cl<sub>4</sub>(Hind)<sub>2</sub>]<sup>\u2212</sup>, which is less cytotoxic in the form of the sodium salt. An explanation is not obvious because the counterion is unlikely to be involved in the molecular effects accounting for cytotoxicity. Experiments are ongoing to clarify whether a different extent of cellular uptake may contribute to these differences.</p>", "clean_text": "The following structure-activity relationships can be inferred from the concentration-effect curves depicted in Figure : Variation of the azole ligand has marked consequences for biological activity within the series of complexes with a sodium counterion. Cytotoxic potency decreases in the following rank order, depending on the azole ligand: pyrazole (6) > indazole (7) > triazole (8), whereas the differences are much less pronounced within the series of azolium analogues (9, 10, 11), which generally have modest cytotoxic potencies, with IC50 values varying only in a small range of 10-4 M concentrations in all three cell lines. This implies that exchange of the counterion influences biological activity to a different extent. In the case of the pyrazole complexes (6 vs 9), formal replacement of the azolium cation with sodium results in a 3.0- to 5.8-fold enhancement of cytotoxicity to IC50 values in the 10-5 M range, while the difference is reduced to factors of 1.3-2.0 in the indazole complexes (7 vs 10) and completely abolished in the triazole complexes (8 vs 11). These findings are remarkable because they contrast with observations made with [RuIIICl4(Hind)2]-, which is less cytotoxic in the form of the sodium salt. An explanation is not obvious because the counterion is unlikely to be involved in the molecular effects accounting for cytotoxicity. Experiments are ongoing to clarify whether a different extent of cellular uptake may contribute to these differences.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 64, "type": "text", "classification": "error", "content": "<p>Comparison with the ruthenium(III) compound (H<sub>2</sub>ind)<sub>2</sub>[RuCl<sub>5</sub>(Hind)] (IC<sub>50</sub> = 35 \u03bcM and 37 \u03bcM in CH1 and SW480 cells, respectively) reveals that the osmium(IV) compound <bold>10</bold> is markedly less cytotoxic despite the lower charge of the complex anion, adding another facet to the hard to predict activity relationships of related ruthenium and osmium compounds.</p>", "clean_text": "Comparison with the ruthenium(III) compound (H2ind)2[RuCl5(Hind)] (IC50 = 35 \u03bcM and 37 \u03bcM in CH1 and SW480 cells, respectively) reveals that the osmium(IV) compound 10 is markedly less cytotoxic despite the lower charge of the complex anion, adding another facet to the hard to predict activity relationships of related ruthenium and osmium compounds.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 65, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<title>Cytotoxicity of Six Osmium(IV) Complexes in Three Human Cancer Cell Lines</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col4\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcM)<xref rid=\"t5fn1\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\">compound</oasis:entry>\n<oasis:entry align=\"center\">CH1</oasis:entry>\n<oasis:entry align=\"center\">A549</oasis:entry>\n<oasis:entry align=\"center\">SW480</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>6</bold>\n</oasis:entry>\n<oasis:entry>26 \u00b1 6</oasis:entry>\n<oasis:entry>77 \u00b1 20</oasis:entry>\n<oasis:entry>18 \u00b1 3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>7</bold>\n</oasis:entry>\n<oasis:entry>73 \u00b1 24</oasis:entry>\n<oasis:entry>247 \u00b1 29</oasis:entry>\n<oasis:entry>114 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>8</bold>\n</oasis:entry>\n<oasis:entry>160 \u00b1 55</oasis:entry>\n<oasis:entry>453 \u00b1 15</oasis:entry>\n<oasis:entry>391 \u00b1 16</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>9</bold>\n</oasis:entry>\n<oasis:entry>142 \u00b1 20</oasis:entry>\n<oasis:entry>229 \u00b1 27</oasis:entry>\n<oasis:entry>105 \u00b1 3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>10</bold>\n</oasis:entry>\n<oasis:entry>148 \u00b1 75</oasis:entry>\n<oasis:entry>329 \u00b1 126</oasis:entry>\n<oasis:entry>163 \u00b1 60</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>11</bold>\n</oasis:entry>\n<oasis:entry>151 \u00b1 28</oasis:entry>\n<oasis:entry>434 \u00b1 10</oasis:entry>\n<oasis:entry>322 \u00b1 79</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t5fn1\">\n<label>a</label>\n<p>50% inhibitory concentrations (means \u00b1 standard deviation), as obtained by the MTT assay (continuous exposure for 96 h).</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 66, "type": "figure", "classification": null, "content": "<fig id=\"fig11\" orientation=\"portrait\" position=\"float\">\n<label>11</label>\n<caption>\n<p>Concentration-effect curves of six osmium(IV) complexes in the human cancer cell lines CH1 (A), A549 (B), and SW480 (C), as obtained by the MTT assay (continuous exposure for 96 h).</p>\n</caption>\n<graphic id=\"gr12\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0012.tif\"></graphic>\n</fig>", "clean_text": " 11  Concentration-effect curves of six osmium(IV) complexes in the human cancer cell lines CH1 (A), A549 (B), and SW480 (C), as obtained by the MTT assay (continuous exposure for 96 h).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 67, "type": "text", "classification": ["else"], "content": "<title>Final Remarks</title><p>Controlled exploration of Anderson type rearrangement reactions of (H<sub>2</sub>azole)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>] in dry ethanol or in isoamyl alcohol in the presence of tetrabutylammonium chloride enabled the synthesis of complexes of the general formula [cation]<sup>+</sup>[Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup>, where [cation]<sup>+</sup> = <italic toggle=\"yes\">n</italic>-Bu<sub>4</sub>N<sup>+</sup>, Hazole = 1<italic toggle=\"yes\">H</italic>-pyrazole, 1<italic toggle=\"yes\">H</italic>-indazole, 1<italic toggle=\"yes\">H</italic>-imidazole, 1<italic toggle=\"yes\">H</italic>-benzimidazole, or 1<italic toggle=\"yes\">H</italic>,2,4-triazole. The efficacy of the observed transformation appears to be dependent on the electron-donating potency of the azole heterocycle and the solvent used. A deeper substitution at osmium(IV) with formation of <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Hazole)<sub>2</sub>] complexes was observed in the case of imidazole and benzimidazole systems with the most pronounced electron-donating properties and highest basicity. Comparison of the osmium complexes described in this work with related ruthenium analogues, namely, (H<sub>2</sub>azole)<sub>2</sub>[Ru<sup>III</sup>Cl<sub>5</sub>(Hazole)] and (H<sub>2</sub>azole)[Ru<sup>III</sup>Cl<sub>4</sub>(Hazole)<sub>2</sub>], shows a clear preference for higher oxidation states of the heavier congener. Preparation of better water-soluble analogues of the [Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup> compounds in the form of sodium and azolium salts permitted the assessment of their antiproliferative activity in vitro against human cancer cell lines. The results reported herein provide an entry to the chemistry of <italic toggle=\"yes\">trans</italic>-bis(azole)tetrachloridoosmium(IV) complexes. Investigations directed at the synthesis and characterization of this type of compounds are underway in our laboratory. This work is of particular interest if one takes into account that the related ruthenium analogue (H<sub>2</sub>ind)[Ru<sup>III</sup>Cl<sub>4</sub>(Hind)<sub>2</sub>] is a potent anticancer drug in clinical trials. In addition, a notable crystallographic contribution has been made. The compounds <bold>1</bold>\u2212<bold>6</bold> are the first complexes of the type [Os<sup>IV</sup>Cl<sub>5</sub>(Hazole)]<sup>\u2212</sup>, and <bold>12</bold> is the first <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Hazole)<sub>2</sub>] complex characterized by X-ray crystallography.</p>", "clean_text": "Final Remarks\n\nControlled exploration of Anderson type rearrangement reactions of (H2azole)2[OsIVCl6] in dry ethanol or in isoamyl alcohol in the presence of tetrabutylammonium chloride enabled the synthesis of complexes of the general formula [cation]+[OsIVCl5(Hazole)]-, where [cation]+ = n-Bu4N+, Hazole = 1H-pyrazole, 1H-indazole, 1H-imidazole, 1H-benzimidazole, or 1H,2,4-triazole. The efficacy of the observed transformation appears to be dependent on the electron-donating potency of the azole heterocycle and the solvent used. A deeper substitution at osmium(IV) with formation of trans-[OsIVCl4(Hazole)2] complexes was observed in the case of imidazole and benzimidazole systems with the most pronounced electron-donating properties and highest basicity. Comparison of the osmium complexes described in this work with related ruthenium analogues, namely, (H2azole)2[RuIIICl5(Hazole)] and (H2azole)[RuIIICl4(Hazole)2], shows a clear preference for higher oxidation states of the heavier congener. Preparation of better water-soluble analogues of the [OsIVCl5(Hazole)]- compounds in the form of sodium and azolium salts permitted the assessment of their antiproliferative activity in vitro against human cancer cell lines. The results reported herein provide an entry to the chemistry of trans-bis(azole)tetrachloridoosmium(IV) complexes. Investigations directed at the synthesis and characterization of this type of compounds are underway in our laboratory. This work is of particular interest if one takes into account that the related ruthenium analogue (H2ind)[RuIIICl4(Hind)2] is a potent anticancer drug in clinical trials. In addition, a notable crystallographic contribution has been made. The compounds 1-6 are the first complexes of the type [OsIVCl5(Hazole)]-, and 12 is the first trans-[OsIVCl4(Hazole)2] complex characterized by X-ray crystallography.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 68, "type": "text", "classification": ["else"], "content": "<p>Synthesis of (H<sub>2</sub>trz)<sub>2</sub>[OsCl<sub>6</sub>], UV\u2212vis spectra of <bold>6</bold> and <bold>7</bold> in water and of <bold>1</bold>, <bold>2</bold>, <bold>4</bold>, <bold>5</bold>, and <bold>12</bold> in ethanol, <sup>13</sup>C,<sup>1</sup>H HSQC spectra of <bold>1</bold>, <bold>2</bold> and <bold>9</bold>, <sup>15</sup>N,<sup>1</sup>H HSQC spectra of <bold>1</bold>, <bold>2</bold> and <bold>9</bold>, <sup>13</sup>C,<sup>1</sup>H HMBC spectra of <bold>2</bold> and <bold>9</bold>, <sup>1</sup>H,<sup>1</sup>H NOESY and <sup>1</sup>H,<sup>1</sup>H COSY spectra of <bold>2</bold>, cyclic voltamogramms of <bold>2</bold>, <bold>4</bold> and <bold>5</bold> in DMSO, magnetic data for <bold>5</bold>, X-ray crystallographic files in CIF format for <bold>1</bold>\u2212<bold>6</bold> and <bold>12</bold>. This material is available free of charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\">http://pubs.acs.org</uri>.</p>", "clean_text": "Synthesis of (H2trz)2[OsCl6], UV-vis spectra of 6 and 7 in water and of 1, 2, 4, 5, and 12 in ethanol, 13C,1H HSQC spectra of 1, 2 and 9, 15N,1H HSQC spectra of 1, 2 and 9, 13C,1H HMBC spectra of 2 and 9, 1H,1H NOESY and 1H,1H COSY spectra of 2, cyclic voltamogramms of 2, 4 and 5 in DMSO, magnetic data for 5, X-ray crystallographic files in CIF format for 1-6 and 12. This material is available free of charge via the Internet at http://pubs.acs.org.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 69, "type": "text", "classification": ["else"], "content": "<title>References</title>", "clean_text": "References", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22", "type": "text", "classification": "synthesis condition", "content": "<title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Hpz)] (<bold>1</bold>)</title><p>To a solution of (H<sub>2</sub>pz)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu<sub>4</sub>NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at \u221220 \u00b0C for 2 days. The yellow product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl<sub>3</sub>/CH<sub>3</sub>OH 4:1 and collecting the first fraction (R<sub>f</sub> = 0.75). Yield: 30 mg, 24%. Anal. Calcd for C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 677.99 g/mol): C, 33.66; H, 5.95; N, 6.20. Found: C, 33.73; H, 5.73; N, 6.11. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 435 [Os<sup>IV</sup>Cl<sub>5</sub>(Hpz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 573, 665, 740, 773, 881, 1053, 1125, 1165, 1265, 1352, 1381, 1404, 1472, 1513, 2872, 2961, 3142, and 3330. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 254 sh (4 064), 360 (9 503). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.71 (s, 1H), \u22122.44 (s, 1H), 0.95 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.4 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.4 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.8 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 6.39 (d, <italic toggle=\"yes\">J</italic> = 1.6 Hz), 15.71 (s, 1H<sub>1</sub>) ppm. <sup>13</sup>C{<sup>1</sup>H} NMR (d<sub>6</sub>-DMSO, 125.81 MHz): \u03b4 14.11 (C<sub>D</sub>), 19.88 (C<sub>C</sub>), 23.78 (C<sub>B</sub>), 58.43 (C<sub>A</sub>), 71.08 {6.39}, 180.92 {\u22122.71}, 191.31 {\u22122.44} ppm. <sup>15</sup>N NMR (d<sub>6</sub>-DMSO, 50.68 MHz): \u03b4 144.3 (N<sub>1</sub>) ppm. Suitable crystals for X-ray diffraction study were selected directly from the reaction vessel.</p><title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Hind)] (<bold>2</bold>)</title><p>To a solution of (H<sub>2</sub>ind)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu<sub>4</sub>NCl (150 mg, 0.54 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at room temperature overnight. The dark-red product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl<sub>3</sub>/CH<sub>3</sub>OH 7:1 and collecting the first fraction (R<sub>f</sub> = 0.67). Yield: 80 mg, 70%. Anal. Calcd for C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 728.05 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 38.05; H, 5.78; N, 5.66. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 431, 613, 752, 883, 1089, 1147, 1241, 1360, 1378, 1475, 1513, 1627, 2872, 2959, and 3341. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 282 (9 492), 362 (11 031). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.54 (s, 1H<sub>3</sub>), 0.95 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.8 Hz), 3.08 (t, 1H<sub>6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 5.89 (d, 1H<sub>4</sub>, <italic toggle=\"yes\">J</italic> = 8.2 Hz), 8.24 (t, 1H<sub>5</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 10.84 (d, 1H<sub>7</sub>, <italic toggle=\"yes\">J</italic> = 8.5 Hz), 17.76 (s, 1H<sub>1</sub>) ppm. <sup>13</sup>C{<sup>1</sup>H} NMR (d<sub>6</sub>-DMSO, 125.81 MHz): \u03b4 14.08 (C<sub>D</sub>), 19.84 (C<sub>C</sub>), 23.74 (C<sub>B</sub>), 58.36 (C<sub>A</sub>), 75.94 (C<sub>9</sub>), 81.88 (C<sub>7</sub>), 106.16 (C<sub>5</sub>), 139.58 (C<sub>4</sub>), 163.74 (C<sub>6</sub>), 173.67 (C<sub>8</sub>), 200.66 (C<sub>3</sub>) ppm. <sup>15</sup>N NMR (d<sub>6</sub>-DMSO, 50.68 MHz): \u03b4 124.7 (N<sub>1</sub>) ppm. X-ray diffraction quality single crystals were obtained by slow diffusion of hexane into a chloroform solution of <bold>2</bold> in a NMR tube.</p><title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Him)] (<bold>3</bold>)</title><p>A mixture of (H<sub>2</sub>im)<sub>2</sub>[OsCl<sub>6</sub>] (12 mg, 0.02 mmol) and excess Bu<sub>4</sub>NCl (16 mg, 0.06 mmol) in isoamyl alcohol (1 mL) was stirred at 100 \u00b0C for 72 h. The solvent was evaporated, and the red residue was dissolved in methanol. The mixture was allowed to stand at \u221220 \u00b0C for 2 days, producing single crystals suitable for X-ray diffraction study.</p><title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Hbzim)] (<bold>4</bold>)</title><p>To a solution of (H<sub>2</sub>bzim)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu<sub>4</sub>NCl (130 mg, 0.47 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter. The dark-red product formed was separated by filtration and purified by column chromatography on silica, using as eluent a mixture of CHCl<sub>3</sub>/CH<sub>3</sub>OH 7:1 and collecting the second fraction (R<sub>f</sub> = 0.47). Yield: 90 mg, 79%. Anal. Calcd for C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 728.09 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 37.84; H, 5.53; N, 5.59. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hbzim)]<sup>\u2212</sup>, 450 [Os<sup>III</sup>Cl<sub>4</sub>(Hbzim)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 613, 699, 737, 760, 798, 882, 981, 1012, 1106, 1150, 1184, 1243, 1265, 1303, 1379, 1411, 1477, 1504, 2873, 2931, 2962, 3269. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 267 (10 253), 342 sh (7 109), 366 (9 034). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.64 (s, 1H<sub>2</sub>), 0.94 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 6.04 (t, 1H<sub>5 or 6</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 6.52 (d, 1H<sub>4 or 7</sub>, <italic toggle=\"yes\">J</italic> = 8.2 Hz), 6.98 (t, 1H<sub>5 or 6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 7.34 (d, 1H<sub>4 or 7</sub>, <italic toggle=\"yes\">J</italic> = 8.1 Hz), 9.41 (s, 1H<sub>1</sub>) ppm. X-ray diffraction quality crystals of <bold>4</bold>\u00b7CH<sub>3</sub>OH were obtained from a solution of <bold>4</bold> in methanol at \u221216 \u00b0C after 24 h.</p><title>(Bu<sub>4</sub>N)[OsCl<sub>5</sub>(Htrz)]\u00b7C<sub>2</sub>H<sub>5</sub>OH (<bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH)</title><p>To a solution of (H<sub>2</sub>trz)<sub>2</sub>[OsCl<sub>6</sub>] (300 mg, 0.55 mmol) in dry ethanol (10 mL) excess Bu<sub>4</sub>NCl (450 mg, 1.62 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The solution produced yellow needle-like crystals on cooling. These were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 130 mg, 33%. Anal. Calcd for C<sub>18</sub>H<sub>39</sub>Cl<sub>5</sub>N<sub>4</sub>Os\u00b7C<sub>2</sub>H<sub>5</sub>OH (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 725.05 g/mol): C, 33.13; H, 6.26; N, 7.73. Found: C, 33.28; H, 6.29; N, 7.81. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 436 [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 584, 631, 736, 880, 1001, 1059, 1306, 1381, 1427, 1466, 1983, 2359, 2872, 2960. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 270 sh (5 076), 366 (10 384), 425 sh (2 365). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.22 (brs), 0.94 (t, 12H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 8H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 8H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 3.17 (t, 8H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.3 Hz), 9.39 (brs), 13.65 (brs) ppm. Suitable crystals of <bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH for X-ray diffraction study were selected directly from the reaction vessel.</p><title>Na[OsCl<sub>5</sub>(Hpz)]\u00b72H<sub>2</sub>O (<bold>6</bold>\u00b72H<sub>2</sub>O)</title><p>To a solution of <bold>1</bold> (106 mg, 0.16 mmol) in water (400 mL) ion exchanger Dowex Marathon C Na<sup>+</sup>\u2212form (10 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 73 mg, 94%. Anal. Calcd for C<sub>3</sub>H<sub>4</sub>Cl<sub>5</sub>N<sub>2</sub>NaOs\u00b72H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 494.55 g/mol): C, 7.29; H, 1.63; N, 5.66. Found: C, 7.77; H, 1.35; N, 5.23. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 400 [Os<sup>III</sup>Cl<sub>4</sub>(Hpz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. Solubility in water 34.3 mM at 298 K. IR, cm<sup>\u22121</sup>: 569, 656, 768, 905, 1055, 1072, 1111, 1169, 1265, 1345, 1398, 1485, 1506, 1620, 3144, 3314, 3481, 3559. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 207 (15 376), 256 sh (3 663), 351 (6 131), 368 sh (6 079). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.75 (s, 1H), \u22122.48 (s, 1H), 6.34 (s, 1H), 15.69 (s, 1H<sub>1</sub>) ppm. X-ray diffraction quality crystals were obtained by slow evaporation of a solution of <bold>6</bold> in water.</p><title>Na[OsCl<sub>5</sub>(Hind)]\u00b72H<sub>2</sub>O (<bold>7</bold>\u00b72H<sub>2</sub>O)</title><p>To a solution of <bold>2</bold> (50 mg, 0.07 mmol) in water/ethanol 1:1 (160 mL) ion exchanger Dowex Marathon C Na<sup>+</sup>\u2212form (5 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 34 mg, 91%. Anal. Calcd for C<sub>7</sub>H<sub>6</sub>Cl<sub>5</sub>N<sub>2</sub>NaOs\u00b72H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 544.65 g/mol): C, 15.44; H, 1.85; N, 5.14. Found: C, 15.64; H, 1.64; N, 5.03. ESI-MS in MeOH/CH<sub>3</sub>CN (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. Solubility in water 3.9 mM at 298 K. IR, cm<sup>\u22121</sup>: 636, 748, 759, 785, 967, 1087, 1243, 1360, 1516, 1626, 3307, 3355, 3471, 3551. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 199 (760 730), 269 (159 591), 359 (143 943), 403 sh (96406). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.54 (s, 1H<sub>3</sub>), 3.08 (t, 1H<sub>6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 5.89 (d, 1H<sub>4</sub>, <italic toggle=\"yes\">J</italic> = 8.2 Hz), 8.24 (t, 1H<sub>5</sub>, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 10.84 (d, 1H<sub>7</sub>, <italic toggle=\"yes\">J</italic> = 8.5 Hz), 17.76 (s, 1H<sub>1</sub>) ppm.</p><title>Na[OsCl<sub>5</sub>(Htrz)]\u00b71.5H<sub>2</sub>O (<bold>8</bold>\u00b71.5H<sub>2</sub>O)</title><p>To a solution of <bold>5</bold> (100 mg, 0.15 mmol) in water (420 mL) ion exchanger Dowex Marathon C Na<sup>+</sup>\u2212form (10 g), after 12 h of soaking in water, was added. The suspension was allowed to stir for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give an orange solid. Yield: 70 mg, 98%. Anal. Calcd for C<sub>2</sub>H<sub>3</sub>Cl<sub>5</sub>N<sub>3</sub>NaOs\u00b71.5H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 486.57 g/mol): C, 4.94; H, 1.24; N, 8.64. Found: C, 5.24; H, 1.08; N, 8.28. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 436 [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup>, 401 [Os<sup>III</sup>Cl<sub>4</sub>(Htrz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. Solubility in water 15.4 mM at 298 K. IR, cm<sup>\u22121</sup>: 573, 614, 676, 865, 890, 962, 1079, 1144, 1192, 1257, 1301, 1374, 1412, 1493, 1523, 1613, 2363, 3127, 3322, 3534. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 343 sh (5 432), 362 (6 112). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22127.23 (brs) ppm.</p><title>(H<sub>2</sub>pz)[OsCl<sub>5</sub>(Hpz)]\u00b7H<sub>2</sub>O (<bold>9</bold>\u00b7H<sub>2</sub>O)</title><p>To pyrazole (14 mg, 0.21 mmol) in water (1.4 mL) 12 M hydrochloric acid (0.02 mL, 0.24 mmol) was added. The resulting solution of pyrazolium chloride was then added to a solution of <bold>6</bold> (47 mg, 0.10 mmol) in water (0.6 mL). The reaction mixture produced red crystals. Yield: 26 mg, 52%. Anal. Calcd for C<sub>6</sub>H<sub>9</sub>Cl<sub>5</sub>N<sub>4</sub>Os\u00b7H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 522.67): C, 13.79; H, 2.12; N, 10.72. Found: C, 13.82; H, 1.82; N, 10.32. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 435 [Os<sup>IV</sup>Cl<sub>5</sub>(Hpz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. Solubility in water 6.7 mM at 298 K. IR, cm<sup>\u22121</sup>: 599, 609, 771, 905, 1051, 1070, 1110, 1131, 1170, 1276, 1351, 1398, 1487, 1524, 1563, 1601, 2862, 3044, 3136, 3472, 3513. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 208 (19 463), 253 sh (3 806), 357 (8 678). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.71 (s, 1H), \u22122.44 (s, 1H), 6.31 (s, 1H<sub>4</sub>\u2032), 6.39 (s, 1H), 7.68 (s, 2H<sub>3,5</sub>\u2032), 15.71 (s, 1H<sub>1</sub>) ppm. <sup>13</sup>C{<sup>1</sup>H} NMR (d<sub>6</sub>-DMSO, 125.81 MHz): \u03b4 71.18 {6.39}, 106.16 (C<sub>4</sub>\u2032), 134.25 (C<sub>3,5</sub>\u2032), 181.33 {\u22122.71}, 191.99 {\u22122.44} ppm. <sup>15</sup>N NMR (d<sub>6</sub>-DMSO, 50.68 MHz): \u03b4 144.1 (N<sub>1</sub>) ppm.</p><title>(H<sub>2</sub>ind)[OsCl<sub>5</sub>(Hind)]\u00b7H<sub>2</sub>O (<bold>10</bold>\u00b7H<sub>2</sub>O)</title><p>To indazole (12 mg, 0.10 mmol) in water (1.2 mL) was added 12 M hydrochloric acid (0.01 mL, 0.12 mmol). The resulting solution of indazolium chloride was then added to a solution of <bold>7</bold> (45 mg, 0.08 mmol) in water (4 mL). The reaction mixture produced a brown solid. Yield: 40 mg, 78%. Anal. Calcd for C<sub>14</sub>H<sub>13</sub>Cl<sub>5</sub>N<sub>4</sub>Os\u00b7H<sub>2</sub>O (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 622.79): C, 27.00; H, 2.43; N, 9.00. Found: C, 27.36; H, 2.31; N, 8.72. ESI-MS in MeOH/CH<sub>3</sub>CN (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 485 [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>. Solubility in water 1.3 mM at 298 K. IR, cm<sup>\u22121</sup>: 614, 744, 787, 830, 967, 1002, 1087, 1126, 1152, 1247, 1359, 1384, 1483, 1516, 1628, 2359, 3127, 3248, 3466, 3519. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 201 (31 605), 249 (4 565), 286 (4 721), 358 (3 571). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22124.56 (s, 1H<sub>3</sub>), 3.06 (t, 1H<sub>6</sub>, <italic toggle=\"yes\">J</italic> = 7.7 Hz), 5.89 (d, 1H<sub>4</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 7.11 (t, 1H<sub>5</sub>\u2032, <italic toggle=\"yes\">J</italic> = 7.4 Hz), 7.34 (t, 1H<sub>6</sub>\u2032, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 7.53 (d, 1H<sub>7</sub>\u2032, <italic toggle=\"yes\">J</italic> = 8.4 Hz), 7.75 (d, 1H<sub>4</sub>\u2032, <italic toggle=\"yes\">J</italic> = 8.1 Hz), 8.08 (s, 1H<sub>3</sub>\u2032), 8.23 (t, 1H<sub>5</sub>, <italic toggle=\"yes\">J</italic> = 7.6 Hz), 10.85 (d, 1H<sub>7</sub>, <italic toggle=\"yes\">J</italic> = 8.5 Hz), 17.76 (s, 1H<sub>1</sub>) ppm.</p><title>(H<sub>2</sub>trz)[OsCl<sub>5</sub>(Htrz)] (<bold>11</bold>)</title><p>To triazole (15 mg, 0.22 mmol) in water (1.5 mL) was added 12 M hydrochloric acid (0.02 mL, 0.24 mmol). The resulting solution of triazolium chloride was then added to a solution of <bold>8</bold> (48 mg, 0.10 mmol) in water (4.8 mL). The reaction mixture produced red needle-like crystals. Yield: 28 mg, 56%. Anal. Calcd for C<sub>4</sub>H<sub>7</sub>Cl<sub>5</sub>N<sub>6</sub>Os (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 506.63 g/mol): C, 9.48; H, 1.39; N, 16.59. Found: C, 9.49; H, 1.23; N, 16.35. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 436 [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup>, 401 [Os<sup>III</sup>Cl<sub>4</sub>(Htrz)]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. Solubility in water 4.4 mM at 298 K. IR, cm<sup>\u22121</sup>: 621, 661, 743, 838, 877, 934, 970, 1027, 1058, 1150, 1258, 1300, 1413, 1518, 1560, 1602, 2807, 2848, 2916, 2955, 3124, 3521, 3601. UV\u2212vis (H<sub>2</sub>O), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 212 sh (117 773), 338 sh (4 890), 363 (8 229). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22122.19 (s, 1H), 8.71 (s, 2H<sub>3,5</sub>\u2032), 8.90 (brs) ppm.</p><title>{(Bu<sub>4</sub>N)<sub>2</sub>[Os<sup>IV</sup>Cl<sub>6</sub>]}<sub>2</sub>\u00b7[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] (<bold>12</bold>)</title><p>To a solution of (H<sub>2</sub>im)<sub>2</sub>[OsCl<sub>6</sub>] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu<sub>4</sub>NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at \u221220 \u00b0C for 2 days. The orange crystals formed were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 80 mg, 58%. Anal. Calcd for C<sub>70</sub>H<sub>152</sub>Cl<sub>16</sub>N<sub>8</sub>Os<sub>3</sub> (<italic toggle=\"yes\">M</italic>\n<sub>r</sub> = 2243.80 g/mol): C, 37.47; H, 6.83; N, 4.99. Found: C, 37.49; H, 6.70; N, 4.93. ESI-MS in MeOH (negative): <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic> 469 [Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>\u2212H<sup>+</sup>]<sup>\u2212</sup>, 367 [Os<sup>IV</sup>Cl<sub>5</sub>]<sup>\u2212</sup>, 332 [Os<sup>III</sup>Cl<sub>4</sub>]<sup>\u2212</sup>. IR, cm<sup>\u22121</sup>: 615, 653, 737, 880, 1025, 1065, 1100, 1135, 1259, 1323, 1378, 1474, 1547, 2873, 2958, 3164, 3251. UV\u2212vis (C<sub>2</sub>H<sub>5</sub>OH), \u03bb<sub>max</sub>, nm (\u03b5, M<sup>\u22121</sup> cm<sup>\u22121</sup>): 254 sh (19 949), 339 (49 763), 371 (45 578), 421 sh (7141). <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500.32 MHz): \u03b4 \u22120.52 (s, 1H), 0.95 (t, 24H<sub>D</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.32 (sxt, 16H<sub>C</sub>, <italic toggle=\"yes\">J</italic> = 7.3 Hz), 1.58 (qui, 16H<sub>B</sub>, <italic toggle=\"yes\">J</italic> = 7.5 Hz), 3.17 (t, 16H<sub>A</sub>, <italic toggle=\"yes\">J</italic> = 8.3 Hz), 7.28 (s, 1H), 7.85 (s, 1H), 12.28 (s, 1H<sub>1</sub>) ppm. X-ray diffraction quality crystals were selected directly from the reaction vessel.</p>", "clean_text": "(Bu4N)[OsCl5(Hpz)] (1)\n\nTo a solution of (H2pz)2[OsCl6] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu4NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at -20 \u00b0C for 2 days. The yellow product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl3/CH3OH 4:1 and collecting the first fraction (Rf = 0.75). Yield: 30 mg, 24%. Anal. Calcd for C19H40Cl5N3Os (M r = 677.99 g/mol): C, 33.66; H, 5.95; N, 6.20. Found: C, 33.73; H, 5.73; N, 6.11. ESI-MS in MeOH (negative): m/z 435 [OsIVCl5(Hpz)]-, 367 [OsIVCl5]-. IR, cm-1: 573, 665, 740, 773, 881, 1053, 1125, 1165, 1265, 1352, 1381, 1404, 1472, 1513, 2872, 2961, 3142, and 3330. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 254 sh (4 064), 360 (9 503). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.71 (s, 1H), -2.44 (s, 1H), 0.95 (t, 12HD, J = 7.4 Hz), 1.32 (sxt, 8HC, J = 7.4 Hz), 1.58 (qui, 8HB, J = 7.8 Hz), 3.17 (t, 8HA, J = 8.4 Hz), 6.39 (d, J = 1.6 Hz), 15.71 (s, 1H1) ppm. 13C{1H} NMR (d6-DMSO, 125.81 MHz): \u03b4 14.11 (CD), 19.88 (CC), 23.78 (CB), 58.43 (CA), 71.08 {6.39}, 180.92 {-2.71}, 191.31 {-2.44} ppm. 15N NMR (d6-DMSO, 50.68 MHz): \u03b4 144.3 (N1) ppm. Suitable crystals for X-ray diffraction study were selected directly from the reaction vessel.\n\n(Bu4N)[OsCl5(Hind)] (2)\n\nTo a solution of (H2ind)2[OsCl6] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu4NCl (150 mg, 0.54 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at room temperature overnight. The dark-red product formed was filtered off and purified by column chromatography on silica, using as eluent a mixture of CHCl3/CH3OH 7:1 and collecting the first fraction (Rf = 0.67). Yield: 80 mg, 70%. Anal. Calcd for C23H42Cl5N3Os (M r = 728.05 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 38.05; H, 5.78; N, 5.66. ESI-MS in MeOH (negative): m/z 485 [OsIVCl5(Hind)]-, 332 [OsIIICl4]-. IR, cm-1: 431, 613, 752, 883, 1089, 1147, 1241, 1360, 1378, 1475, 1513, 1627, 2872, 2959, and 3341. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 282 (9 492), 362 (11 031). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.54 (s, 1H3), 0.95 (t, 12HD, J = 7.3 Hz), 1.32 (sxt, 8HC, J = 7.3 Hz), 1.58 (qui, 8HB, J = 7.8 Hz), 3.08 (t, 1H6, J = 7.7 Hz), 3.17 (t, 8HA, J = 8.4 Hz), 5.89 (d, 1H4, J = 8.2 Hz), 8.24 (t, 1H5, J = 7.5 Hz), 10.84 (d, 1H7, J = 8.5 Hz), 17.76 (s, 1H1) ppm. 13C{1H} NMR (d6-DMSO, 125.81 MHz): \u03b4 14.08 (CD), 19.84 (CC), 23.74 (CB), 58.36 (CA), 75.94 (C9), 81.88 (C7), 106.16 (C5), 139.58 (C4), 163.74 (C6), 173.67 (C8), 200.66 (C3) ppm. 15N NMR (d6-DMSO, 50.68 MHz): \u03b4 124.7 (N1) ppm. X-ray diffraction quality single crystals were obtained by slow diffusion of hexane into a chloroform solution of 2 in a NMR tube.\n\n(Bu4N)[OsCl5(Him)] (3)\n\nA mixture of (H2im)2[OsCl6] (12 mg, 0.02 mmol) and excess Bu4NCl (16 mg, 0.06 mmol) in isoamyl alcohol (1 mL) was stirred at 100 \u00b0C for 72 h. The solvent was evaporated, and the red residue was dissolved in methanol. The mixture was allowed to stand at -20 \u00b0C for 2 days, producing single crystals suitable for X-ray diffraction study.\n\n(Bu4N)[OsCl5(Hbzim)] (4)\n\nTo a solution of (H2bzim)2[OsCl6] (100 mg, 0.16 mmol) in dry ethanol (15 mL) excess Bu4NCl (130 mg, 0.47 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter. The dark-red product formed was separated by filtration and purified by column chromatography on silica, using as eluent a mixture of CHCl3/CH3OH 7:1 and collecting the second fraction (Rf = 0.47). Yield: 90 mg, 79%. Anal. Calcd for C23H42Cl5N3Os (M r = 728.09 g/mol): C, 37.94; H, 5.81; N, 5.77. Found: C, 37.84; H, 5.53; N, 5.59. ESI-MS in MeOH (negative): m/z 485 [OsIVCl5(Hbzim)]-, 450 [OsIIICl4(Hbzim)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. IR, cm-1: 613, 699, 737, 760, 798, 882, 981, 1012, 1106, 1150, 1184, 1243, 1265, 1303, 1379, 1411, 1477, 1504, 2873, 2931, 2962, 3269. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 267 (10 253), 342 sh (7 109), 366 (9 034). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.64 (s, 1H2), 0.94 (t, 12HD, J = 7.3 Hz), 1.32 (sxt, 8HC, J = 7.3 Hz), 1.58 (qui, 8HB, J = 7.6 Hz), 3.17 (t, 8HA, J = 8.4 Hz), 6.04 (t, 1H5 or 6, J = 7.3 Hz), 6.52 (d, 1H4 or 7, J = 8.2 Hz), 6.98 (t, 1H5 or 6, J = 7.7 Hz), 7.34 (d, 1H4 or 7, J = 8.1 Hz), 9.41 (s, 1H1) ppm. X-ray diffraction quality crystals of 4\u22c5CH3OH were obtained from a solution of 4 in methanol at -16 \u00b0C after 24 h.\n\n(Bu4N)[OsCl5(Htrz)]\u22c5C2H5OH (5\u22c5C2H5OH)\n\nTo a solution of (H2trz)2[OsCl6] (300 mg, 0.55 mmol) in dry ethanol (10 mL) excess Bu4NCl (450 mg, 1.62 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The solution produced yellow needle-like crystals on cooling. These were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 130 mg, 33%. Anal. Calcd for C18H39Cl5N4Os\u22c5C2H5OH (M r = 725.05 g/mol): C, 33.13; H, 6.26; N, 7.73. Found: C, 33.28; H, 6.29; N, 7.81. ESI-MS in MeOH (negative): m/z 436 [OsIVCl5(Htrz)]-, 367 [OsIVCl5]-. IR, cm-1: 584, 631, 736, 880, 1001, 1059, 1306, 1381, 1427, 1466, 1983, 2359, 2872, 2960. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 270 sh (5 076), 366 (10 384), 425 sh (2 365). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.22 (brs), 0.94 (t, 12HD, J = 7.3 Hz), 1.32 (sxt, 8HC, J = 7.3 Hz), 1.58 (qui, 8HB, J = 7.5 Hz), 3.17 (t, 8HA, J = 8.3 Hz), 9.39 (brs), 13.65 (brs) ppm. Suitable crystals of 5\u22c5C2H5OH for X-ray diffraction study were selected directly from the reaction vessel.\n\nNa[OsCl5(Hpz)]\u22c52H2O (6\u22c52H2O)\n\nTo a solution of 1 (106 mg, 0.16 mmol) in water (400 mL) ion exchanger Dowex Marathon C Na+-form (10 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 73 mg, 94%. Anal. Calcd for C3H4Cl5N2NaOs\u22c52H2O (M r = 494.55 g/mol): C, 7.29; H, 1.63; N, 5.66. Found: C, 7.77; H, 1.35; N, 5.23. ESI-MS in MeOH (negative): m/z 400 [OsIIICl4(Hpz)]-, 367 [OsIVCl5]-. Solubility in water 34.3 mM at 298 K. IR, cm-1: 569, 656, 768, 905, 1055, 1072, 1111, 1169, 1265, 1345, 1398, 1485, 1506, 1620, 3144, 3314, 3481, 3559. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 207 (15 376), 256 sh (3 663), 351 (6 131), 368 sh (6 079). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.75 (s, 1H), -2.48 (s, 1H), 6.34 (s, 1H), 15.69 (s, 1H1) ppm. X-ray diffraction quality crystals were obtained by slow evaporation of a solution of 6 in water.\n\nNa[OsCl5(Hind)]\u22c52H2O (7\u22c52H2O)\n\nTo a solution of 2 (50 mg, 0.07 mmol) in water/ethanol 1:1 (160 mL) ion exchanger Dowex Marathon C Na+-form (5 g), after 12 h of soaking in water, was added. The suspension was stirred for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give a brown solid. Yield: 34 mg, 91%. Anal. Calcd for C7H6Cl5N2NaOs\u22c52H2O (M r = 544.65 g/mol): C, 15.44; H, 1.85; N, 5.14. Found: C, 15.64; H, 1.64; N, 5.03. ESI-MS in MeOH/CH3CN (negative): m/z 485 [OsIVCl5(Hind)]-, 367 [OsIVCl5]-. Solubility in water 3.9 mM at 298 K. IR, cm-1: 636, 748, 759, 785, 967, 1087, 1243, 1360, 1516, 1626, 3307, 3355, 3471, 3551. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 199 (760 730), 269 (159 591), 359 (143 943), 403 sh (96406). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.54 (s, 1H3), 3.08 (t, 1H6, J = 7.7 Hz), 5.89 (d, 1H4, J = 8.2 Hz), 8.24 (t, 1H5, J = 7.6 Hz), 10.84 (d, 1H7, J = 8.5 Hz), 17.76 (s, 1H1) ppm.\n\nNa[OsCl5(Htrz)]\u22c51.5H2O (8\u22c51.5H2O)\n\nTo a solution of 5 (100 mg, 0.15 mmol) in water (420 mL) ion exchanger Dowex Marathon C Na+-form (10 g), after 12 h of soaking in water, was added. The suspension was allowed to stir for 30 min, the ion exchanger separated by filtration, and the solution lyophilized, to give an orange solid. Yield: 70 mg, 98%. Anal. Calcd for C2H3Cl5N3NaOs\u22c51.5H2O (M r = 486.57 g/mol): C, 4.94; H, 1.24; N, 8.64. Found: C, 5.24; H, 1.08; N, 8.28. ESI-MS in MeOH (negative): m/z 436 [OsIVCl5(Htrz)]-, 401 [OsIIICl4(Htrz)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. Solubility in water 15.4 mM at 298 K. IR, cm-1: 573, 614, 676, 865, 890, 962, 1079, 1144, 1192, 1257, 1301, 1374, 1412, 1493, 1523, 1613, 2363, 3127, 3322, 3534. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 343 sh (5 432), 362 (6 112). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -7.23 (brs) ppm.\n\n(H2pz)[OsCl5(Hpz)]\u22c5H2O (9\u22c5H2O)\n\nTo pyrazole (14 mg, 0.21 mmol) in water (1.4 mL) 12 M hydrochloric acid (0.02 mL, 0.24 mmol) was added. The resulting solution of pyrazolium chloride was then added to a solution of 6 (47 mg, 0.10 mmol) in water (0.6 mL). The reaction mixture produced red crystals. Yield: 26 mg, 52%. Anal. Calcd for C6H9Cl5N4Os\u22c5H2O (M r = 522.67): C, 13.79; H, 2.12; N, 10.72. Found: C, 13.82; H, 1.82; N, 10.32. ESI-MS in MeOH (negative): m/z 435 [OsIVCl5(Hpz)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. Solubility in water 6.7 mM at 298 K. IR, cm-1: 599, 609, 771, 905, 1051, 1070, 1110, 1131, 1170, 1276, 1351, 1398, 1487, 1524, 1563, 1601, 2862, 3044, 3136, 3472, 3513. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 208 (19 463), 253 sh (3 806), 357 (8 678). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.71 (s, 1H), -2.44 (s, 1H), 6.31 (s, 1H4'), 6.39 (s, 1H), 7.68 (s, 2H3,5'), 15.71 (s, 1H1) ppm. 13C{1H} NMR (d6-DMSO, 125.81 MHz): \u03b4 71.18 {6.39}, 106.16 (C4'), 134.25 (C3,5'), 181.33 {-2.71}, 191.99 {-2.44} ppm. 15N NMR (d6-DMSO, 50.68 MHz): \u03b4 144.1 (N1) ppm.\n\n(H2ind)[OsCl5(Hind)]\u22c5H2O (10\u22c5H2O)\n\nTo indazole (12 mg, 0.10 mmol) in water (1.2 mL) was added 12 M hydrochloric acid (0.01 mL, 0.12 mmol). The resulting solution of indazolium chloride was then added to a solution of 7 (45 mg, 0.08 mmol) in water (4 mL). The reaction mixture produced a brown solid. Yield: 40 mg, 78%. Anal. Calcd for C14H13Cl5N4Os\u22c5H2O (M r = 622.79): C, 27.00; H, 2.43; N, 9.00. Found: C, 27.36; H, 2.31; N, 8.72. ESI-MS in MeOH/CH3CN (negative): m/z 485 [OsIVCl5(Hind)]-, 367 [OsIVCl5]-. Solubility in water 1.3 mM at 298 K. IR, cm-1: 614, 744, 787, 830, 967, 1002, 1087, 1126, 1152, 1247, 1359, 1384, 1483, 1516, 1628, 2359, 3127, 3248, 3466, 3519. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 201 (31 605), 249 (4 565), 286 (4 721), 358 (3 571). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -4.56 (s, 1H3), 3.06 (t, 1H6, J = 7.7 Hz), 5.89 (d, 1H4, J = 7.5 Hz), 7.11 (t, 1H5', J = 7.4 Hz), 7.34 (t, 1H6', J = 7.6 Hz), 7.53 (d, 1H7', J = 8.4 Hz), 7.75 (d, 1H4', J = 8.1 Hz), 8.08 (s, 1H3'), 8.23 (t, 1H5, J = 7.6 Hz), 10.85 (d, 1H7, J = 8.5 Hz), 17.76 (s, 1H1) ppm.\n\n(H2trz)[OsCl5(Htrz)] (11)\n\nTo triazole (15 mg, 0.22 mmol) in water (1.5 mL) was added 12 M hydrochloric acid (0.02 mL, 0.24 mmol). The resulting solution of triazolium chloride was then added to a solution of 8 (48 mg, 0.10 mmol) in water (4.8 mL). The reaction mixture produced red needle-like crystals. Yield: 28 mg, 56%. Anal. Calcd for C4H7Cl5N6Os (M r = 506.63 g/mol): C, 9.48; H, 1.39; N, 16.59. Found: C, 9.49; H, 1.23; N, 16.35. ESI-MS in MeOH (negative): m/z 436 [OsIVCl5(Htrz)]-, 401 [OsIIICl4(Htrz)]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. Solubility in water 4.4 mM at 298 K. IR, cm-1: 621, 661, 743, 838, 877, 934, 970, 1027, 1058, 1150, 1258, 1300, 1413, 1518, 1560, 1602, 2807, 2848, 2916, 2955, 3124, 3521, 3601. UV-vis (H2O), \u03bbmax, nm (\u03b5, M-1 cm-1): 212 sh (117 773), 338 sh (4 890), 363 (8 229). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -2.19 (s, 1H), 8.71 (s, 2H3,5'), 8.90 (brs) ppm.\n\n{(Bu4N)2[OsIVCl6]}2\u22c5[OsIVCl4(Him)2] (12)\n\nTo a solution of (H2im)2[OsCl6] (100 mg, 0.18 mmol) in dry ethanol (10 mL) excess Bu4NCl (153 mg, 0.55 mmol) was added. The suspension was stirred at 85 \u00b0C for 24 h. The volume of the solvent was then reduced to a quarter, and the reaction mixture was allowed to stand at -20 \u00b0C for 2 days. The orange crystals formed were filtered off, washed with diethyl ether (2 \u00d7 5 mL) and dried in vacuo. Yield: 80 mg, 58%. Anal. Calcd for C70H152Cl16N8Os3 (M r = 2243.80 g/mol): C, 37.47; H, 6.83; N, 4.99. Found: C, 37.49; H, 6.70; N, 4.93. ESI-MS in MeOH (negative): m/z 469 [OsIVCl4(Him)2-H+]-, 367 [OsIVCl5]-, 332 [OsIIICl4]-. IR, cm-1: 615, 653, 737, 880, 1025, 1065, 1100, 1135, 1259, 1323, 1378, 1474, 1547, 2873, 2958, 3164, 3251. UV-vis (C2H5OH), \u03bbmax, nm (\u03b5, M-1 cm-1): 254 sh (19 949), 339 (49 763), 371 (45 578), 421 sh (7141). 1H NMR (d6-DMSO, 500.32 MHz): \u03b4 -0.52 (s, 1H), 0.95 (t, 24HD, J = 7.3 Hz), 1.32 (sxt, 16HC, J = 7.3 Hz), 1.58 (qui, 16HB, J = 7.5 Hz), 3.17 (t, 16HA, J = 8.3 Hz), 7.28 (s, 1H), 7.85 (s, 1H), 12.28 (s, 1H1) ppm. X-ray diffraction quality crystals were selected directly from the reaction vessel.", "data": [["This model's maximum context length is 8192 tokens. However, your messages resulted in 8971 tokens. Please reduce the length of the messages."]], "include_properties": ["chemical_synthesis", "filtration"], "intermediate_step": {"text-synthesis-type": "['chemical_synthesis', 'filtration']", "text-synthesis-struct": "This model's maximum context length is 8192 tokens. However, your messages resulted in 8971 tokens. Please reduce the length of the messages."}}, {"idx": 56, "type": "text", "classification": "property", "content": "<title>Magnetic Properties</title><p>Complex <bold>5</bold> is paramagnetic at 300 K in the solid state (\u03bc<sub>eff</sub> = 1.86 \u03bc<sub>B</sub>). The magnetic moment is temperature-dependent, decreasing continuously with temperature and reaching the value of 0.40 \u03bc<sub>B</sub> at 2 K (). This behavior indicates a non-magnetic ground state resulting from antiparallel coupling of the effective orbital moment <italic toggle=\"yes\">L</italic> = 1 of the t<sub>2</sub> shell with the total spin <italic toggle=\"yes\">S</italic> = 1 of the ground t<sub arrange=\"stack\">2</sub>\n<sup arrange=\"stack\">4</sup> configuration, induced by spin\u2212orbit coupling on Os(IV) in octahedral geometry. Given a very large spin\u2212orbit coupling constant on the osmium ion (&gt;5000 cm<sup>\u22121</sup>), the reduction of symmetry caused by axial ligands will not affect the character of the ground state, which thus will remain non-degenerate (non-magnetic) in the real geometry too (Figure ). Measurement of the same complex in DMSO by Evans method resulted in an increase of the effective magnetic moment (3.18 \u03bc<sub>B</sub> at 297 K). Similar behavior has been also documented in the literature for magnetically diluted hexahalogenidoosmates(IV). Detailed magnetic studies are underway in our laboratory and will be reported in due course.</p>", "clean_text": "Magnetic Properties\n\nComplex 5 is paramagnetic at 300 K in the solid state (\u03bceff = 1.86 \u03bcB). The magnetic moment is temperature-dependent, decreasing continuously with temperature and reaching the value of 0.40 \u03bcB at 2 K (). This behavior indicates a non-magnetic ground state resulting from antiparallel coupling of the effective orbital moment L = 1 of the t2 shell with the total spin S = 1 of the ground t2 4 configuration, induced by spin-orbit coupling on Os(IV) in octahedral geometry. Given a very large spin-orbit coupling constant on the osmium ion (>5000 cm-1), the reduction of symmetry caused by axial ligands will not affect the character of the ground state, which thus will remain non-degenerate (non-magnetic) in the real geometry too (Figure ). Measurement of the same complex in DMSO by Evans method resulted in an increase of the effective magnetic moment (3.18 \u03bcB at 297 K). Similar behavior has been also documented in the literature for magnetically diluted hexahalogenidoosmates(IV). Detailed magnetic studies are underway in our laboratory and will be reported in due course.", "data": [[[{"meta": {"name": "Complex 5", "symbol": "", "chemical formula": ""}, "magnetic moment": [{"value": "1.86", "unit": "\u03bcB", "temperature": "300 K", "condition": "paramagnetic, solid state"}, {"value": "0.40", "unit": "\u03bcB", "temperature": "2 K", "condition": "non-magnetic ground state, antiparallel coupling of the effective orbital moment L = 1 of the t2 shell with the total spin S = 1 of the ground t2 4 configuration, induced by spin-orbit coupling on Os(IV) in octahedral geometry"}, {"value": "3.18", "unit": "\u03bcB", "temperature": "297 K", "condition": "measured in DMSO by Evans method"}]}]]], "include_properties": ["magnetic_moment"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['magnetic_moment']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Complex 5\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"magnetic moment\": [\n            {\n                \"value\": \"1.86\",\n                \"unit\": \"\u03bcB\",\n                \"temperature\": \"300 K\",\n                \"condition\": \"paramagnetic, solid state\"\n            },\n            {\n                \"value\": \"0.40\",\n                \"unit\": \"\u03bcB\",\n                \"temperature\": \"2 K\",\n                \"condition\": \"non-magnetic ground state, antiparallel coupling of the effective orbital moment L = 1 of the t2 shell with the total spin S = 1 of the ground t2 4 configuration, induced by spin-orbit coupling on Os(IV) in octahedral geometry\"\n            },\n            {\n                \"value\": \"3.18\",\n                \"unit\": \"\u03bcB\",\n                \"temperature\": \"297 K\",\n                \"condition\": \"measured in DMSO by Evans method\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 25, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystal Data and Details of Data Collection for <bold>1</bold>\u2212<bold>5</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>4</bold>\u00b7CH<sub>3</sub>OH</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os</oasis:entry>\n<oasis:entry>C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os</oasis:entry>\n<oasis:entry>C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os</oasis:entry>\n<oasis:entry>C<sub>24</sub>H<sub>46</sub>Cl<sub>5</sub>N<sub>3</sub>OOs</oasis:entry>\n<oasis:entry>C<sub>20</sub>H<sub>45</sub>Cl<sub>5</sub>N<sub>4</sub>OOs</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Fw</oasis:entry>\n<oasis:entry>677.99</oasis:entry>\n<oasis:entry>728.05</oasis:entry>\n<oasis:entry>677.99</oasis:entry>\n<oasis:entry>760.09</oasis:entry>\n<oasis:entry>725.05</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> [\u00c5]</oasis:entry>\n<oasis:entry>10.6292(8)</oasis:entry>\n<oasis:entry>9.8278(8)</oasis:entry>\n<oasis:entry>10.7865(6)</oasis:entry>\n<oasis:entry>10.2229(7)</oasis:entry>\n<oasis:entry>9.6679(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> [\u00c5]</oasis:entry>\n<oasis:entry>11.4265(8)</oasis:entry>\n<oasis:entry>10.9541(8)</oasis:entry>\n<oasis:entry>19.3982(13)</oasis:entry>\n<oasis:entry>11.2755(8)</oasis:entry>\n<oasis:entry>10.4061(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> [\u00c5]</oasis:entry>\n<oasis:entry>11.7079(9)</oasis:entry>\n<oasis:entry>14.7537(12)</oasis:entry>\n<oasis:entry>13.3421(8)</oasis:entry>\n<oasis:entry>14.9270(11)</oasis:entry>\n<oasis:entry>15.1487(6)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 [deg]</oasis:entry>\n<oasis:entry>68.717(4)</oasis:entry>\n<oasis:entry>109.992(5)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>74.902(4)</oasis:entry>\n<oasis:entry>98.195(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 [deg]</oasis:entry>\n<oasis:entry>85.748(4)</oasis:entry>\n<oasis:entry>96.282(6)</oasis:entry>\n<oasis:entry>109.892(3)</oasis:entry>\n<oasis:entry>72.132(4)</oasis:entry>\n<oasis:entry>103.674(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 [deg]</oasis:entry>\n<oasis:entry>83.527(3)</oasis:entry>\n<oasis:entry>91.468(5)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry>78.163(4)</oasis:entry>\n<oasis:entry>90.020(1)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> [\u00c5<sup>3</sup>]</oasis:entry>\n<oasis:entry>1315.70(17)</oasis:entry>\n<oasis:entry>1480.3(2)</oasis:entry>\n<oasis:entry>2625.1(3)</oasis:entry>\n<oasis:entry>1566.34(19)</oasis:entry>\n<oasis:entry>1464.80(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bb [\u00c5]</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>]</oasis:entry>\n<oasis:entry>1.711</oasis:entry>\n<oasis:entry>1.633</oasis:entry>\n<oasis:entry>1.715</oasis:entry>\n<oasis:entry>1.612</oasis:entry>\n<oasis:entry>1.644</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size [mm<sup>3</sup>]</oasis:entry>\n<oasis:entry>0.25 \u00d7 0.10 \u00d7 0.10</oasis:entry>\n<oasis:entry>0.10 \u00d7 0.10 \u00d7 0.06</oasis:entry>\n<oasis:entry>0.10 \u00d7 0.07 \u00d7 0.03</oasis:entry>\n<oasis:entry>0.14 \u00d7 0.08 \u00d7 0.02</oasis:entry>\n<oasis:entry>0.30 \u00d7 0.30 \u00d7 0.02</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">T</italic> [K]</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc [mm<sup>\u22121</sup>]</oasis:entry>\n<oasis:entry>5.365</oasis:entry>\n<oasis:entry>4.775</oasis:entry>\n<oasis:entry>5.378</oasis:entry>\n<oasis:entry>4.518</oasis:entry>\n<oasis:entry>4.828</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub>\n<xref rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0314</oasis:entry>\n<oasis:entry>0.0282</oasis:entry>\n<oasis:entry>0.0339</oasis:entry>\n<oasis:entry>0.0377</oasis:entry>\n<oasis:entry>0.0264</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub>\n<xref rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.0742</oasis:entry>\n<oasis:entry>0.0600</oasis:entry>\n<oasis:entry>0.0806</oasis:entry>\n<oasis:entry>0.0787</oasis:entry>\n<oasis:entry>0.0669</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF<xref rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>1.008</oasis:entry>\n<oasis:entry>1.009</oasis:entry>\n<oasis:entry>1.008</oasis:entry>\n<oasis:entry>1.021</oasis:entry>\n<oasis:entry>1.069</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = \u2211\u2223\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223 \u2212 \u2223<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\u2223\u2223/\u2211\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223.</p>\n</fn>\n<fn id=\"t1fn2\">\n<label>b</label>\n<p>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = {\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>/\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.</p>\n</fn>\n<fn id=\"t1fn3\">\n<label>c</label>\n<p>GOF = {\u2211[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/(<italic toggle=\"yes\">n</italic> \u2212 <italic toggle=\"yes\">p</italic>)}<sup>1/2</sup>, where <italic toggle=\"yes\">n</italic> is the number of reflections and <italic toggle=\"yes\">p</italic> is the total number of parameters refined.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Crystal Data and Details of Data Collection for 1\u22125\n\n|                   | 1                      | 2                      | 3                      | 4\u00b7CH<sub>3</sub>OH     | 5\u00b7C<sub>2</sub>H<sub>5</sub>OH |\n|-------------------|------------------------|------------------------|------------------------|------------------------|-------------------------------|\n| empirical formula | C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os | C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os | C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os | C<sub>24</sub>H<sub>46</sub>Cl<sub>5</sub>N<sub>3</sub>OOs | C<sub>20</sub>H<sub>45</sub>Cl<sub>5</sub>N<sub>4</sub>OOs |\n| Fw                | 677.99                 | 728.05                 | 677.99                 | 760.09                 | 725.05                        |\n| space group       | <italic toggle=\"yes\">P</italic>1\u0305                  | <italic toggle=\"yes\">P</italic>1\u0305                  | <italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic> | <italic toggle=\"yes\">P</italic>1\u0305                  | <italic toggle=\"yes\">P</italic>1                     |\n| <italic toggle=\"yes\">a</italic> [\u00c5]       | 10.6292(8)             | 9.8278(8)              | 10.7865(6)             | 10.2229(7)             | 9.6679(3)                     |\n| <italic toggle=\"yes\">b</italic> [\u00c5]       | 11.4265(8)             | 10.9541(8)             | 19.3982(13)            | 11.2755(8)             | 10.4061(3)                    |\n| <italic toggle=\"yes\">c</italic> [\u00c5]       | 11.7079(9)             | 14.7537(12)            | 13.3421(8)             | 14.9270(11)            | 15.1487(6)                    |\n| \u03b1 [deg]           | 68.717(4)              | 109.992(5)             |                        | 74.902(4)              | 98.195(2)                     |\n| \u03b2 [deg]           | 85.748(4)              | 96.282(6)              | 109.892(3)             | 72.132(4)              | 103.674(2)                    |\n| \u03b3 [deg]           | 83.527(3)              | 91.468(5)              |                        | 78.163(4)              | 90.020(1)                     |\n| <italic toggle=\"yes\">V</italic> [\u00c5<sup>3</sup>] | 1315.70(17)            | 1480.3(2)              | 2625.1(3)              | 1566.34(19)            | 1464.80(8)                    |\n| <italic toggle=\"yes\">Z</italic>             | 2                      | 2                      | 4                      | 2                      | 2                             |\n| \u03bb [\u00c5]             | 0.71073                | 0.71073                | 0.71073                | 0.71073                | 0.71073                       |\n| \u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>] | 1.711                  | 1.633                  | 1.715                  | 1.612                  | 1.644                         |\n| crystal size [mm<sup>3</sup>]         | 0.25 \u00d7 0.10 \u00d7 0.10      | 0.10 \u00d7 0.10 \u00d7 0.06      | 0.10 \u00d7 0.07 \u00d7 0.03      | 0.14 \u00d7 0.08 \u00d7 0.02      | 0.30 \u00d7 0.30 \u00d7 0.02             |\n| <italic toggle=\"yes\">T</italic> [K]       | 100                    | 100                    | 100                    | 100                    | 100                           |\n| \u03bc [mm<sup>\u22121</sup>]                   | 5.365                  | 4.775                  | 5.378                  | 4.518                  | 4.828                         |\n| <italic toggle=\"yes\">R</italic><sub>1</sub><xref rid=\"t1fn1\"></xref> | 0.0314                 | 0.0282                 | 0.0339                 | 0.0377                 | 0.0264                        |\n| <italic toggle=\"yes\">wR</italic><sub>2</sub><xref rid=\"t1fn2\"></xref> | 0.0742                 | 0.0600                 | 0.0806                 | 0.0787                 | 0.0669                        |\n| GOF<xref rid=\"t1fn3\"></xref>             | 1.008                  | 1.009                  | 1.008                  | 1.021                  | 1.069                         |\n\na <italic toggle=\"yes\">R</italic><sub>1</sub> = \u2211\u2223\u2223<italic toggle=\"yes\">F</italic><sub>o</sub>\u2223 \u2212 \u2223<italic toggle=\"yes\">F</italic><sub>c</sub>\u2223\u2223/\u2211\u2223<italic toggle=\"yes\">F</italic><sub>o</sub>\u2223.\nb <italic toggle=\"yes\">wR</italic><sub>2</sub> = {\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic><sub>o</sub><sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic><sub>c</sub><sup>2</sup>)<sup>2</sup>/\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic><sub>o</sub><sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.\nc GOF = {\u2211[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic><sub>o</sub><sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic><sub>c</sub><sup>2</sup>)<sup>2</sup>]/(<italic toggle=\"yes\">n</italic> \u2212 <italic toggle=\"yes\">p</italic>)}<sup>1/2</sup>, where <italic toggle=\"yes\">n</italic> is the number of reflections and <italic toggle=\"yes\">p</italic> is the total number of parameters refined.", "data": [[{"meta": {"name": "", "symbol": "1", "chemical formula": "C19H40Cl5N3Os"}, "chemical formula weight": [{"value": "677.99", "unit": "", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "10.6292(8)", "b": "11.4265(8)", "c": "11.7079(9)", "alpha": "68.717(4)", "beta": "85.748(4)", "gamma": "83.527(3)"}, "condition": ""}], "cell volume": [{"value": "1315.70(17)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.711", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.25 x 0.10 x 0.10", "unit": "mm", "condition": ""}]}, {"meta": {"name": "", "symbol": "2", "chemical formula": "C23H42Cl5N3Os"}, "chemical formula weight": [{"value": "728.05", "unit": "", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "9.8278(8)", "b": "10.9541(8)", "c": "14.7537(12)", "alpha": "109.992(5)", "beta": "96.282(6)", "gamma": "91.468(5)"}, "condition": ""}], "cell volume": [{"value": "1480.3(2)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.633", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.10 x 0.10 x 0.06", "unit": "mm", "condition": ""}]}, {"meta": {"name": "", "symbol": "3", "chemical formula": "C19H40Cl5N3Os"}, "chemical formula weight": [{"value": "677.99", "unit": "", "condition": ""}], "space group": [{"value": "P21/n", "condition": ""}], "lattice parameters": [{"value": {"a": "10.7865(6)", "b": "19.3982(13)", "c": "13.3421(8)", "alpha": "", "beta": "109.892(3)", "gamma": ""}, "condition": ""}], "cell volume": [{"value": "2625.1(3)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.715", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.10 x 0.07 x 0.03", "unit": "mm", "condition": ""}]}, {"meta": {"name": "", "symbol": "4\u00b7CH3OH", "chemical formula": "C24H46Cl5N3OOs"}, "chemical formula weight": [{"value": "760.09", "unit": "", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "10.2229(7)", "b": "11.2755(8)", "c": "14.9270(11)", "alpha": "74.902(4)", "beta": "72.132(4)", "gamma": "78.163(4)"}, "condition": ""}], "cell volume": [{"value": "1566.34(19)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.612", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.14 x 0.08 x 0.02", "unit": "mm", "condition": ""}]}, {"meta": {"name": "", "symbol": "5\u00b7C2H5OH", "chemical formula": "C20H45Cl5N4OOs"}, "chemical formula weight": [{"value": "725.05", "unit": "", "condition": ""}], "space group": [{"value": "P1", "condition": ""}], "lattice parameters": [{"value": {"a": "9.6679(3)", "b": "10.4061(3)", "c": "15.1487(6)", "alpha": "98.195(2)", "beta": "103.674(2)", "gamma": "90.020(1)"}, "condition": ""}], "cell volume": [{"value": "1464.80(8)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.644", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.30 x 0.30 x 0.02", "unit": "mm", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "space_group", "lattice_parameters", "cell_volume", "density", "crystal_size"], "intermediate_step": {"table-convert2MD": "[gpt3.5]Table 1. Crystal Data and Details of Data Collection for 1\u22125\n\n|                   | 1                      | 2                      | 3                      | 4\u00b7CH<sub>3</sub>OH     | 5\u00b7C<sub>2</sub>H<sub>5</sub>OH |\n|-------------------|------------------------|------------------------|------------------------|------------------------|-------------------------------|\n| empirical formula | C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os | C<sub>23</sub>H<sub>42</sub>Cl<sub>5</sub>N<sub>3</sub>Os | C<sub>19</sub>H<sub>40</sub>Cl<sub>5</sub>N<sub>3</sub>Os | C<sub>24</sub>H<sub>46</sub>Cl<sub>5</sub>N<sub>3</sub>OOs | C<sub>20</sub>H<sub>45</sub>Cl<sub>5</sub>N<sub>4</sub>OOs |\n| Fw                | 677.99                 | 728.05                 | 677.99                 | 760.09                 | 725.05                        |\n| space group       | <italic toggle=\"yes\">P</italic>1\u0305                  | <italic toggle=\"yes\">P</italic>1\u0305                  | <italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic> | <italic toggle=\"yes\">P</italic>1\u0305                  | <italic toggle=\"yes\">P</italic>1                     |\n| <italic toggle=\"yes\">a</italic> [\u00c5]       | 10.6292(8)             | 9.8278(8)              | 10.7865(6)             | 10.2229(7)             | 9.6679(3)                     |\n| <italic toggle=\"yes\">b</italic> [\u00c5]       | 11.4265(8)             | 10.9541(8)             | 19.3982(13)            | 11.2755(8)             | 10.4061(3)                    |\n| <italic toggle=\"yes\">c</italic> [\u00c5]       | 11.7079(9)             | 14.7537(12)            | 13.3421(8)             | 14.9270(11)            | 15.1487(6)                    |\n| \u03b1 [deg]           | 68.717(4)              | 109.992(5)             |                        | 74.902(4)              | 98.195(2)                     |\n| \u03b2 [deg]           | 85.748(4)              | 96.282(6)              | 109.892(3)             | 72.132(4)              | 103.674(2)                    |\n| \u03b3 [deg]           | 83.527(3)              | 91.468(5)              |                        | 78.163(4)              | 90.020(1)                     |\n| <italic toggle=\"yes\">V</italic> [\u00c5<sup>3</sup>] | 1315.70(17)            | 1480.3(2)              | 2625.1(3)              | 1566.34(19)            | 1464.80(8)                    |\n| <italic toggle=\"yes\">Z</italic>             | 2                      | 2                      | 4                      | 2                      | 2                             |\n| \u03bb [\u00c5]             | 0.71073                | 0.71073                | 0.71073                | 0.71073                | 0.71073                       |\n| \u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>] | 1.711                  | 1.633                  | 1.715                  | 1.612                  | 1.644                         |\n| crystal size [mm<sup>3</sup>]         | 0.25 \u00d7 0.10 \u00d7 0.10      | 0.10 \u00d7 0.10 \u00d7 0.06      | 0.10 \u00d7 0.07 \u00d7 0.03      | 0.14 \u00d7 0.08 \u00d7 0.02      | 0.30 \u00d7 0.30 \u00d7 0.02             |\n| <italic toggle=\"yes\">T</italic> [K]       | 100                    | 100                    | 100                    | 100                    | 100                           |\n| \u03bc [mm<sup>\u22121</sup>]                   | 5.365                  | 4.775                  | 5.378                  | 4.518                  | 4.828                         |\n| <italic toggle=\"yes\">R</italic><sub>1</sub><xref rid=\"t1fn1\"></xref> | 0.0314                 | 0.0282                 | 0.0339                 | 0.0377                 | 0.0264                        |\n| <italic toggle=\"yes\">wR</italic><sub>2</sub><xref rid=\"t1fn2\"></xref> | 0.0742                 | 0.0600                 | 0.0806                 | 0.0787                 | 0.0669                        |\n| GOF<xref rid=\"t1fn3\"></xref>             | 1.008                  | 1.009                  | 1.008                  | 1.021                  | 1.069                         |\n\na <italic toggle=\"yes\">R</italic><sub>1</sub> = \u2211\u2223\u2223<italic toggle=\"yes\">F</italic><sub>o</sub>\u2223 \u2212 \u2223<italic toggle=\"yes\">F</italic><sub>c</sub>\u2223\u2223/\u2211\u2223<italic toggle=\"yes\">F</italic><sub>o</sub>\u2223.\nb <italic toggle=\"yes\">wR</italic><sub>2</sub> = {\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic><sub>o</sub><sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic><sub>c</sub><sup>2</sup>)<sup>2</sup>/\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic><sub>o</sub><sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.\nc GOF = {\u2211[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic><sub>o</sub><sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic><sub>c</sub><sup>2</sup>)<sup>2</sup>]/(<italic toggle=\"yes\">n</italic> \u2212 <italic toggle=\"yes\">p</italic>)}<sup>1/2</sup>, where <italic toggle=\"yes\">n</italic> is the number of reflections and <italic toggle=\"yes\">p</italic> is the total number of parameters refined.\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"1\",\n            \"chemical formula\": \"C19H40Cl5N3Os\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"677.99\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"10.6292(8)\",\n                    \"b\": \"11.4265(8)\",\n                    \"c\": \"11.7079(9)\",\n                    \"alpha\": \"68.717(4)\",\n                    \"beta\": \"85.748(4)\",\n                    \"gamma\": \"83.527(3)\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1315.70(17)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.711\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.25 x 0.10 x 0.10\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"2\",\n            \"chemical formula\": \"C23H42Cl5N3Os\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"728.05\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.8278(8)\",\n                    \"b\": \"10.9541(8)\",\n                    \"c\": \"14.7537(12)\",\n                    \"alpha\": \"109.992(5)\",\n                    \"beta\": \"96.282(6)\",\n                    \"gamma\": \"91.468(5)\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1480.3(2)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.633\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.10 x 0.10 x 0.06\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"C19H40Cl5N3Os\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"677.99\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P21/n\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"10.7865(6)\",\n                    \"b\": \"19.3982(13)\",\n                    \"c\": \"13.3421(8)\",\n                    \"alpha\": \"\",\n                    \"beta\": \"109.892(3)\",\n                    \"gamma\": \"\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"2625.1(3)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.715\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.10 x 0.07 x 0.03\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"4\u00b7CH3OH\",\n            \"chemical formula\": \"C24H46Cl5N3OOs\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"760.09\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"10.2229(7)\",\n                    \"b\": \"11.2755(8)\",\n                    \"c\": \"14.9270(11)\",\n                    \"alpha\": \"74.902(4)\",\n                    \"beta\": \"72.132(4)\",\n                    \"gamma\": \"78.163(4)\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1566.34(19)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.612\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.14 x 0.08 x 0.02\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"5\u00b7C2H5OH\",\n            \"chemical formula\": \"C20H45Cl5N4OOs\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"725.05\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.6679(3)\",\n                    \"b\": \"10.4061(3)\",\n                    \"c\": \"15.1487(6)\",\n                    \"alpha\": \"98.195(2)\",\n                    \"beta\": \"103.674(2)\",\n                    \"gamma\": \"90.020(1)\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1464.80(8)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.644\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.30 x 0.30 x 0.02\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 26, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Crystal Data and Details of Data Collection for <bold>6</bold> and <bold>12</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"3\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>6</bold>\u00b72H<sub>2</sub>O</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>12</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>3</sub>H<sub>8</sub>Cl<sub>5</sub>N<sub>2</sub>NaO<sub>2</sub>Os</oasis:entry>\n<oasis:entry>C<sub>70</sub>H<sub>152</sub>Cl<sub>16</sub>N<sub>8</sub>Os<sub>3</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Fw</oasis:entry>\n<oasis:entry>494.55</oasis:entry>\n<oasis:entry>2243.80</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic toggle=\"yes\">P</italic>2<sub>1</sub>/<italic toggle=\"yes\">n</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">a</italic> [\u00c5]</oasis:entry>\n<oasis:entry>6.5037(3)</oasis:entry>\n<oasis:entry>11.1066(7)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">b</italic> [\u00c5]</oasis:entry>\n<oasis:entry>6.8557(3)</oasis:entry>\n<oasis:entry>16.2484(9)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">c</italic> [\u00c5]</oasis:entry>\n<oasis:entry>13.5359(6)</oasis:entry>\n<oasis:entry>26.7804(15)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 [deg]</oasis:entry>\n<oasis:entry>96.816(3)</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 [deg]</oasis:entry>\n<oasis:entry>91.235(2)</oasis:entry>\n<oasis:entry>94.799(3)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 [deg]</oasis:entry>\n<oasis:entry>94.297(3)</oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">V</italic> [\u00c5<sup>3</sup>]</oasis:entry>\n<oasis:entry>597.30(5)</oasis:entry>\n<oasis:entry>4816.0(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">Z</italic>\n</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>2</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bb [\u00c5]</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n<oasis:entry>0.71073</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>]</oasis:entry>\n<oasis:entry>2.750</oasis:entry>\n<oasis:entry>1.547</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>crystal size [mm<sup>3</sup>]</oasis:entry>\n<oasis:entry>0.20 \u00d7 0.06 \u00d7 0.03</oasis:entry>\n<oasis:entry>0.10 \u00d7 0.05 \u00d7 0.01</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">T</italic> [K]</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc [mm<sup>\u22121</sup>]</oasis:entry>\n<oasis:entry>11.803</oasis:entry>\n<oasis:entry>4.431</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub>\n<xref rid=\"t2fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0203</oasis:entry>\n<oasis:entry>0.0465</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub>\n<xref rid=\"t2fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.0547</oasis:entry>\n<oasis:entry>0.0848</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF<xref rid=\"t2fn3\"></xref>\n</oasis:entry>\n<oasis:entry>1.099</oasis:entry>\n<oasis:entry>0.974</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>\n<italic toggle=\"yes\">R</italic>\n<sub>1</sub> = \u2211\u2223\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223 \u2212 \u2223<italic toggle=\"yes\">F</italic>\n<sub>c</sub>\u2223\u2223/\u2211\u2223<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\u2223.</p>\n</fn>\n<fn id=\"t2fn2\">\n<label>b</label>\n<p>\n<italic toggle=\"yes\">wR</italic>\n<sub>2</sub> = {\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>/\u2211<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.</p>\n</fn>\n<fn id=\"t2fn3\">\n<label>c</label>\n<p>GOF = {\u2211[<italic toggle=\"yes\">w</italic>(<italic toggle=\"yes\">F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2212 <italic toggle=\"yes\">F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/(<italic toggle=\"yes\">n</italic> \u2212 <italic toggle=\"yes\">p</italic>)}<sup>1/2</sup>, where <italic toggle=\"yes\">n</italic> is the number of reflections and <italic toggle=\"yes\">p</italic> is the total number of parameters refined.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 2. Crystal Data and Details of Data Collection for 6 and 12\n\n|                      | 6\u00b72H<sub>2</sub>O | 12                |\n|----------------------|-------------------|-------------------|\n| empirical formula    | C<sub>3</sub>H<sub>8</sub>Cl<sub>5</sub>N<sub>2</sub>NaO<sub>2</sub>Os | C<sub>70</sub>H<sub>152</sub>Cl<sub>16</sub>N<sub>8</sub>Os<sub>3</sub> |\n| Fw                   | 494.55            | 2243.80           |\n| space group          | P1\u0305                | P2<sub>1</sub>/n   |\n| a [\u00c5]                 | 6.5037(3)         | 11.1066(7)        |\n| b [\u00c5]                 | 6.8557(3)         | 16.2484(9)        |\n| c [\u00c5]                 | 13.5359(6)        | 26.7804(15)       |\n| \u03b1 [deg]               | 96.816(3)         |                   |\n| \u03b2 [deg]               | 91.235(2)         | 94.799(3)         |\n| \u03b3 [deg]               | 94.297(3)         |                   |\n| V [\u00c5<sup>3</sup>]     | 597.30(5)         | 4816.0(5)         |\n| Z                     | 2                 | 2                 |\n| \u03bb [\u00c5]                 | 0.71073           | 0.71073           |\n| \u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>] | 2.750 | 1.547 |\n| crystal size [mm<sup>3</sup>] | 0.20 \u00d7 0.06 \u00d7 0.03 | 0.10 \u00d7 0.05 \u00d7 0.01 |\n| T [K]                 | 100               | 100               |\n| \u03bc [mm<sup>\u22121</sup>]  | 11.803            | 4.431             |\n| R<sub>1</sub><sup>a</sup> | 0.0203       | 0.0465            |\n| wR<sub>2</sub><sup>b</sup> | 0.0547       | 0.0848            |\n| GOF<sup>c</sup>       | 1.099             | 0.974             |\n\n[^a]: R<sub>1</sub> = \u2211\u2223\u2223F<sub>o</sub>\u2223 \u2212 \u2223F<sub>c</sub>\u2223\u2223/\u2211\u2223F<sub>o</sub>\u2223.\n[^b]: wR<sub>2</sub> = {\u2211w(F<sub>o</sub><sup>2</sup> \u2212 F<sub>c</sub><sup>2</sup>)<sup>2</sup>/\u2211w(F<sub>o</sub><sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.\n[^c]: GOF = {\u2211[w(F<sub>o</sub><sup>2</sup> \u2212 F<sub>c</sub><sup>2</sup>)<sup>2</sup>]/(n \u2212 p)}<sup>1/2</sup>, where n is the number of reflections and p is the total number of parameters refined.", "data": [[{"meta": {"name": "", "symbol": "6\u00b72H2O", "chemical formula": "C3H8Cl5N2NaO2Os"}, "chemical formula weight": [{"value": "494.55", "unit": "", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "6.5037(3)", "b": "6.8557(3)", "c": "13.5359(6)", "alpha": "96.816(3)", "beta": "91.235(2)", "gamma": "94.297(3)"}, "condition": ""}], "cell volume": [{"value": "597.30(5)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "2.750", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.20 x 0.06 x 0.03", "unit": "mm^3", "condition": ""}]}, {"meta": {"name": "", "symbol": "12", "chemical formula": "C70H152Cl16N8Os3"}, "chemical formula weight": [{"value": "2243.80", "unit": "", "condition": ""}], "space group": [{"value": "P21/n", "condition": ""}], "lattice parameters": [{"value": {"a": "11.1066(7)", "b": "16.2484(9)", "c": "26.7804(15)", "alpha": "", "beta": "94.799(3)", "gamma": ""}, "condition": ""}], "cell volume": [{"value": "4816.0(5)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.547", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.10 x 0.05 x 0.01", "unit": "mm^3", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "space_group", "lattice_parameters", "cell_volume", "density", "crystal_size"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 2. Crystal Data and Details of Data Collection for 6 and 12\n\n|                      | 6\u00b72H<sub>2</sub>O | 12                |\n|----------------------|-------------------|-------------------|\n| empirical formula    | C<sub>3</sub>H<sub>8</sub>Cl<sub>5</sub>N<sub>2</sub>NaO<sub>2</sub>Os | C<sub>70</sub>H<sub>152</sub>Cl<sub>16</sub>N<sub>8</sub>Os<sub>3</sub> |\n| Fw                   | 494.55            | 2243.80           |\n| space group          | P1\u0305                | P2<sub>1</sub>/n   |\n| a [\u00c5]                 | 6.5037(3)         | 11.1066(7)        |\n| b [\u00c5]                 | 6.8557(3)         | 16.2484(9)        |\n| c [\u00c5]                 | 13.5359(6)        | 26.7804(15)       |\n| \u03b1 [deg]               | 96.816(3)         |                   |\n| \u03b2 [deg]               | 91.235(2)         | 94.799(3)         |\n| \u03b3 [deg]               | 94.297(3)         |                   |\n| V [\u00c5<sup>3</sup>]     | 597.30(5)         | 4816.0(5)         |\n| Z                     | 2                 | 2                 |\n| \u03bb [\u00c5]                 | 0.71073           | 0.71073           |\n| \u03c1<sub>calcd</sub> [g cm<sup>\u22123</sup>] | 2.750 | 1.547 |\n| crystal size [mm<sup>3</sup>] | 0.20 \u00d7 0.06 \u00d7 0.03 | 0.10 \u00d7 0.05 \u00d7 0.01 |\n| T [K]                 | 100               | 100               |\n| \u03bc [mm<sup>\u22121</sup>]  | 11.803            | 4.431             |\n| R<sub>1</sub><sup>a</sup> | 0.0203       | 0.0465            |\n| wR<sub>2</sub><sup>b</sup> | 0.0547       | 0.0848            |\n| GOF<sup>c</sup>       | 1.099             | 0.974             |\n\n[^a]: R<sub>1</sub> = \u2211\u2223\u2223F<sub>o</sub>\u2223 \u2212 \u2223F<sub>c</sub>\u2223\u2223/\u2211\u2223F<sub>o</sub>\u2223.\n[^b]: wR<sub>2</sub> = {\u2211w(F<sub>o</sub><sup>2</sup> \u2212 F<sub>c</sub><sup>2</sup>)<sup>2</sup>/\u2211w(F<sub>o</sub><sup>2</sup>)<sup>2</sup>}<sup>1/2</sup>.\n[^c]: GOF = {\u2211[w(F<sub>o</sub><sup>2</sup> \u2212 F<sub>c</sub><sup>2</sup>)<sup>2</sup>]/(n \u2212 p)}<sup>1/2</sup>, where n is the number of reflections and p is the total number of parameters refined.\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"6\u00b72H2O\",\n            \"chemical formula\": \"C3H8Cl5N2NaO2Os\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"494.55\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"6.5037(3)\",\n                    \"b\": \"6.8557(3)\",\n                    \"c\": \"13.5359(6)\",\n                    \"alpha\": \"96.816(3)\",\n                    \"beta\": \"91.235(2)\",\n                    \"gamma\": \"94.297(3)\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"597.30(5)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"2.750\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.20 x 0.06 x 0.03\",\n                \"unit\": \"mm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"12\",\n            \"chemical formula\": \"C70H152Cl16N8Os3\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"2243.80\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P21/n\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"11.1066(7)\",\n                    \"b\": \"16.2484(9)\",\n                    \"c\": \"26.7804(15)\",\n                    \"alpha\": \"\",\n                    \"beta\": \"94.799(3)\",\n                    \"gamma\": \"\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"4816.0(5)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.547\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.10 x 0.05 x 0.01\",\n                \"unit\": \"mm^3\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 36, "type": "table", "classification": ["Bond & Angle"], "content": "<table-wrap id=\"tbl3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Selected Bond Distances (\u00c5) in <bold>1</bold>\u2212<bold>5</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"6\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>4</bold>\u00b7CH<sub>3</sub>OH</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Os\u2212N1 [Os1\u2212N1, Os2\u2212N4]</oasis:entry>\n<oasis:entry>2.094(3)</oasis:entry>\n<oasis:entry>2.068(3)</oasis:entry>\n<oasis:entry>2.084(4)</oasis:entry>\n<oasis:entry>2.076(4)</oasis:entry>\n<oasis:entry>[2.086(4), 2.081(4)]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Os\u2212Cl<sub>axial</sub> [Os1\u2212Cl5, Os2\u2212Cl10]</oasis:entry>\n<oasis:entry>2.3132(9)</oasis:entry>\n<oasis:entry>2.3332(10)</oasis:entry>\n<oasis:entry>2.3445(13)</oasis:entry>\n<oasis:entry>2.3549(12)</oasis:entry>\n<oasis:entry>[2.3270(11), 2.3136(12)]</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Os\u2212Cl<sub>equatorial</sub>(av) [Os1\u2212Cl1\u22124, Os2\u2212Cl6\u22129]</oasis:entry>\n<oasis:entry>2.333(11)</oasis:entry>\n<oasis:entry>2.325(11)</oasis:entry>\n<oasis:entry>2.331(21)</oasis:entry>\n<oasis:entry>2.332(4)</oasis:entry>\n<oasis:entry>[2.326(10), 2.328(11)]</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 3. Selected Bond Distances (\u00c5) in 1\u22125\n\n|                    | 1       | 2       | 3       | 4\u00b7CH\u2083OH | 5\u00b7C\u2082H\u2085OH |\n|--------------------|---------|---------|---------|---------|----------|\n| Os\u2212N1 [Os1\u2212N1, Os2\u2212N4] | 2.094(3) | 2.068(3) | 2.084(4) | 2.076(4) | [2.086(4), 2.081(4)] |\n| Os\u2212Cl\u2090\u2093\u1d62\u2090\u2097 [Os1\u2212Cl5, Os2\u2212Cl10] | 2.3132(9) | 2.3332(10) | 2.3445(13) | 2.3549(12) | [2.3270(11), 2.3136(12)] |\n| Os\u2212Cl\u2091\u2098\u1d64\u2090\u209c\u2092\u1d62\u1d65\u2090\u2097(av) [Os1\u2212Cl1\u22124, Os2\u2212Cl6\u22129] | 2.333(11) | 2.325(11) | 2.331(21) | 2.332(4) | [2.326(10), 2.328(11)] |", "data": [["Bond & Angle type of table is not target"]], "include_properties": null, "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 3. Selected Bond Distances (\u00c5) in 1\u22125\n\n|                    | 1       | 2       | 3       | 4\u00b7CH\u2083OH | 5\u00b7C\u2082H\u2085OH |\n|--------------------|---------|---------|---------|---------|----------|\n| Os\u2212N1 [Os1\u2212N1, Os2\u2212N4] | 2.094(3) | 2.068(3) | 2.084(4) | 2.076(4) | [2.086(4), 2.081(4)] |\n| Os\u2212Cl\u2090\u2093\u1d62\u2090\u2097 [Os1\u2212Cl5, Os2\u2212Cl10] | 2.3132(9) | 2.3332(10) | 2.3445(13) | 2.3549(12) | [2.3270(11), 2.3136(12)] |\n| Os\u2212Cl\u2091\u2098\u1d64\u2090\u209c\u2092\u1d62\u1d65\u2090\u2097(av) [Os1\u2212Cl1\u22124, Os2\u2212Cl6\u22129] | 2.333(11) | 2.325(11) | 2.331(21) | 2.332(4) | [2.326(10), 2.328(11)] |\n<END>", "table-categorize": "Bond & Angle"}}, {"idx": 59, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<title>Cyclic Voltammetric Data for <bold>1</bold>, <bold>2</bold>, <bold>4</bold>, and <bold>5</bold>\n</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">complex</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">E</italic>\n<sub>p</sub> Os(III/II)</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">E</italic>\n<sub>1/2</sub> Os(IV/III)<xref rid=\"t4fn1\"></xref>, (\u0394<italic toggle=\"yes\">E</italic>\n<sub>p</sub>)<xref rid=\"t4fn2\"></xref>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<italic toggle=\"yes\">E</italic>\n<sub>calc</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">p<italic toggle=\"yes\">K</italic>\n<sub>a</sub> (H<sub>2</sub>azole<sup>+</sup>)</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>\u22121.66</oasis:entry>\n<oasis:entry>0.03 (75)</oasis:entry>\n<oasis:entry>\u22121.41</oasis:entry>\n<oasis:entry>2.64</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry>\u22121.39</oasis:entry>\n<oasis:entry>0.12 (69)</oasis:entry>\n<oasis:entry>\u22121.35</oasis:entry>\n<oasis:entry>1.25</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>\u22121.78</oasis:entry>\n<oasis:entry>\u22120.03 (72)</oasis:entry>\n<oasis:entry>\u22121.51</oasis:entry>\n<oasis:entry>5.63</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>5</bold>\n</oasis:entry>\n<oasis:entry>\u22121.50</oasis:entry>\n<oasis:entry>0.05 (87)</oasis:entry>\n<oasis:entry>\u22121.43</oasis:entry>\n<oasis:entry>2.55</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t4fn1\">\n<label>a</label>\n<p>Potentials <italic toggle=\"yes\">E</italic>\n<sub>1/2</sub> (<italic toggle=\"yes\">E</italic>\n<sub>1/2</sub> = (<italic toggle=\"yes\">E</italic>\n<sub>pa</sub> + <italic toggle=\"yes\">E</italic>\n<sub>pc</sub>)/2, where <italic toggle=\"yes\">E</italic>\n<sub>pa</sub> and <italic toggle=\"yes\">E</italic>\n<sub>pc</sub> are the anodic and cathodic peak potentials, are given in V and measured at a scan rate of 0.2 V/s in DMSO, using ferrocene as internal standard, and are quoted relative to NHE.</p>\n</fn>\n<fn id=\"t4fn2\">\n<label>b</label>\n<p>\u0394<italic toggle=\"yes\">E</italic>\n<sub>p</sub> values (\u0394<italic toggle=\"yes\">E</italic>\n<sub>p</sub> = <italic toggle=\"yes\">E</italic>\n<sub>pa</sub> \u2212 <italic toggle=\"yes\">E</italic>\n<sub>pc</sub>) are given in mV.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 4. Cyclic Voltammetric Data for 1, 2, 4, and 5\n\n| complex | Ep Os(III/II) | E1/2 Os(IV/III), (\u0394Ep) | Ecalc | pKa (H2azole+) |\n|---------|--------------|-----------------------|-------|----------------|\n| 1       | -1.66        | 0.03 (75)             | -1.41 | 2.64           |\n| 2       | -1.39        | 0.12 (69)             | -1.35 | 1.25           |\n| 4       | -1.78        | -0.03 (72)            | -1.51 | 5.63           |\n| 5       | -1.50        | 0.05 (87)             | -1.43 | 2.55           |\n\na. Potentials E1/2 (E1/2 = (Epa + Epc)/2, where Epa and Epc are the anodic and cathodic peak potentials, are given in V and measured at a scan rate of 0.2 V/s in DMSO, using ferrocene as internal standard, and are quoted relative to NHE.\nb. \u0394Ep values (\u0394Ep = Epa \u2212 Epc) are given in mV.", "data": [[{"meta": {"name": "1", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ep Os(III/II)", "value": "-1.66", "unit": "", "condition": ""}, {"property name": "E1/2 Os(IV/III), (\u0394Ep)", "value": "0.03 (75)", "unit": "", "condition": ""}, {"property name": "Ecalc", "value": "-1.41", "unit": "", "condition": ""}, {"property name": "pKa (H2azole+)", "value": "2.64", "unit": "", "condition": ""}]}, {"meta": {"name": "2", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ep Os(III/II)", "value": "-1.39", "unit": "", "condition": ""}, {"property name": "E1/2 Os(IV/III), (\u0394Ep)", "value": "0.12 (69)", "unit": "", "condition": ""}, {"property name": "Ecalc", "value": "-1.35", "unit": "", "condition": ""}, {"property name": "pKa (H2azole+)", "value": "1.25", "unit": "", "condition": ""}]}, {"meta": {"name": "4", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ep Os(III/II)", "value": "-1.78", "unit": "", "condition": ""}, {"property name": "E1/2 Os(IV/III), (\u0394Ep)", "value": "-0.03 (72)", "unit": "", "condition": ""}, {"property name": "Ecalc", "value": "-1.51", "unit": "", "condition": ""}, {"property name": "pKa (H2azole+)", "value": "5.63", "unit": "", "condition": ""}]}, {"meta": {"name": "5", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "Ep Os(III/II)", "value": "-1.50", "unit": "", "condition": ""}, {"property name": "E1/2 Os(IV/III), (\u0394Ep)", "value": "0.05 (87)", "unit": "", "condition": ""}, {"property name": "Ecalc", "value": "-1.43", "unit": "", "condition": ""}, {"property name": "pKa (H2azole+)", "value": "2.55", "unit": "", "condition": ""}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 4. Cyclic Voltammetric Data for 1, 2, 4, and 5\n\n| complex | Ep Os(III/II) | E1/2 Os(IV/III), (\u0394Ep) | Ecalc | pKa (H2azole+) |\n|---------|--------------|-----------------------|-------|----------------|\n| 1       | -1.66        | 0.03 (75)             | -1.41 | 2.64           |\n| 2       | -1.39        | 0.12 (69)             | -1.35 | 1.25           |\n| 4       | -1.78        | -0.03 (72)            | -1.51 | 5.63           |\n| 5       | -1.50        | 0.05 (87)             | -1.43 | 2.55           |\n\na. Potentials E1/2 (E1/2 = (Epa + Epc)/2, where Epa and Epc are the anodic and cathodic peak potentials, are given in V and measured at a scan rate of 0.2 V/s in DMSO, using ferrocene as internal standard, and are quoted relative to NHE.\nb. \u0394Ep values (\u0394Ep = Epa \u2212 Epc) are given in mV.\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ep Os(III/II)\",\n                \"value\": \"-1.66\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"E1/2 Os(IV/III), (\u0394Ep)\",\n                \"value\": \"0.03 (75)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"Ecalc\",\n                \"value\": \"-1.41\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"pKa (H2azole+)\",\n                \"value\": \"2.64\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ep Os(III/II)\",\n                \"value\": \"-1.39\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"E1/2 Os(IV/III), (\u0394Ep)\",\n                \"value\": \"0.12 (69)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"Ecalc\",\n                \"value\": \"-1.35\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"pKa (H2azole+)\",\n                \"value\": \"1.25\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"4\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ep Os(III/II)\",\n                \"value\": \"-1.78\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"E1/2 Os(IV/III), (\u0394Ep)\",\n                \"value\": \"-0.03 (72)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"Ecalc\",\n                \"value\": \"-1.51\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"pKa (H2azole+)\",\n                \"value\": \"5.63\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"5\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Ep Os(III/II)\",\n                \"value\": \"-1.50\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"E1/2 Os(IV/III), (\u0394Ep)\",\n                \"value\": \"0.05 (87)\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"Ecalc\",\n                \"value\": \"-1.43\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n            {\n                \"property name\": \"pKa (H2azole+)\",\n                \"value\": \"2.55\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 65, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<title>Cytotoxicity of Six Osmium(IV) Complexes in Three Human Cancer Cell Lines</title>\n</caption>\n<oasis:table>\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\" nameend=\"col4\" namest=\"col2\" rowsep=\"1\">IC<sub>50</sub> (\u03bcM)<xref rid=\"t5fn1\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry align=\"center\">compound</oasis:entry>\n<oasis:entry align=\"center\">CH1</oasis:entry>\n<oasis:entry align=\"center\">A549</oasis:entry>\n<oasis:entry align=\"center\">SW480</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>\n<bold>6</bold>\n</oasis:entry>\n<oasis:entry>26 \u00b1 6</oasis:entry>\n<oasis:entry>77 \u00b1 20</oasis:entry>\n<oasis:entry>18 \u00b1 3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>7</bold>\n</oasis:entry>\n<oasis:entry>73 \u00b1 24</oasis:entry>\n<oasis:entry>247 \u00b1 29</oasis:entry>\n<oasis:entry>114 \u00b1 5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>8</bold>\n</oasis:entry>\n<oasis:entry>160 \u00b1 55</oasis:entry>\n<oasis:entry>453 \u00b1 15</oasis:entry>\n<oasis:entry>391 \u00b1 16</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>9</bold>\n</oasis:entry>\n<oasis:entry>142 \u00b1 20</oasis:entry>\n<oasis:entry>229 \u00b1 27</oasis:entry>\n<oasis:entry>105 \u00b1 3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>10</bold>\n</oasis:entry>\n<oasis:entry>148 \u00b1 75</oasis:entry>\n<oasis:entry>329 \u00b1 126</oasis:entry>\n<oasis:entry>163 \u00b1 60</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<bold>11</bold>\n</oasis:entry>\n<oasis:entry>151 \u00b1 28</oasis:entry>\n<oasis:entry>434 \u00b1 10</oasis:entry>\n<oasis:entry>322 \u00b1 79</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t5fn1\">\n<label>a</label>\n<p>50% inhibitory concentrations (means \u00b1 standard deviation), as obtained by the MTT assay (continuous exposure for 96 h).</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 5. Cytotoxicity of Six Osmium(IV) Complexes in Three Human Cancer Cell Lines\n\n| compound | IC<sub>50</sub> (\u03bcM)[^a] CH1 | IC<sub>50</sub> (\u03bcM)[^a] A549 | IC<sub>50</sub> (\u03bcM)[^a] SW480 |\n|----------|----------------------------|-------------------------------|-------------------------------|\n| 6        | 26 \u00b1 6                     | 77 \u00b1 20                       | 18 \u00b1 3                        |\n| 7        | 73 \u00b1 24                    | 247 \u00b1 29                      | 114 \u00b1 5                       |\n| 8        | 160 \u00b1 55                   | 453 \u00b1 15                      | 391 \u00b1 16                      |\n| 9        | 142 \u00b1 20                   | 229 \u00b1 27                      | 105 \u00b1 3                       |\n| 10       | 148 \u00b1 75                   | 329 \u00b1 126                     | 163 \u00b1 60                      |\n| 11       | 151 \u00b1 28                   | 434 \u00b1 10                      | 322 \u00b1 79                      |\n\n[^a]: 50% inhibitory concentrations (means \u00b1 standard deviation), as obtained by the MTT assay (continuous exposure for 96 h).", "data": [[{"meta": {"name": "Osmium(IV) Complex", "symbol": "6", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "26 \u00b1 6", "unit": "\u03bcM", "condition": "CH1"}, {"property name": "IC50", "value": "77 \u00b1 20", "unit": "\u03bcM", "condition": "A549"}, {"property name": "IC50", "value": "18 \u00b1 3", "unit": "\u03bcM", "condition": "SW480"}]}, {"meta": {"name": "Osmium(IV) Complex", "symbol": "7", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "73 \u00b1 24", "unit": "\u03bcM", "condition": "CH1"}, {"property name": "IC50", "value": "247 \u00b1 29", "unit": "\u03bcM", "condition": "A549"}, {"property name": "IC50", "value": "114 \u00b1 5", "unit": "\u03bcM", "condition": "SW480"}]}, {"meta": {"name": "Osmium(IV) Complex", "symbol": "8", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "160 \u00b1 55", "unit": "\u03bcM", "condition": "CH1"}, {"property name": "IC50", "value": "453 \u00b1 15", "unit": "\u03bcM", "condition": "A549"}, {"property name": "IC50", "value": "391 \u00b1 16", "unit": "\u03bcM", "condition": "SW480"}]}, {"meta": {"name": "Osmium(IV) Complex", "symbol": "9", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "142 \u00b1 20", "unit": "\u03bcM", "condition": "CH1"}, {"property name": "IC50", "value": "229 \u00b1 27", "unit": "\u03bcM", "condition": "A549"}, {"property name": "IC50", "value": "105 \u00b1 3", "unit": "\u03bcM", "condition": "SW480"}]}, {"meta": {"name": "Osmium(IV) Complex", "symbol": "10", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "148 \u00b1 75", "unit": "\u03bcM", "condition": "CH1"}, {"property name": "IC50", "value": "329 \u00b1 126", "unit": "\u03bcM", "condition": "A549"}, {"property name": "IC50", "value": "163 \u00b1 60", "unit": "\u03bcM", "condition": "SW480"}]}, {"meta": {"name": "Osmium(IV) Complex", "symbol": "11", "chemical formula": ""}, "etc": [{"property name": "IC50", "value": "151 \u00b1 28", "unit": "\u03bcM", "condition": "CH1"}, {"property name": "IC50", "value": "434 \u00b1 10", "unit": "\u03bcM", "condition": "A549"}, {"property name": "IC50", "value": "322 \u00b1 79", "unit": "\u03bcM", "condition": "SW480"}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 5. Cytotoxicity of Six Osmium(IV) Complexes in Three Human Cancer Cell Lines\n\n| compound | IC<sub>50</sub> (\u03bcM)[^a] CH1 | IC<sub>50</sub> (\u03bcM)[^a] A549 | IC<sub>50</sub> (\u03bcM)[^a] SW480 |\n|----------|----------------------------|-------------------------------|-------------------------------|\n| 6        | 26 \u00b1 6                     | 77 \u00b1 20                       | 18 \u00b1 3                        |\n| 7        | 73 \u00b1 24                    | 247 \u00b1 29                      | 114 \u00b1 5                       |\n| 8        | 160 \u00b1 55                   | 453 \u00b1 15                      | 391 \u00b1 16                      |\n| 9        | 142 \u00b1 20                   | 229 \u00b1 27                      | 105 \u00b1 3                       |\n| 10       | 148 \u00b1 75                   | 329 \u00b1 126                     | 163 \u00b1 60                      |\n| 11       | 151 \u00b1 28                   | 434 \u00b1 10                      | 322 \u00b1 79                      |\n\n[^a]: 50% inhibitory concentrations (means \u00b1 standard deviation), as obtained by the MTT assay (continuous exposure for 96 h).\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Osmium(IV) Complex\",\n            \"symbol\": \"6\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"26 \u00b1 6\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"CH1\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"77 \u00b1 20\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"18 \u00b1 3\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"SW480\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"Osmium(IV) Complex\",\n            \"symbol\": \"7\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"73 \u00b1 24\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"CH1\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"247 \u00b1 29\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"114 \u00b1 5\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"SW480\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"Osmium(IV) Complex\",\n            \"symbol\": \"8\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"160 \u00b1 55\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"CH1\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"453 \u00b1 15\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"391 \u00b1 16\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"SW480\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"Osmium(IV) Complex\",\n            \"symbol\": \"9\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"142 \u00b1 20\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"CH1\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"229 \u00b1 27\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"105 \u00b1 3\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"SW480\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"Osmium(IV) Complex\",\n            \"symbol\": \"10\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"148 \u00b1 75\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"CH1\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"329 \u00b1 126\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"163 \u00b1 60\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"SW480\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"Osmium(IV) Complex\",\n            \"symbol\": \"11\",\n            \"chemical formula\": \"\",\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"151 \u00b1 28\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"CH1\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"434 \u00b1 10\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"A549\",\n            },\n            {\n                \"property name\": \"IC50\",\n                \"value\": \"322 \u00b1 79\",\n                \"unit\": \"\u03bcM\",\n                \"condition\": \"SW480\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig fig-type=\"chart\" id=\"cht1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Compounds Reported in This Work<xref rid=\"c1fn1\"></xref>\n</title>\n</caption>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0002.tif\"></graphic>\n<p>\n<fn id=\"c1fn1\">\n<label>a</label>\n<p>Underlined complexes have been characterized by X-ray crystallography; atom labeling was introduced for assignments of resonances in NMR spectra.</p>\n</fn>\n</p>\n</fig>", "clean_text": " 1  Compounds Reported in This Work      a Underlined complexes have been characterized by X-ray crystallography; atom labeling was introduced for assignments of resonances in NMR spectra.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 39, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>ORTEP view of the [Os<sup>IV</sup>Cl<sub>5</sub>(Hpz)]<sup>\u2212</sup> anion involved in hydrogen bonding interactions with the adjacent complex anion in <bold>1</bold>, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (\u2212<italic toggle=\"yes\">x</italic> + 2, \u2212<italic toggle=\"yes\">y</italic> + 2, \u2212<italic toggle=\"yes\">z</italic> + 1). Hydrogen bonding parameters: N2\u2212H\u00b7\u00b7\u00b7Cl3 and N2\u2212H\u00b7\u00b7\u00b7Cl4<sup>i</sup> (N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl3 2.580, N2\u00b7\u00b7\u00b7Cl3 3.093 \u00c5, N2HCl3 118.04\u00b0, H\u00b7\u00b7\u00b7Cl4<sup>i</sup> 2.693, N2\u00b7\u00b7\u00b7Cl4<sup>i</sup> 3.296 \u00c5, N2HCl4<sup>i</sup> 126.71\u00b0).</p>\n</caption>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0003.tif\"></graphic>\n</fig>", "clean_text": " 1  ORTEP view of the [OsIVCl5(Hpz)]- anion involved in hydrogen bonding interactions with the adjacent complex anion in 1, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (-x + 2, -y + 2, -z + 1). Hydrogen bonding parameters: N2-H\u22c5\u22c5\u22c5Cl3 and N2-H\u22c5\u22c5\u22c5Cl4i (N2-H 0.88, H\u22c5\u22c5\u22c5Cl3 2.580, N2\u22c5\u22c5\u22c5Cl3 3.093 \u00c5, N2HCl3 118.04\u00b0, H\u22c5\u22c5\u22c5Cl4i 2.693, N2\u22c5\u22c5\u22c5Cl4i 3.296 \u00c5, N2HCl4i 126.71\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 41, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>ORTEP view of the [Os<sup>IV</sup>Cl<sub>5</sub>(Hind)]<sup>\u2212</sup> anion involved in hydrogen bonding interactions with the adjacent complex anion in <bold>2</bold>, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (\u2212<italic toggle=\"yes\">x</italic> + 1, \u2212<italic toggle=\"yes\">y</italic> + 1, \u2212<italic toggle=\"yes\">z</italic> + 1). Hydrogen bonding parameters: N2\u2212H\u00b7\u00b7\u00b7Cl1<sup>i</sup> (N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl1<sup>i</sup> 2.611, N2\u00b7\u00b7\u00b7Cl1<sup>i</sup> 3.354 \u00c5, N2HCl1<sup>i</sup> 142.81\u00b0).</p>\n</caption>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0004.tif\"></graphic>\n</fig>", "clean_text": " 2  ORTEP view of the [OsIVCl5(Hind)]- anion involved in hydrogen bonding interactions with the adjacent complex anion in 2, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level. Atoms marked i are at the symmetry positions (-x + 1, -y + 1, -z + 1). Hydrogen bonding parameters: N2-H\u22c5\u22c5\u22c5Cl1i (N2-H 0.88, H\u22c5\u22c5\u22c5Cl1i 2.611, N2\u22c5\u22c5\u22c5Cl1i 3.354 \u00c5, N2HCl1i 142.81\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 42, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>ORTEP view of the [Os<sup>IV</sup>Cl<sub>5</sub>(Him)]<sup>\u2212</sup> anion (a) in <bold>3</bold>, the [Os<sup>IV</sup>Cl<sub>5</sub>(Hbzim)]<sup>\u2212</sup> anion (b) in <bold>4</bold>\u00b7CH<sub>3</sub>OH, and of the two crystallographically independent [Os<sup>IV</sup>Cl<sub>5</sub>(Htrz)]<sup>\u2212</sup> anions (c) in <bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level.</p>\n</caption>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0005.tif\"></graphic>\n</fig>", "clean_text": " 3  ORTEP view of the [OsIVCl5(Him)]- anion (a) in 3, the [OsIVCl5(Hbzim)]- anion (b) in 4\u22c5CH3OH, and of the two crystallographically independent [OsIVCl5(Htrz)]- anions (c) in 5\u22c5C2H5OH, showing the atom-numbering schemes. Thermal ellipsoids are drawn at 50% probability level.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 43, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Part of the crystal structure of <bold>3</bold>, showing the 1D arrangement of osmium(IV) complexes via intermolecular hydrogen-bonding interactions. Atoms marked i are at the symmetry positions (<italic toggle=\"yes\">x</italic> \u2212 0.5, \u2212<italic toggle=\"yes\">y</italic> + 0.5, <italic toggle=\"yes\">z</italic> \u2212 0.5). Hydrogen-bonding parameters: N2\u2212H\u00b7\u00b7\u00b7Cl1<sup>i</sup> and N2\u2212H\u00b7\u00b7\u00b7Cl5<sup>i</sup> (N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl1<sup>i</sup> 2.652, N2\u00b7\u00b7\u00b7Cl1<sup>i</sup> 3.340 \u00c5, N2HCl1<sup>i</sup> 135.78; H\u00b7\u00b7\u00b7Cl5<sup>i</sup> 2.679, N2\u00b7\u00b7\u00b7Cl5<sup>i</sup> 3.380 \u00c5, N2HCl5<sup>i</sup> 137.44\u00b0).</p>\n</caption>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0006.tif\"></graphic>\n</fig>", "clean_text": " 4  Part of the crystal structure of 3, showing the 1D arrangement of osmium(IV) complexes via intermolecular hydrogen-bonding interactions. Atoms marked i are at the symmetry positions (x - 0.5, -y + 0.5, z - 0.5). Hydrogen-bonding parameters: N2-H\u22c5\u22c5\u22c5Cl1i and N2-H\u22c5\u22c5\u22c5Cl5i (N2-H 0.88, H\u22c5\u22c5\u22c5Cl1i 2.652, N2\u22c5\u22c5\u22c5Cl1i 3.340 \u00c5, N2HCl1i 135.78; H\u22c5\u22c5\u22c5Cl5i 2.679, N2\u22c5\u22c5\u22c5Cl5i 3.380 \u00c5, N2HCl5i 137.44\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 44, "type": "figure", "classification": null, "content": "<fig id=\"fig5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Part of the crystal structure of <bold>4</bold>\u00b7CH<sub>3</sub>OH,, showing the intermolecular hydrogen-bonding interactions between complex anions and solvent molecules. Atoms marked i are at the symmetry positions (\u2212<italic toggle=\"yes\">x +</italic> 1, \u2212<italic toggle=\"yes\">y</italic> + 2, \u2212<italic toggle=\"yes\">z</italic> + 1). Hydrogen-bonding parameters: N2\u2212H\u00b7\u00b7\u00b7O1 (N2\u2212H 0.88, H\u00b7\u00b7\u00b7O1 1.886, N2\u00b7\u00b7\u00b7O1 2.763 \u00c5, N2HO1 174.08\u00b0) and O1\u2212H\u00b7\u00b7\u00b7Cl2<sup>i</sup> and O1\u2212H\u00b7\u00b7\u00b7Cl5<sup>i</sup> (O1\u2212H 0.84, H\u00b7\u00b7\u00b7Cl2<sup>i</sup> 2.829, O1\u00b7\u00b7\u00b7Cl2<sup>i</sup> 3.473 \u00c5, O1HCl2<sup>i</sup> 134.90; H\u00b7\u00b7\u00b7Cl5<sup>i</sup> 2.507, O1\u00b7\u00b7\u00b7Cl5<sup>i</sup> 3.235 \u00c5, O1HCl5<sup>i</sup> 145.44\u00b0).</p>\n</caption>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0007.tif\"></graphic>\n</fig>", "clean_text": " 5  Part of the crystal structure of 4\u22c5CH3OH,, showing the intermolecular hydrogen-bonding interactions between complex anions and solvent molecules. Atoms marked i are at the symmetry positions (-x + 1, -y + 2, -z + 1). Hydrogen-bonding parameters: N2-H\u22c5\u22c5\u22c5O1 (N2-H 0.88, H\u22c5\u22c5\u22c5O1 1.886, N2\u22c5\u22c5\u22c5O1 2.763 \u00c5, N2HO1 174.08\u00b0) and O1-H\u22c5\u22c5\u22c5Cl2i and O1-H\u22c5\u22c5\u22c5Cl5i (O1-H 0.84, H\u22c5\u22c5\u22c5Cl2i 2.829, O1\u22c5\u22c5\u22c5Cl2i 3.473 \u00c5, O1HCl2i 134.90; H\u22c5\u22c5\u22c5Cl5i 2.507, O1\u22c5\u22c5\u22c5Cl5i 3.235 \u00c5, O1HCl5i 145.44\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 46, "type": "figure", "classification": null, "content": "<fig id=\"fig6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Part of the crystal structure of <bold>5</bold>\u00b7C<sub>2</sub>H<sub>5</sub>OH, showing the 1D arrangement of osmium(IV) complexes via strong intermolecular hydrogen-bonding interactions. Atoms marked i and ii are at the symmetry positions (<italic toggle=\"yes\">x</italic>, <italic toggle=\"yes\">y</italic> + 1, <italic toggle=\"yes\">z</italic>) and (<italic toggle=\"yes\">x</italic> + 1, <italic toggle=\"yes\">y</italic> \u2212 1, <italic toggle=\"yes\">z</italic>), respectively. Hydrogen-bonding parameters: N3\u2212H\u00b7\u00b7\u00b7N5<sup>i</sup> (N3\u2212H 0.88, H\u00b7\u00b7\u00b7N5<sup>i</sup> 1.920, N3\u00b7\u00b7\u00b7N5<sup>i</sup> 2.792 \u00c5, N3HN5 170.39\u00b0), N6<sup>ii</sup>\u2212H\u00b7\u00b7\u00b7N2, and N6<sup>ii</sup>\u2212H\u00b7\u00b7\u00b7Cl2 (N6<sup>ii</sup>\u2212H 0.88, H\u00b7\u00b7\u00b7N2 1.918, N6<sup>ii</sup>\u00b7\u00b7\u00b7N2 2.785 \u00c5, N6<sup>ii</sup>HN2 168.0\u00b0; H\u00b7\u00b7\u00b7Cl2 2.926, N6<sup>ii</sup>\u00b7\u00b7\u00b7Cl2 3.344 \u00c5, N6<sup>ii</sup>HCl2 111.03\u00b0).</p>\n</caption>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0008.tif\"></graphic>\n</fig>", "clean_text": " 6  Part of the crystal structure of 5\u22c5C2H5OH, showing the 1D arrangement of osmium(IV) complexes via strong intermolecular hydrogen-bonding interactions. Atoms marked i and ii are at the symmetry positions (x, y + 1, z) and (x + 1, y - 1, z), respectively. Hydrogen-bonding parameters: N3-H\u22c5\u22c5\u22c5N5i (N3-H 0.88, H\u22c5\u22c5\u22c5N5i 1.920, N3\u22c5\u22c5\u22c5N5i 2.792 \u00c5, N3HN5 170.39\u00b0), N6ii-H\u22c5\u22c5\u22c5N2, and N6ii-H\u22c5\u22c5\u22c5Cl2 (N6ii-H 0.88, H\u22c5\u22c5\u22c5N2 1.918, N6ii\u22c5\u22c5\u22c5N2 2.785 \u00c5, N6iiHN2 168.0\u00b0; H\u22c5\u22c5\u22c5Cl2 2.926, N6ii\u22c5\u22c5\u22c5Cl2 3.344 \u00c5, N6iiHCl2 111.03\u00b0).   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 48, "type": "figure", "classification": null, "content": "<fig id=\"fig7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<caption>\n<p>Projection of a part of the crystal structure of [Na(H<sub>2</sub>O)<sub>2</sub>OsCl<sub>5</sub>(Hpz)]<sub>\n<italic toggle=\"yes\">n</italic>\n</sub> on the <italic toggle=\"yes\">ac</italic> plane of the unit cell, showing the formation of an infinite 1D chain in <bold>6</bold>\u00b72H<sub>2</sub>O.</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0009.tif\"></graphic>\n</fig>", "clean_text": " 7  Projection of a part of the crystal structure of [Na(H2O)2OsCl5(Hpz)] n  on the ac plane of the unit cell, showing the formation of an infinite 1D chain in 6\u22c52H2O.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 50, "type": "figure", "classification": null, "content": "<fig id=\"fig8\" orientation=\"portrait\" position=\"float\">\n<label>8</label>\n<caption>\n<p>ORTEP view of the fragment of the crystal structure of <bold>12</bold>, showing intra- and intermolecular hydrogen bonding interactions between the complex <italic toggle=\"yes\">trans</italic>-[Os<sup>IV</sup>Cl<sub>4</sub>(Him)<sub>2</sub>] and the complex anion [Os<sup>IV</sup>Cl<sub>6</sub>]<sup>2\u2212</sup> with atom-numbering scheme. The thermal displacement ellipsoids are drawn at 50% probability level. Hydrogen bonding parameters: Cl1\u00b7\u00b7\u00b7H\u2212C1 [Cl1\u00b7\u00b7\u00b7H 2.565, Cl1\u00b7\u00b7\u00b7C1 3.117, H\u2212C1 0.95 \u00c5, Cl1HC1 117.2\u00b0], Cl1\u00b7\u00b7\u00b7H\u2212C3<sup>i</sup> [Cl1\u00b7\u00b7\u00b7H 2.737, Cl1\u00b7\u00b7\u00b7C3<sup>i</sup> 3.216, H\u2212C3<sup>i</sup> 0.95 \u00c5, Cl1HC3<sup>i</sup> 112.1\u00b0], C1\u2212H\u00b7\u00b7\u00b7Cl6<sup>ii</sup> [C1\u2212H 0.95, H\u00b7\u00b7\u00b7Cl6<sup>ii</sup> 2.671, C1\u00b7\u00b7\u00b7Cl6<sup>ii</sup> 3.395 \u00c5, C1HCl6<sup>ii</sup> 133.4\u00b0], N2\u2212H\u00b7\u00b7\u00b7Cl3<sup>ii</sup> and N2\u2212H\u00b7\u00b7\u00b7Cl8<sup>ii</sup> [N2\u2212H 0.88, H\u00b7\u00b7\u00b7Cl3<sup>ii</sup> 2.471, N2\u00b7\u00b7\u00b7Cl3<sup>ii</sup> 3.314 \u00c5, N2HCl3<sup>ii</sup> 160.64\u00b0; H\u00b7\u00b7\u00b7Cl8<sup>ii</sup> 2.925, N2\u00b7\u00b7\u00b7Cl8<sup>ii</sup> 3.491 \u00c5, N2HCl8<sup>ii</sup> 123.77\u00b0]. Atoms marked i are at the symmetry positions <italic toggle=\"yes\">x</italic> + 2, <italic toggle=\"yes\">y</italic> + 1, <italic toggle=\"yes\">z</italic> + 2, and those marked ii at the symmetry positions <italic toggle=\"yes\">x</italic> + 1, <italic toggle=\"yes\">y</italic> + 1, <italic toggle=\"yes\">z</italic> + 1.</p>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0010.tif\"></graphic>\n</fig>", "clean_text": " 8  ORTEP view of the fragment of the crystal structure of 12, showing intra- and intermolecular hydrogen bonding interactions between the complex trans-[OsIVCl4(Him)2] and the complex anion [OsIVCl6]2- with atom-numbering scheme. The thermal displacement ellipsoids are drawn at 50% probability level. Hydrogen bonding parameters: Cl1\u22c5\u22c5\u22c5H-C1 [Cl1\u22c5\u22c5\u22c5H 2.565, Cl1\u22c5\u22c5\u22c5C1 3.117, H-C1 0.95 \u00c5, Cl1HC1 117.2\u00b0], Cl1\u22c5\u22c5\u22c5H-C3i [Cl1\u22c5\u22c5\u22c5H 2.737, Cl1\u22c5\u22c5\u22c5C3i 3.216, H-C3i 0.95 \u00c5, Cl1HC3i 112.1\u00b0], C1-H\u22c5\u22c5\u22c5Cl6ii [C1-H 0.95, H\u22c5\u22c5\u22c5Cl6ii 2.671, C1\u22c5\u22c5\u22c5Cl6ii 3.395 \u00c5, C1HCl6ii 133.4\u00b0], N2-H\u22c5\u22c5\u22c5Cl3ii and N2-H\u22c5\u22c5\u22c5Cl8ii [N2-H 0.88, H\u22c5\u22c5\u22c5Cl3ii 2.471, N2\u22c5\u22c5\u22c5Cl3ii 3.314 \u00c5, N2HCl3ii 160.64\u00b0; H\u22c5\u22c5\u22c5Cl8ii 2.925, N2\u22c5\u22c5\u22c5Cl8ii 3.491 \u00c5, N2HCl8ii 123.77\u00b0]. Atoms marked i are at the symmetry positions x + 2, y + 1, z + 2, and those marked ii at the symmetry positions x + 1, y + 1, z + 1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 60, "type": "figure", "classification": null, "content": "<fig id=\"fig9\" orientation=\"portrait\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Cyclic voltammogram of 0.2 M <bold>1</bold> in DMSO at a carbon disk working electrode and a scan rate of 0.2 V/s, starting the scan in cathodic direction.</p>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0011.tif\"></graphic>\n</fig>", "clean_text": " 9  Cyclic voltammogram of 0.2 M 1 in DMSO at a carbon disk working electrode and a scan rate of 0.2 V/s, starting the scan in cathodic direction.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 61, "type": "figure", "classification": null, "content": "<fig id=\"fig10\" orientation=\"portrait\" position=\"float\">\n<label>10</label>\n<caption>\n<p>UV\u2212vis spectra of an aqueous solution of <bold>9</bold>, measured immediately after dissolution of the sample and 24 h thereafter.</p>\n</caption>\n<graphic id=\"gr11\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0014.tif\"></graphic>\n</fig>", "clean_text": " 10  UV-vis spectra of an aqueous solution of 9, measured immediately after dissolution of the sample and 24 h thereafter.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 66, "type": "figure", "classification": null, "content": "<fig id=\"fig11\" orientation=\"portrait\" position=\"float\">\n<label>11</label>\n<caption>\n<p>Concentration-effect curves of six osmium(IV) complexes in the human cancer cell lines CH1 (A), A549 (B), and SW480 (C), as obtained by the MTT assay (continuous exposure for 96 h).</p>\n</caption>\n<graphic id=\"gr12\" orientation=\"portrait\" position=\"anchor\" xlink:href=\"ic-2009-01671j_0012.tif\"></graphic>\n</fig>", "clean_text": " 11  Concentration-effect curves of six osmium(IV) complexes in the human cancer cell lines CH1 (A), A549 (B), and SW480 (C), as obtained by the MTT assay (continuous exposure for 96 h).   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/ic901671j", "title": "\n[OsIVCl5(Hazole)]\u2212 Complexes: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity\n", "journal": "American Chemical Society", "date": "2009.10", "author_list": ["Bu\u0308chel\nGabriel E.", "Stepanenko\nIryna N.", "Hejl\nMichaela", "Jakupec\nMichael A.", "Arion\nVladimir B.", "Keppler\nBernhard K."]}}